Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGRP,Agouti-related protein,42296,0.298317385675172,0.0049486379868919,0.288618055220864,0.30801671612948,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL27,C-C motif chemokine 27,42145,0.267884447854846,0.00632746565462618,0.255482615171779,0.280286280537914,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN1,CCN family member 1,42047,0.37805721445153,0.00700999585226042,0.364317622581099,0.39179680632196,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES1,Liver carboxylesterase 1,42163,0.354187084568251,0.00864391546103632,0.33724501026462,0.371129158871882,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCG,Pro-glucagon,41843,0.521603078735535,0.0126298363939365,0.49684859940342,0.546357558067651,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHR,Growth hormone receptor,39736,0.115361082388168,0.002851884376139,0.109771389010936,0.1209507757654,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF9,Protein turtle homolog A,39958,0.352919170168814,0.00868686077479285,0.33589292305022,0.369945417287408,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LDLR,Low-density lipoprotein receptor,42170,0.418082733938985,0.00417287236663307,0.409903904100384,0.426261563777585,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPL,Lipoprotein lipase,42145,-0.202972608798137,0.00488111891121208,-0.212539601864113,-0.193405615732161,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFGE8,Lactadherin,42137,0.268823054849996,0.004310882592359,0.260373724968973,0.27727238473102,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPY,Pro-neuropeptide Y,42262,0.369099896461561,0.00607703869145511,0.357188900626309,0.381010892296813,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.13239274333109,0.00327885392579641,0.125966189636529,0.138819297025651,0
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0854188055798144,0.00219890775903537,0.0811089463721051,0.0897286647875238,1.13351406779437e-308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTH,Parathyroid hormone,39649,0.326806985078162,0.00844864281588607,0.310247645159026,0.343366324997299,4.24079774612493e-307
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.125483019985302,0.00331602056613682,0.118983619675673,0.13198242029493,4.32265798017371e-298
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.295524822547066,0.00783942061679743,0.280159558138143,0.310890086955989,4.3687565953331e-293
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F7,Coagulation factor VII,42194,0.118237803286328,0.00318691128585162,0.111991457166059,0.124484149406597,4.32048073176354e-287
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,42230,0.18387124165282,0.00496748484216037,0.174134971362185,0.193607511943454,7.24824293967577e-286
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FURIN,Furin,42181,0.124710822324423,0.00339829257122504,0.118050168884822,0.131371475764024,3.32680354199047e-281
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.160885794847818,0.00440548763696691,0.152251039079363,0.169520550616273,1.1921922001493e-278
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRAP1,Proline-rich acidic protein 1,39966,0.143531519981638,0.00400163496969776,0.135688315441031,0.151374724522246,5.18315427796385e-267
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.295125426172186,0.00843279740407624,0.278597143260196,0.311653709084175,9.01268062875531e-257
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C9,Complement component C9,39990,-0.206872091803219,0.0059079944742482,-0.218451760972745,-0.195292422633692,3.27183399440515e-255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD4,T-cell surface glycoprotein CD4,42100,0.103955109120986,0.00300432845179026,0.0980666253554769,0.109843592886495,1.92179023225325e-251
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.299478292803169,0.0086920131126398,0.282441947102395,0.316514638503943,3.25379948675409e-249
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.52022212958637,0.0151280069434459,0.490571235977216,0.549873023195524,2.31400203659411e-248
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.29815985777382,0.00884225133886823,0.280829045149638,0.315490670398002,2.27565778647374e-239
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLTP,Phospholipid transfer protein,42267,-0.12947315405478,0.00392744113134043,-0.137170938672207,-0.121775369437353,2.10334332802487e-229
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INHBC,Inhibin beta C chain,42137,0.135975744586642,0.00412592929102222,0.127888923176239,0.144062565997046,3.43251022284273e-229
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCHE,Cholinesterase,39806,0.091044203691461,0.00277564442272415,0.0856039406229217,0.0964844667600004,2.08916216942438e-225
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APCS,Serum amyloid P-component,39870,0.110154004977168,0.00336286334950499,0.103562792812139,0.116745217142198,7.08032338556684e-225
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.20492811892082,0.00628420214483714,-0.217245155124701,-0.192611082716939,1.04427576744159e-224
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.113023071369563,0.00347274546136661,0.106216490265284,0.119829652473841,7.55319382472886e-224
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.268448722128328,0.00831066807707588,0.25215981269726,0.284737631559397,1.52734030522521e-220
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC39A5,Zinc transporter ZIP5,42119,0.178127062349941,0.00552086931203606,0.167306158498351,0.188947966201532,4.38756225136437e-220
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADIPOQ,Adiponectin,39979,-0.229767394902418,0.007121403419658,-0.243725345604948,-0.215809444199889,1.29920605259876e-218
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL23,C-C motif chemokine 23,42185,0.141057112261136,0.0043950579870592,0.1324427986065,0.149671425915772,6.47628797287994e-218
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROC,Vitamin K-dependent protein C,42199,0.0848544566422651,0.00266979229130943,0.0796216637512986,0.0900872495332316,6.6711944223366e-214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR37,Prosaposin receptor GPR37,41900,0.21521732783824,0.0067789746336002,0.201930537556384,0.228504118120097,2.78698839697254e-213
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.418563577104232,0.0132064638873689,-0.444448246323475,-0.392678907884989,8.40399757659086e-213
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRP1,Neuropilin-1,42230,-0.0885029547883957,0.00284617572042603,-0.0940814592004307,-0.0829244503763607,3.73205583689702e-205
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG2,Desmoglein-2,42137,-0.0866076720136674,0.00282211709730718,-0.0921390215243895,-0.0810763225029454,5.23007516785344e-200
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA5,Plasma serine protease inhibitor,39835,0.0956200367084451,0.00313153679655759,0.0894822245871922,0.101757848829698,8.67110424212756e-197
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.338660263591644,0.0111395432064736,0.316826758906955,0.360493768276332,2.08304841819737e-196
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN3,Contactin-3,42137,0.0897716124385945,0.00295820433224616,0.0839735319473921,0.095569692929797,9.26958428306727e-196
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA4,Kallistatin,39802,0.0739365656970547,0.00243505088474939,0.0691638659629459,0.0787092654311635,1.12730271790422e-194
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFM,Afamin,39979,0.0635111767042967,0.00210142430212932,0.0593923850721233,0.0676299683364702,4.45905349036729e-193
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAT,Tissue-type plasminogen activator,42272,0.160643141202797,0.00534580557325135,0.150165362279224,0.17112092012637,3.57173583222368e-192
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRIP2,Cysteine-rich protein 2,42016,0.114040108006387,0.00380154800081669,0.106589073924786,0.121491142087987,2.00590377168041e-191
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0961606699743557,0.00319879556420885,-0.102430309280205,-0.0898910306685063,5.7759718907477e-191
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.214087927929245,0.00717258412947914,0.200029663035466,0.228146192823024,1.29126375552579e-189
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.18536987064704,0.00626969747797716,0.173081263590205,0.197658477703875,4.2434906172874e-186
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUSB,Beta-glucuronidase,42211,0.18826681661268,0.00638252044520125,0.175757076540086,0.200776556685275,2.00095900342098e-185
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNCA,Alpha-synuclein,39736,0.360209318304383,0.0122684685658413,0.336163119915335,0.384255516693432,1.41670273866042e-182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTR,Transthyretin,39862,0.075888527105966,0.00258662491754202,0.0708187422675837,0.0809583119443484,2.1656985593628e-182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL6,C-X-C motif chemokine 6,42296,0.230922712678514,0.00789985353093346,0.215438999757884,0.246406425599143,2.89399407141806e-182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTA3,Glutathione S-transferase A3,41843,0.235845328309752,0.00807587449264848,0.220016614304161,0.251674042315343,9.40572947137125e-182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0627562554949489,0.00215585762900538,0.0585307745420983,0.0669817364477994,1.37640683841338e-180
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPM,Carboxypeptidase M,42195,0.103353028619603,0.0035564401821575,0.0963824058625742,0.110323651376632,3.42261652208784e-180
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.074244711278075,0.00255500096623279,0.0692369093842587,0.0792525131718912,3.68341423725002e-180
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHMP6,Charged multivesicular body protein 6,39958,0.172507921593316,0.00597388862150886,0.160799099895158,0.184216743291473,5.24846403662817e-177
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACY1,Aminoacylase-1,42145,0.188245658348001,0.0065795428975246,0.175349754268853,0.20114156242715,7.41917068618351e-175
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0580499031356521,0.00202951008231779,0.0540720633743092,0.062027742896995,9.65528277721282e-175
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS15,Enteropeptidase,42070,0.263218827795632,0.00920551238096729,0.245176023528936,0.281261632062328,1.25614024780568e-174
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON3,Serum paraoxonase/lactonase 3,42185,-0.0869846370190645,0.00307710608695756,-0.0930157649495013,-0.0809535090886276,7.11688668255255e-171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GH1,Somatotropin,42129,-0.523655358883437,0.018615294125233,-0.560141335368894,-0.487169382397981,2.94768184261205e-169
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELN,Elastin,39958,0.100924166373518,0.00363007393443457,0.0938092214620258,0.108039111285009,1.22839860261868e-164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTA1,Glutathione S-transferase A1,42119,0.245135148138852,0.00888153348741127,0.227727342503526,0.262542953774178,3.50302713954524e-163
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFH,Complement factor H,39418,0.0668624358082421,0.00245272560941728,0.0620550936137843,0.0716697780027,2.58298863339508e-158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKB,Creatine kinase B-type,39966,-0.16305525235864,0.00601091855308085,-0.174836652722678,-0.151273851994601,4.5056050304865e-157
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,41843,0.316350353467462,0.0117393839966223,0.293341160834083,0.339359546100842,9.23440826532798e-156
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.14672453973939,0.00547503715461861,0.135993466916337,0.157455612562442,3.15227190731177e-154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCS1,Neuronal calcium sensor 1,42262,0.0794903191717275,0.00297307881807982,0.073663084688291,0.0853175536551639,1.52084800147806e-153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASGR1,Asialoglycoprotein receptor 1,42016,0.0853018975696891,0.00318974724185398,0.0790499929756553,0.0915538021637229,1.53989669701978e-153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS3,"Nitric oxide synthase, endothelial",41839,0.14203292232486,0.00532220294133573,0.131601404559842,0.152464440089878,7.12563488314949e-153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL13,C-X-C motif chemokine 13,42249,0.161064561806182,0.006042055108331,0.149222133793853,0.172906989818511,1.15457318285968e-152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAMR1,Inactive serine protease PAMR1,42137,0.0740888665948855,0.00278000160170388,0.0686400634555459,0.0795376697342251,1.46608759701412e-152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFPI,Tissue factor pathway inhibitor,42152,0.0869841426590107,0.00327705071544948,0.0805611232567297,0.0934071620612917,2.19190420861924e-151
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.344796426905956,0.0130289197276734,0.319259744239716,0.370333109572196,1.65278820994653e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.203515924814579,0.00768989111285371,0.188443738233386,0.218588111395772,1.71153662188506e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0911799693903302,0.00344857624807284,0.0844207599441074,0.097939178836553,3.14277798651093e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPB1,Beta-ureidopropionase,39958,0.251676316231407,0.00949911585116566,0.233058049163122,0.270294583299691,3.84868977014799e-150
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORT1,Sortilin,42129,0.105675962762301,0.00400875339095634,0.0978188061160267,0.113533119408576,2.18431609825672e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.200443679009451,0.00760474681700264,0.185538375248126,0.215348982770776,2.5961363170133e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFP,Properdin,39979,0.0655326997228846,0.00248247362854119,0.0606670514109439,0.0703983480348253,4.20362585395117e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KYNU,Kynureninase,42296,0.125794993634604,0.00478311887207886,0.116420080645329,0.135169906623879,9.23681155946826e-149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF21,Fibroblast growth factor 21,42247,0.331311855761483,0.0126340412373353,0.306549134936305,0.35607457658666,6.38337240725722e-148
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL16,C-C motif chemokine 16,42310,0.141436048882484,0.00539857401146409,0.130854843820015,0.152017253944954,1.14767490802874e-147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO3,Beta-enolase,39638,0.17322411899031,0.0065929955300802,0.160301847751353,0.186146390229267,1.24269495526978e-147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.106189161305905,0.0040647091937043,-0.114155991325565,-0.0982223312862443,7.70395418255307e-147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHBG,Sex hormone-binding globulin,39990,-0.127542071797232,0.00491320595711858,-0.137171955473185,-0.11791218812128,2.16445566985218e-144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.090832148766392,0.00352746344217629,-0.0977459771130575,-0.0839183204197265,7.79953329886762e-143
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP5,Retinol-binding protein 5,42070,0.152445825592745,0.00592673474901169,0.140829425484682,0.164062225700808,1.78669286555233e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRP,Gastrin-releasing peptide,39638,0.144420892980173,0.00560635099665426,0.133432445026731,0.155409340933616,3.72991115592185e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFI,Complement factor I,39979,0.0524582603536154,0.00203902495095347,0.0484617714497466,0.0564547492574842,6.3294054270278e-142
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAT2,Linker for activation of T-cells family member 2,42070,0.340568756852775,0.0132892268463118,0.314521872234004,0.366615641471547,1.80253380386893e-141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.189974533427025,0.00746591079276254,0.17534134827321,0.20460771858084,6.07931615632802e-139
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUMB,Protein numb homolog,39657,0.22353811920153,0.00880939871177294,0.206271697726455,0.240804540676605,4.07523957408084e-138
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEG1,Protein HEG homolog 1,39736,0.0733614136260175,0.00289574588015,0.0676857517009235,0.0790370755511115,1.019097265045e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.229932719509809,0.00909897140893395,0.212098735548298,0.247766703471319,4.14433761514972e-137
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.109818978638217,0.0043635140813774,0.101266491038717,0.118371466237717,1.27054151194985e-136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0689057876488817,0.00274061335949211,0.0635341854642772,0.0742773898334863,2.35152688009305e-136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR2,Cadherin-related family member 2,42070,0.174442573708284,0.00694027660920708,0.160839631554238,0.188045515862329,2.79314196544888e-136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINF1,Pigment epithelium-derived factor,39815,0.0693419114664284,0.00276226745968246,0.0639278672454507,0.074755955687406,2.39485669706718e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.180383655819231,0.00720543077381393,0.166261011502556,0.194506300135906,3.4998277722065e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPPC,C-type natriuretic peptide,42119,0.138919245357027,0.00555646982091103,0.128028564508042,0.149809926206013,6.6955092121161e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTYMK,Thymidylate kinase,39958,0.177149382784343,0.00707303236281602,0.163286239353224,0.191012526215462,8.48163967960262e-135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTSS1,Protein MTSS 1,39930,0.293334924027109,0.0117240680396743,0.270355750669348,0.316314097384871,1.59931758740675e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0578854398303235,0.00231818956563863,0.0533417882816718,0.0624290913789752,5.99137638064492e-134
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.173012837477831,0.00694242012143529,0.159405694039818,0.186619980915845,1.6307445354736e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0514444786030265,0.00207128125772374,0.0473847673378879,0.055504189868165,3.13595855714885e-133
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0830671881453715,0.00335111334269046,0.0764990059936982,0.0896353702970449,1.02447525338695e-132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,39657,0.225920201565361,0.00912153208601633,0.208041998676769,0.243798404453953,7.50691718719189e-132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F9,Coagulation factor IX,42199,0.0475578187087602,0.00193422468568693,0.0437667383248138,0.0513488990927066,1.1981306407322e-130
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROS1,Vitamin K-dependent protein S,39979,0.0657625720373721,0.0026725249941391,0.0605244230488595,0.0710007210258848,2.61625405025846e-130
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATRN,"Attractin, Isoform 2",39979,0.0431038483460622,0.00175358890367118,0.0396668140948667,0.0465408825972577,4.86788049106958e-130
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KDR,Vascular endothelial growth factor receptor 2,42181,0.0646494369564845,0.00264776661306838,0.0594598143948704,0.0698390595180985,6.71555871975843e-129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.167910253262186,0.00689269289436447,0.154400575189232,0.181419931335141,2.91127821852968e-128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOMO1,Nodal modulator 1,42137,0.0598162841287346,0.00245729063193752,0.0549999944901371,0.0646325737673322,3.8892626804154e-128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL2,Angiopoietin-related protein 2,42140,0.101530203778439,0.00417855620643441,0.0933402336138275,0.10972017394305,1.09634069825176e-127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH9,Myosin-9,39966,0.289825803066486,0.011966133146322,0.266372182099695,0.313279424033277,2.09259617357184e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300LG,CMRF35-like molecule 9,42137,-0.0951301363396984,0.00394201978677496,-0.102856495121777,-0.0874037775576195,5.15713813624387e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EEF1D,Elongation factor 1-delta,39958,0.232251790268898,0.00960641868306758,0.213423209650085,0.25108037088771,5.76907352064366e-126
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGR3,Anterior gradient protein 3,41827,0.150730957079535,0.00625710748165471,0.138467026415491,0.162994887743578,1.59452189710028e-125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADH1B,All-trans-retinol dehydrogenase,39736,0.193577828115604,0.00803244136203608,0.177834243046014,0.209321413185195,3.91581516034407e-125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF8,Immunoglobulin superfamily member 8,42145,0.0785274786807435,0.00327555197489042,0.0721073968099583,0.0849475605515287,2.00302318105555e-124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OXT,Oxytocin-neurophysin 1,42249,0.366473278064715,0.0153089953896926,0.336467647100917,0.396478909028512,4.32973942488196e-124
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.081153436459143,0.003402991912808,0.0744835723100393,0.0878233006082467,3.52946911404689e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP29,Synaptosomal-associated protein 29,42181,0.230569021648268,0.0096700596854165,0.211615704664852,0.249522338631685,3.93340506978705e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YES1,Tyrosine-protein kinase Yes,42070,0.287507001993161,0.0120586891498029,0.263871971259547,0.311142032726775,4.24445482580946e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPIND1,Heparin cofactor 2,39959,0.0734204475801685,0.00307479019753178,0.0673938587930062,0.0794470363673308,5.37602659061943e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.144619061007845,0.00605849818837714,0.132744404558626,0.156493717457064,7.79602092933291e-123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.139991458610226,0.00588669699025654,0.128453532509323,0.151529384711129,1.85665902929008e-122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPY,Pancreatic prohormone,42089,0.25802383955976,0.0108728048605828,0.236713142033018,0.279334537086502,5.3539490693538e-122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.350766485460713,0.0147890325347171,0.321779981692668,0.379752989228759,2.07705950769179e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOST,Sclerostin,42129,0.0966694326584772,0.00409192261443575,0.0886492643341832,0.104689600982771,5.9786483948076e-121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.122350216062236,0.00518541623299185,0.112186800245572,0.1325136318789,1.24565450244319e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.170502248754762,0.00721561389303996,0.156359645524404,0.18464485198512,1.88704511347738e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFR2,Fibroblast growth factor receptor 2,42181,0.0560137889210403,0.00237773858472216,0.0513534212949849,0.0606741565470957,2.67152059119608e-120
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0736056747196559,0.00313920838721521,0.0674528262807141,0.0797585231585977,9.10369630469597e-119
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FYB1,FYN-binding protein 1,42115,0.228733667719353,0.00978649831502641,0.209552131021901,0.247915204416804,1.79927186972291e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,P4HB,Protein disulfide-isomerase,42073,0.0952621587483976,0.00408152069771017,0.0872623781808857,0.10326193931591,3.79873873185661e-118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SARG,Specifically androgen-regulated gene protein,39915,0.269997994328775,0.0116084556779056,0.24724542120008,0.29275056745747,6.25910304207329e-117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEP,Leptin,42145,0.170668267911081,0.00735496579146691,0.156252534959806,0.185084000862356,7.68374947633159e-117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HJV,Hemojuvelin,39934,0.103155676458903,0.00444116188711627,0.094450999160155,0.111860353757651,1.24923790711516e-116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MME,Neprilysin,42070,0.190210957857766,0.0082358587237536,0.174068674759209,0.206353240956323,8.99765481239007e-116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORD,Sorbitol dehydrogenase,42204,0.167872593899228,0.00727115986105371,0.153621120571562,0.182124067226893,1.02324615964071e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPY30,Protein dpy-30 homolog,42216,0.146650517966247,0.00635757511214033,0.134189670746452,0.159111365186042,1.60417321822232e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YTHDF3,YTH domain-containing family protein 3,41913,0.209164771801687,0.00906645782211537,0.191394514470341,0.226935029133033,1.67527025835345e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MLN,Promotilin,42119,0.217807084728329,0.00946481704298273,0.199256043324083,0.236358126132576,5.61004597463206e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLA,Alpha-galactosidase A,39713,0.0952799176608065,0.00413297275498832,0.0871792910610294,0.103380544260584,6.54995758937124e-115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL16,Pro-interleukin-16,42296,0.102869326474242,0.00447719988135625,0.0940940147067836,0.1116446382417,1.17008147652377e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.125667713430991,0.00548809158513814,0.114911053924121,0.136424372937862,7.01708421779796e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.141075228652209,0.00616064745446815,-0.153150097662967,-0.129000359641452,7.08348443307692e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAPIN,SNARE-associated protein Snapin,39934,0.141226936207102,0.0061577555882051,0.12915773525422,0.153296137159984,7.96266024181305e-114
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F10,Coagulation factor X,39990,0.0700205820876974,0.00305926329719091,0.0640244260252032,0.0760167381501916,2.15925556989838e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.192110070649883,0.00839626821235733,0.175653384953663,0.208566756346104,2.64572395249682e-113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KHK,Ketohexokinase,39638,0.15161991038906,0.00665547314739278,0.13857518302017,0.16466463775795,2.67017649631262e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABL1,Tyrosine-protein kinase ABL1,42070,0.162219431595993,0.00714126650850892,0.148222549239315,0.17621631395267,3.94839279782964e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLKB1,Plasma kallikrein,39759,0.0588741706793043,0.00258954027711606,0.0537986717361569,0.0639496696224518,6.81427701087428e-112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAA80,N-alpha-acetyltransferase 80,39649,0.29556120038106,0.0130162529307763,0.270049344636739,0.321073056125382,1.33369862356898e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYAP1,Synapse-associated protein 1,39736,0.14034427361654,0.00618409790774697,0.128223441717356,0.152465105515724,1.68167165839814e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA1,Ephrin type-A receptor 1,42162,0.0771639991123132,0.00341586662705604,0.0704689005232833,0.083859097701343,6.00234870070903e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FN1,Fibronectin,39979,0.0650993613656603,0.00287950599703718,0.0594555296114675,0.0707431931198532,9.76897976124146e-111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD2AP,CD2-associated protein,42145,0.148825624064315,0.00668009085932854,0.135732645980031,0.161918602148599,5.09504666567286e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.129187900941232,0.00580477641286809,0.11781053917201,0.140565262710453,9.523213199996e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F11R,Junctional adhesion molecule A,42137,0.131371599620499,0.00590481781724744,0.119798156698694,0.142945042542304,9.90622707707304e-108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YOD1,Ubiquitin thioesterase OTU1,39575,0.143056956216186,0.00641877562639006,0.130476155988462,0.155637756443911,1.17599938109933e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MVK,Mevalonate kinase,41913,0.194674248061974,0.00876906459900264,0.177486881447929,0.211861614676019,2.99221416107339e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STC1,Stanniocalcin-1,42249,0.107647880070568,0.00485488853340476,0.0981322985450946,0.117163461596041,4.7992218357191e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCLY,Selenocysteine lyase,42224,0.11424903782466,0.00515629561812337,0.104142698413139,0.124355377236182,6.80062762353452e-107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISM1,Isthmin-1,42119,0.0927569314612009,0.00419035075828847,0.0845438439749555,0.100970018947446,1.1102711059326e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM20A,Pseudokinase FAM20A,39958,0.0660293013894033,0.00297802096022874,0.060192380307355,0.0718662224714516,1.14565289074083e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAB2,Stabilin-2,39966,0.0656584874946468,0.00297210226495985,0.0598331670553255,0.0714838079339681,6.33607338503482e-106
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR5,Cadherin-related family member 5,42145,0.0902675552163761,0.00410118200635878,0.0822292384839129,0.0983058719488393,1.61242313219195e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAMDC4,Apical endosomal glycoprotein,39919,0.131597178353123,0.00598832220808683,0.119860066825273,0.143334289880974,7.53349524201557e-105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TJAP1,Tight junction-associated protein 1,42181,0.192931207356335,0.00880862035025083,0.175666311469843,0.210196103242827,1.56844156296138e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTSS2,Protein MTSS 2,39919,0.23280111295243,0.0106359104961165,0.211954728380041,0.253647497524818,4.75721960701914e-104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTN4R,Reticulon-4 receptor,42262,0.0779702729637854,0.00357536432733702,0.0709625588822048,0.0849779870453659,1.14065711566137e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.195865992850098,0.00897312076753659,0.178278676145726,0.21345330955447,1.90064654588722e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES3,Carboxylesterase 3,42070,0.163894278104476,0.00753187842856678,0.149131796384485,0.178656759824467,3.29086964732811e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.229860773492134,0.0105524905381593,0.209177892037342,0.250543654946926,4.34151905006767e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0692264805958198,0.00317858111922121,0.0629964616021462,0.0754564995894934,4.68526871001898e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.262437141753428,0.0120654416956764,0.238788876029902,0.286085407476953,9.03851987929222e-103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.2070915394213,0.0095463402586076,0.188380712514429,0.225802366328171,1.37225586638557e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLUL1,Clusterin-like protein 1,42123,-0.102712222639478,0.00473623532678673,-0.11199524387998,-0.0934292013989757,1.52398888404442e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL10,C-X-C motif chemokine 10,42185,0.15158375077153,0.00699020063574624,0.137882957525468,0.165284544017593,1.53807621095898e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.224438864138117,0.0103601951090398,0.204132881724399,0.244744846551835,2.50251272706402e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0842887135042184,0.00390231212950876,0.0766401817303812,0.0919372452780555,9.54273806914024e-102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCXR,L-xylulose reductase,42181,0.124134449729494,0.0057525259017212,0.112859498962121,0.135409400496868,1.4214339632548e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0636456915859384,0.00295522805075805,0.0578534446064526,0.0694379385654241,3.51285171730968e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.114006769789943,0.00528473247023453,0.103648694148283,0.124364845431603,3.73993511838492e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MASP1,Mannan-binding lectin serine protease 1,41997,0.0526299989876883,0.00244586943754325,0.0478360948901035,0.0574239030852731,5.375362049656e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.242893609925843,0.0112964214212522,0.220752623940189,0.265034595911498,7.26124127100784e-101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0939207948024987,0.00436950262599541,0.0853565696555477,0.10248501994945,1.75002516526787e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCN2,Ficolin-2,42116,0.0921631060011835,0.00429837310839653,0.0837382947087263,0.100587917293641,2.55530638766573e-100
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXLNA,Alpha-taxilin,42016,0.199580295118506,0.00934014572110295,0.181273609505145,0.217886980731868,1.20419208583763e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0808111288898579,0.00379091110508957,-0.0882413146558335,-0.0733809431238824,3.35781542520429e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA2,Apolipoprotein A-II,39990,-0.111586258584802,0.00522778918294539,-0.121832725383375,-0.101339791786229,3.75830577101355e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGF,Hepatocyte growth factor,42296,0.0779415513217208,0.00366322710915186,0.0707616261877831,0.0851214764556584,7.36686729155135e-99
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1R2,Interleukin-1 receptor type 2,42100,0.045139913382486,0.00212475412794053,0.0409753952917225,0.0493044314732494,1.50060758990215e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.176631330020752,0.0083054979634529,0.160352554012385,0.19291010602912,1.9239049726846e-98
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD63,CD63 antigen,41992,0.113094799728187,0.00535547563141533,0.102598067490613,0.123591531965761,2.10556385700729e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BECN1,Beclin-1,39638,0.133274421793285,0.00629996435255323,0.12092649166228,0.145622351924289,2.10703079536352e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP20,Centrosomal protein 20,41843,0.168507145128392,0.00798678971197601,0.152853037292919,0.184161252963865,3.25813419105546e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP3S2,AP-3 complex subunit sigma-2,39929,0.10793478391029,0.0051090671660593,0.097921012264814,0.117948555555766,3.38221582159984e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.137293221599438,0.00651116982260012,0.124531328747142,0.150055114451734,4.20601887342994e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.224045454076824,0.0106308784579961,0.203208932299152,0.244881975854497,4.87281046192883e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFB1,BPI fold-containing family B member 1,42098,-0.144634056766068,0.00686862469622421,-0.158096561170667,-0.131171552361468,7.04440697795396e-97
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.18199761381374,0.00865148988790824,0.16504069363344,0.19895453399404,1.03060019157346e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA3F,Semaphorin-3F,42145,0.0592980062321611,0.00282864952426002,0.0537538531646115,0.0648421592997108,4.71747715310555e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A4,Protein S100-A4,42181,0.124644776829308,0.00594720298536855,0.112988258977986,0.136301294680631,5.15532801333725e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP85,Centrosomal protein of 85 kDa,41843,0.144855520959622,0.00691773003128336,0.131296770098307,0.158414271820938,8.24392541820522e-96
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.16272915882481,0.00778165495276273,0.147477115117395,0.177981202532225,1.4511234907663e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACE2,Angiotensin-converting enzyme 2,41900,0.121035950068166,0.00579144433440731,0.109684719172728,0.132387180963605,1.85358765257772e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFC,Platelet-derived growth factor C,41843,0.0619962510606474,0.00296827083227051,0.0561784402293972,0.0678140618918976,2.43753941730051e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.116515991095361,0.00558035409909353,0.105578497061138,0.127453485129585,2.66725365736535e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.107564222196378,0.00514368174050683,0.0974826059849846,0.117645838407771,2.79938663441409e-95
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.161136590437626,0.0077434441592531,0.14595943988549,0.176313740989762,1.05005014091497e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPK9,Mitogen-activated protein kinase 9,42119,0.0947573217395691,0.00455416149711529,0.0858311652052231,0.103683478273915,1.13708413794906e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EZR,Ezrin,42249,0.053693198699087,0.00258099979964339,0.048634439091786,0.058751958306388,1.18221254833214e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFX1,Transcriptional repressor NF-X1,39575,0.14894613910266,0.00715701587697028,0.134918387983798,0.162973890221521,2.24635644237018e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK1,Dickkopf-related protein 1,42249,0.129919369231133,0.00625935140675889,0.117651040473886,0.14218769798838,3.06654093288181e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PYY,Peptide YY,39575,0.220018381928513,0.0105971713861427,0.199247926011673,0.240788837845352,6.02459401669649e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.146225244687636,0.00706041667010913,0.132386828014222,0.16006366136105,8.46765029150426e-94
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AXIN1,Axin-1,42119,0.212386909762631,0.0102636249692025,0.192270204822994,0.232503614702268,1.12226400065603e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGRN,Agrin,42185,0.0786494238081512,0.00380811950876877,0.0711855095709644,0.086113338045338,2.47107888737808e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18R1,Interleukin-18 receptor 1,42296,0.0724481895986427,0.00350847807580035,0.065571572570074,0.0793248066272114,2.58889578971057e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0618379787736625,0.00299507620616893,0.0559676294095714,0.0677083281377536,5.33894061739306e-93
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN1,Dynactin subunit 1,42262,0.139675648020931,0.00678710853555522,0.126372915291243,0.152978380750619,1.05930448748954e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARF6,ADP-ribosylation factor 6,39930,0.237046800659411,0.011526205978737,0.214455436941087,0.259638164377736,2.65906382661423e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F13B,Coagulation factor XIII B chain,39925,0.0556930544960232,0.00271669363107988,0.0503683349791066,0.0610177740129397,9.78830497003517e-92
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL22,C-C motif chemokine 22,41991,0.112707938365082,0.00551135716230687,0.101905678326961,0.123510198403204,1.4909793189682e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0865021898814109,0.00423220017770611,-0.0947973022297149,-0.0782070775331069,1.79576165525272e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.114475381300254,0.0056089425075016,0.103481853985551,0.125468908614957,3.4668486592886e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0581169455651354,0.00285202915259339,0.0525269684260523,0.0637069227042184,6.13692533352993e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",42070,0.183751401053203,0.00902083297885295,0.166070568414651,0.201432233691755,7.22500991151476e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL17,C-X-C motif chemokine 17,42296,0.0921518328048162,0.00452604001673601,0.0832807943720137,0.101022871237619,8.25663129282581e-91
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.115036352251592,0.00564878308489281,0.103964737405202,0.126107967097982,1.42558324572711e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.178580886145496,0.00879554996585113,0.161341608212428,0.195820164078565,5.04386009582144e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EHBP1,EH domain-binding protein 1,39958,0.161373473698863,0.00795133957714332,0.145788848127662,0.176958099270064,5.54045658485496e-90
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KAZN,Kazrin,39930,0.225419731599403,0.011128691905801,0.203607495464033,0.247231967734773,1.21066830057172e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.233202304256154,0.0115576900975431,0.210549231664969,0.255855376847338,5.6217507744299e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSD,Cathepsin D,41225,0.0886404971297237,0.00439720956512537,0.080021966382078,0.0972590278773694,5.67351405601643e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.0426741380821656,0.00211822020638396,0.038522426477653,0.0468258496866781,5.90488594072296e-89
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINF2,Alpha-2-antiplasmin,39786,0.0286944346033536,0.00142453332983751,0.0259023492768721,0.0314865199298351,1.14544707210019e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTD,Biotinidase,39979,0.043841696586957,0.00217748814809551,0.0395738198166898,0.0481095733572241,1.28515715564279e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBIN,Erbin,42070,0.218699923011723,0.0108895512210159,0.197356402618532,0.240043443404914,2.01732572635477e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,41839,0.168948563816508,0.0084133834054881,0.152458332341751,0.185438795291265,2.23041247627625e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUOM,Fucose mutarotase,39736,0.137436974144413,0.00683864989722246,0.124033220345857,0.150840727942969,2.84598398940206e-88
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAXX,Protein PAXX,39736,0.0982469376967246,0.00491035817966899,0.0886226356645734,0.107871239728876,1.59984704121711e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP10,Stromelysin-2,42124,-0.122127276199247,0.00612604428726785,-0.134134323002292,-0.110120229396202,3.54465147734974e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KITLG,Kit ligand,42145,-0.0807905175941604,0.00405711267071295,-0.0887424584287578,-0.0728385767595631,5.45541709344955e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNA4,Plexin-A4,42119,0.170353959186726,0.00856551136307134,0.153565556915106,0.187142361458346,8.89533532810168e-87
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANG,Angiogenin,42152,0.0692637600787146,0.0034849402975711,0.0624332770954752,0.0760942430619539,1.14072064435327e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.115097771220725,0.00582126095058449,0.103688099757579,0.12650744268387,8.79132789078145e-86
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCTN3,Tectonic-3,39958,0.0635456088339313,0.00322964417666798,0.0572155062476621,0.0698757114202005,8.91099665498972e-85
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0811350776372762,0.00413130577064826,0.0730377183268056,0.0892324369477468,1.04707858100715e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDLIM7,PDZ and LIM domain protein 7,42185,0.261872561871469,0.0133359701475644,0.235734060382243,0.288011063360695,1.12031205470967e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCR,Breakpoint cluster region protein,42119,0.193021866980392,0.0098342149890651,0.173746805601824,0.212296928358959,1.34759340035517e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0494180468508633,0.00251829351281274,0.0444821915657503,0.0543539021359763,1.43245338841835e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD6,T-cell differentiation antigen CD6,42284,0.108646792060431,0.00554216554128225,0.0977841475995173,0.119509436521344,2.06195948032443e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC1B,C-type lectin domain family 1 member B,42249,0.199086665616974,0.0101579078355956,0.179177166259207,0.218996164974742,2.26190040950298e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5E,5'-nucleotidase,42181,0.112093926272121,0.00572061805692883,0.100881514880541,0.123306337663702,2.49546960636004e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP5,Microfibrillar-associated protein 5,42310,0.0841021972616795,0.00430040081058644,0.0756734116729301,0.0925309828504289,5.01922900487041e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE4,Ribonuclease 4,39645,0.0576160470820542,0.00294494638089396,0.051843952175502,0.0633881419886064,8.09386025821507e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.155279362061705,0.00793741681558243,0.139722025103163,0.170836699020246,8.48523992368439e-84
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH2,Cadherin-2,42145,0.0732086196611982,0.00375131806950493,0.0658560362449686,0.0805612030774279,1.13954788777878e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.228185962733645,0.0116978477576774,0.205258181128598,0.251113744338693,2.24454442132924e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASAH2,Neutral ceramidase,42016,0.110171452424952,0.00566037443217585,0.0990771185378873,0.121265786312017,3.12679649071287e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.218351548000044,0.0112223023682145,0.196355835358344,0.240347260641745,3.52374799148695e-83
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOE,Apolipoprotein E,39979,0.143992392586928,0.00741880549950507,0.129451533807898,0.158533251365958,1.38828281126976e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0768664430305034,0.00397764051183208,0.0690702676273125,0.0846626184336942,7.24578782025674e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,42070,0.281351829455258,0.0145849232704134,0.252765379845248,0.309938279065268,8.14786453908405e-82
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IKBKG,NF-kappa-B essential modulator,42119,0.187595631817874,0.00973746988855892,0.168510190836299,0.20668107279945,1.29860718424553e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R9B,Neurabin-2,42296,0.194015872162844,0.0100873941083103,0.174244579710556,0.213787164615132,2.28802637276554e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPL,N-acetylneuraminate lyase,39958,0.0949966563717432,0.004935592640855,0.0853228947956674,0.104670417947819,2.90842669506605e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.183556978694072,0.00953935447568301,0.164859843921733,0.20225411346641,3.22850013017145e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.212740074155355,0.011088401589356,0.191006807040217,0.234473341270493,5.77398166555702e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATG16L1,Autophagy-related protein 16-1,39930,0.175922670524915,0.00916438670967666,0.157960472573948,0.193884868475881,7.5785752885088e-81
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0907240805408373,0.0047351237643213,-0.100004923118907,-0.0814432379627676,1.49488714541558e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAB2,Disabled homolog 2,42262,0.225440102955614,0.0118009154741881,0.202310308626205,0.248569897285022,2.6175160849744e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS8,Prostasin,42080,0.0848774830299504,0.0044463423186313,0.0761626520854331,0.0935923139744678,3.53006936827705e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNIP1,TNFAIP3-interacting protein 1,39929,0.179355883648912,0.00939433587497135,0.160942985333969,0.197768781963856,5.28387684862414e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELP,P-selectin,42217,0.113161469839782,0.00593626260943484,0.101526395125289,0.124796544554274,5.64988629689728e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLA2,Src-like-adapter 2,39934,0.216440057116906,0.0113410148754884,0.194211667960949,0.238668446272863,6.03117184610792e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.113883319737154,0.00597886481738604,0.102164744695077,0.12560189477923,7.75050582637057e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,42310,0.134614169962355,0.00707197293159711,0.120753103016425,0.148475236908286,9.33889167892016e-80
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFC,Vascular endothelial growth factor C,42181,0.112098915878577,0.00589612386924871,0.100542513094849,0.123655318662304,1.45229446999977e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.217936816031574,0.0114513823515195,0.195492106622595,0.240381525440552,1.60663170577667e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.185137914495093,0.00975855556756269,0.16601114558267,0.204264683407515,3.2299954307995e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.191394777282466,0.0101057329699083,0.171587540661445,0.211202013903486,5.62820455137726e-79
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSP1,Lymphocyte-specific protein 1,42119,0.0814334216830897,0.00431633157220135,0.0729734118015751,0.0898934315646043,2.18498390722448e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP23,Synaptosomal-associated protein 23,42145,0.174406785134667,0.00924467408877975,0.156287223920659,0.192526346348675,2.20371159386774e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.13995765220563,0.00742782663058724,0.125399112009679,0.154516192401581,5.26032844865699e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0988628706205778,0.00525942797527526,0.0885543917890383,0.109171349452117,8.16294027166211e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEFTY2,Left-right determination factor 2,42247,0.103131740821269,0.00548828232316831,0.0923747074678594,0.113888774174679,8.51794782007261e-78
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,42119,0.131617034210035,0.00701189935807662,0.117873711468205,0.145360356951865,1.2727690051504e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLIN1,Perilipin-1,41839,0.0678355765051773,0.00361594153843243,0.0607483310898498,0.0749228219205049,1.61396407598567e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD5,Programmed cell death protein 5,42249,0.114346811073477,0.00609841314613387,0.102393921307055,0.126299700839899,1.80702514589678e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NHLRC3,NHL repeat-containing protein 3,39481,0.064383803612769,0.00343192516626124,0.057657230286897,0.071110376938641,2.62996126568175e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.14152593146886,0.00755530408419341,0.126717535463841,0.156334327473879,2.66862605479091e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.145297026499234,0.0077568085498079,0.130093681741611,0.160500371256858,4.26749909986582e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0398507061738099,0.00213117255848464,0.03567360795918,0.0440278043884398,4.74677509600814e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THOP1,Thimet oligopeptidase,42081,0.0622485694651638,0.00333502134164837,0.055711927635533,0.0687852112947946,8.81048814535023e-77
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEP1A,Meprin A subunit alpha,39930,0.151044690202545,0.0080895581310039,0.135189156265777,0.166900224139313,1.18577790704028e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CMIP,C-Maf-inducing protein,39919,0.16670950482598,0.00892909549418125,0.149208477657384,0.184210531994575,1.21482715958317e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FETUB,Fetuin-B,42199,0.0638318787293941,0.0034244658043979,0.0571199257527742,0.0705438317060139,1.36805278899568e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BACH1,Transcription regulator protein BACH1,42119,0.149053264610525,0.00799806963786394,0.133377048120311,0.164729481100738,1.48491369070535e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.135988056667007,0.00730289551165023,0.121674381464173,0.150301731869841,3.16905787078485e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMOT,Angiomotin,39736,0.0756984532583414,0.00407575705327422,0.0677099694339239,0.0836869370827589,7.41289760917358e-76
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRPK2,SRSF protein kinase 2,42119,0.168247481397164,0.00907973321535385,0.15045120429507,0.186043758499258,1.02204779154984e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PXN,Paxillin,41839,0.101299161180115,0.00546680372408751,0.0905842258809038,0.112014096479327,1.07149502284753e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCK2,Cytoplasmic protein NCK2,42185,0.210243301193019,0.0113855138497593,0.18792769404749,0.232558908338547,3.2291825260805e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.165853746203335,0.00897083421627322,0.14827091113944,0.183436581267231,3.26820138053958e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXO1,Forkhead box protein O1,42119,0.170648980417549,0.00924344058173751,0.152531836877343,0.188766123957754,3.5211590385376e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLSCR3,Phospholipid scramblase 3,39911,0.113391812239776,0.00613610479620182,0.101365046839221,0.125418577640332,3.83885266744776e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAT,Linker for activation of T-cells family member 1,42296,0.148945076831314,0.00807622361901138,0.133115678538052,0.164774475124576,4.84872929105166e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF3,Immunoglobulin superfamily member 3,42070,0.0727269199640846,0.00394353746350173,0.0649975865356212,0.080456253392548,5.05198450875208e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL5,C-C motif chemokine 5,42217,0.198067238629868,0.0107409941470753,0.177014890101601,0.219119587158136,5.0971689319927e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP2B,DNA topoisomerase 2-beta,39657,0.157831935441067,0.00855761247073687,0.141059014998422,0.174604855883711,7.75890870164585e-75
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELE,E-selectin,42310,0.0989658564926719,0.00537905274980923,0.0884229131030458,0.109508799882298,1.07028389753147e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.221745038141185,0.012058693609172,0.198109998667207,0.245380077615162,1.30849317899581e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL5,C-X-C motif chemokine 5,42101,0.220275513546151,0.0119916156935457,0.196771946786802,0.243779080305501,1.86936305396094e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.223427551557726,0.0121531712986634,0.199607335812346,0.247247767303106,2.11362254215177e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMPR,GMP reductase 1,42296,0.0931372876673416,0.0050740192340173,0.0831922099686677,0.103082365366016,2.31015445599496e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINH1,Serpin H1,39757,0.251811021048982,0.0137057383195748,0.224947773942616,0.278674268155349,2.69631751409209e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C19orf12,Protein C19orf12,41839,0.130593479395793,0.00711989275115959,0.11663848960352,0.144548469188065,3.1650883440627e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17RB,Interleukin-17 receptor B,41934,-0.105750192666608,0.00577032779464601,-0.117060035144114,-0.094440350189102,4.11867264291823e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSO,Cathepsin O,42296,0.0597484943595775,0.00326094331429828,0.0533570454635529,0.0661399432556022,4.19755753175242e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSME1,Proteasome activator complex subunit 1,42002,0.0707646947630611,0.00386910762672193,0.0631812438146861,0.0783481457114361,7.89141473105811e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN2,CCN family member 2,42146,0.11002552497039,0.00601683704632229,0.0982325243595982,0.121818525581182,8.20666312683288e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.129607369005199,0.00708809389835803,0.115714704964418,0.143500033045981,8.76120741734437e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.190455464592505,0.0104189661379314,0.17003429096216,0.210876638222851,9.03209173842708e-74
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUCB2,Nucleobindin-2,42231,0.0729251134266242,0.00399398268000402,0.0650969073738163,0.080753319479432,1.32612432489955e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOC1,Apolipoprotein C-I,39959,0.0749160837721952,0.0041060522393473,0.0668682213830745,0.0829639461613159,2.50328098168297e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.143986534695429,0.00790220751964732,0.12849820795692,0.159474861433937,4.1222047106355e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0788256344689957,0.00432968856797019,0.0703394448757741,0.0873118240622172,5.07361619806471e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.102093682242785,0.00561938786782593,0.0910796820218457,0.113107682463723,6.81162758457903e-73
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.135267027735667,0.00745978314635389,0.120645852768813,0.149888202702521,1.30894249280269e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.123262447551971,0.0067985668412708,0.10993725654308,0.136587638560862,1.3749807786851e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MINK1,Misshapen-like kinase 1,39929,0.180072806156009,0.00992160326628663,0.160626463754087,0.199519148557931,1.37527658086793e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREG1,Protein CREG1,41960,0.077926415168207,0.00430558675061295,0.0694874651370056,0.0863653651994084,2.37263443522142e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL32,Interleukin-32,42119,-0.0857329438357365,0.00474418329366412,-0.0950315430913181,-0.0764343445801548,3.78958252207968e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCBP2,Poly(rC)-binding protein 2,39934,0.140452785792862,0.00777131110428891,0.125221016028455,0.155684555557268,5.28662093966007e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0461886393457241,0.00255958016992075,0.0411718622126794,0.0512054164787687,5.96294058935714e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPB2,Carboxypeptidase B2,39959,0.0432170613035248,0.002393946490076,0.0385249261829758,0.0479091964240737,7.56061053421312e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.148125353093176,0.00820920419202682,0.132035312876803,0.164215393309549,8.83331007425212e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFRP4,Secreted frizzled-related protein 4,39736,0.0768444874925648,0.00425905819022059,0.0684967334397325,0.0851922415453972,9.43957008517002e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH1A1,Retinal dehydrogenase 1,42137,0.102288337716905,0.00567672908771749,0.0911619487049782,0.113414726728831,9.52395179490361e-72
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.159830365161404,0.00892235571727276,0.142342547955549,0.177318182367258,6.14686626573559e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.148046738748326,0.00826713055499066,0.131843162860544,0.164250314636108,6.78121049095307e-71
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.045779343482859,0.0025616541375852,0.040758501373192,0.050800185592526,1.31827914426094e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMBP,Protein AMBP,42239,0.0382160793013487,0.00214872251819892,0.0340045831656788,0.0424275754370186,5.63789017692763e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP43,Centrosomal protein 43,41797,0.133268668380178,0.00750022891095157,0.118568219714713,0.147969117045643,8.03114178142617e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH2B3,SH2B adapter protein 3,41843,0.186840925082889,0.0105185124974715,0.166224640587844,0.207457209577933,8.79049413998814e-70
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL17,C-C motif chemokine 17,42107,0.173168630970947,0.00975401800848941,0.154050755674308,0.192286506267587,1.00039741139707e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.118386456720304,0.00666989003003046,0.105313472261444,0.131459441179164,1.5089277377044e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.20471080838071,0.0115346411132456,0.182102911798748,0.227318704962671,1.56779681168475e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.194326817262596,0.0109539221439206,0.172857129860511,0.21579650466468,1.87494319487632e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.178717088554636,0.0101205354531393,0.158880839066482,0.198553338042789,5.24070414280722e-69
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPD52L2,Tumor protein D54,39736,0.204407724375919,0.0115957408937344,0.181680072224199,0.227135376527638,1.28292011849578e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOK2,Docking protein 2,42145,0.230455905037664,0.0130969887932147,0.204785807002964,0.256126003072365,1.52492737235009e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL13,C-C motif chemokine 13,42275,0.127696010888657,0.00726639268035514,0.113453881235161,0.141938140542153,2.21494786045115e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFB,Platelet-derived growth factor subunit B,42185,0.160532059443389,0.00914120112357743,0.142615305241177,0.178448813645601,2.76101965414566e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTBS,Di-N-acetylchitobiase,39860,0.0515076272172562,0.00293379986336583,0.0457573794850592,0.0572578749494532,4.25875855167797e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.177528579024633,0.0101496209144216,0.157635322032366,0.197421836016899,9.57397588316126e-68
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGF,Placenta growth factor,42296,0.0488292665195165,0.0027938311610501,0.0433533574438583,0.0543051755951747,1.15088808970913e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC27,Cell division cycle protein 27 homolog,41843,0.1134889743458,0.00650591605839606,0.100737378871343,0.126240569820256,2.16448431719595e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0692944622445369,0.00397298908581318,0.0615074036363431,0.0770815208527308,2.16781564835522e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP3B1,AP-3 complex subunit beta-1,39930,0.14335389408001,0.00821590889233955,0.127250712651024,0.159457075508995,2.67851741591391e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYTL4,Synaptotagmin-like protein 4,39958,0.135058056382257,0.00775463713726028,0.119858967593226,0.150257145171287,4.58977448153806e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0949422828461401,0.00545280177267443,0.0842547913716982,0.105629774320582,5.3059668729426e-67
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3GLB2,Endophilin-B2,39929,0.121777803405332,0.00701066479137366,0.10803690041424,0.135518706396425,1.00919803617956e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USO1,General vesicular transport factor p115,42070,0.164772835980271,0.00949641474604599,0.146159863078021,0.183385808882521,1.02722303818711e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOLM2,Protein GOLM2,42249,0.0420388994008376,0.00242672494414402,0.0372825185103153,0.0467952802913599,1.61220824765473e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.206544246032036,0.0119286226871037,0.183164145565313,0.22992434649876,1.9134474597334e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTUD7B,OTU domain-containing protein 7B,39934,0.11658602888662,0.0067358054142111,0.103383850274766,0.129788207498474,2.88169629826957e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0994858147987807,0.00574953374940231,0.0882167286499522,0.110754900947609,3.23960613259434e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0721608333452328,0.00418970509831995,-0.0803726553379399,-0.0639490113525256,8.88771183473239e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NIT2,Omega-amidase NIT2,39903,0.134129914087948,0.00778157411005478,0.118878028832241,0.149381799343655,9.69476176004638e-66
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEC31A,Protein transport protein Sec31A,39638,0.141969806473618,0.00825932838359111,0.12578152284178,0.158158090105457,2.26851802326151e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK11,Serine/threonine-protein kinase STK11,41900,0.133633982987993,0.0077835340303133,0.118378256288579,0.148889709687407,2.29854794951032e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.11714054879226,0.00682520618806836,0.103763144663646,0.130517952920874,3.34685984480005e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYN,Tyrosine-protein kinase Lyn,42070,0.155040594628373,0.00905478492589362,0.137293216173621,0.172787973083124,4.91186477102956e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.201816440252141,0.0118015712457555,-0.224947519893822,-0.17868536061046,7.01181919186788e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.143334433400943,0.00838494105628613,-0.159768917871264,-0.126899948930622,7.8074713755791e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP2,Methionine aminopeptidase 2,42247,0.101666682676905,0.00594992513771964,0.0900048294069741,0.113328535946835,8.73286222420413e-65
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,39736,0.140310999724841,0.00821205394993757,0.124215373982963,0.156406625466719,1.25356351377553e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM5,Tripartite motif-containing protein 5,42119,0.158258530066437,0.00927433012423131,0.140080843022944,0.176436217109931,1.30102634683708e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0971914668727065,0.00569815868458949,0.0860230758509111,0.108359857894502,1.52388595526966e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPHN1,Oligophrenin-1,39929,0.197281422600805,0.0115696884092901,0.174604833318596,0.219958011883013,2.15708535558362e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.114827957116698,0.00675096141776212,0.101596072737884,0.128059841495512,3.37204320013157e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEXIM1,Protein HEXIM1,42119,0.146661140031907,0.00862595898920325,0.129754260413068,0.163568019650745,3.66198153238444e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.0766267225468845,0.00450775653494799,0.0677915197383864,0.0854619253553825,3.823910905592e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRP14,Signal recognition particle 14 kDa protein,42070,0.108321852994779,0.00638055529300538,0.0958159646204882,0.120827741369069,5.6291086146315e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.186059316772932,0.0109495606487454,0.164598177901391,0.207520455644473,5.77846214580181e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIT1,ARF GTPase-activating protein GIT1,39657,0.175715935595758,0.0103392399512186,0.15545102529137,0.195980845900147,5.77913777888908e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NSFL1C,NSFL1 cofactor p47,42249,0.11384932460888,0.00671024539431187,0.100697243636029,0.127001405581731,6.56156757068607e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA5,Integrin alpha-5,42137,0.0450413985266551,0.00265484921626135,0.0398378940627829,0.0502449029905274,6.73005115941604e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SULT2A1,Bile salt sulfotransferase,42119,0.106606061714037,0.00628458196477356,0.0942882810630811,0.118923842364993,7.04188530592575e-64
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.185141247301887,0.0109326763574432,0.163713201641299,0.206569292962476,1.11939663518191e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0996962485163376,0.00590141379004058,0.0881294774878581,0.111263019544817,2.19492583592697e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSTN,Growth/differentiation factor 8,41900,0.0972966008832206,0.00576216671611884,0.0860027541196276,0.108590447646814,2.62633107033504e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0878893473434989,0.00521234213298183,0.0776731567628545,0.0981055379241433,3.91154468338595e-63
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.145393594370689,0.00864542115425796,0.128448568908343,0.162338619833035,1.0447675840732e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0526822896962243,0.00313697306338651,0.0465338224919868,0.0588307569004619,1.20027546613692e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.186202410271796,0.0111036203728014,0.164439314341106,0.207965506202487,1.73107210909901e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.110695218362933,0.00659738222969888,0.0977643491927233,0.123626087533143,1.97740249828631e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0489882620459037,0.00292408079858793,0.0432570636806714,0.0547194604111361,2.27308179509754e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.139851937058382,0.00834249288479883,0.123500651004176,0.156203223112588,2.52207295327649e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.129120274278424,0.00770509055985532,0.114018296781108,0.144222251775741,2.79019647574217e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0932625650368433,0.00557376265541609,0.0823379902322277,0.104187139841459,3.19542043062237e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMN,Protein amnionless,41913,0.0843308304108204,0.00504765704926897,0.0744374225942532,0.0942242382273876,4.99118312619262e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AZI2,5-azacytidine-induced protein 2,39934,0.0991938147288423,0.00593192080689638,0.0875672499473254,0.110820379510359,5.00241378269691e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTBDN,Retbindin,42070,0.053450111723676,0.00319968380312246,0.047178731469556,0.059721491977796,5.08198987018661e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLK1,Protein delta homolog 1,42310,0.103104775527418,0.00617737676153995,0.0909971170748001,0.115212433980037,6.249836541425e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GASK1A,Golgi-associated kinase 1A,39575,0.0761641852602841,0.0045586350595586,0.0672292605435492,0.085099109977019,6.68520713113836e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,39627,0.101358526363136,0.00607140244007422,0.089458577580591,0.113258475145682,8.23537042249966e-62
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0676426244764588,0.00406486263496321,0.0596754937119309,0.0756097552409867,1.44371012711203e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AAMDC,Mth938 domain-containing protein,39638,0.0940901499585473,0.0056542785977563,0.0830077639069449,0.10517253601015,1.98082510467492e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.146448096177006,0.00881484711589043,0.129170995829861,0.163725196524152,2.31121307802039e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRAP,BRCA1-associated protein,39813,0.195245700643884,0.0117495867385869,0.172216510636254,0.218274890651515,2.81875821048046e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGCC,Regulator of cell cycle RGCC,39934,0.135665590011945,0.00816851436883252,0.119655301849033,0.151675878174856,3.20015845715861e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.193565441123989,0.0116723813007743,0.170687573774471,0.216443308473507,3.67613126062215e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNMBP,Dynamin-binding protein,42016,0.10737935163253,0.00647685168059368,0.0946847223385668,0.120073980926494,4.00878454815334e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNST,Consortin,42145,0.192667189861054,0.0116241478079226,0.169883860157526,0.215450519564583,4.23727334981191e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAMBP,STAM-binding protein,41997,0.111503484529253,0.00672937996262317,0.0983138998025111,0.124693069255994,4.67336565491414e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LBR,Delta(14)-sterol reductase LBR,42249,0.120323982658039,0.0072672903758239,0.106080093521424,0.134567871794654,5.60581743331072e-61
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0450090432706342,0.00272631597119211,0.0396654639670976,0.0503526225741707,1.21470643339761e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX15,Sorting nexin-15,39736,0.095055212130973,0.00575667809048911,0.0837721230736143,0.106338301188332,1.5683326903766e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RLN2,Prorelaxin H2,39709,0.0906593388263803,0.00549375397068728,0.0798915810438333,0.101427096608927,1.84812917434327e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0343650106934916,0.00208858921957162,-0.0384586455638519,-0.0302713758231312,3.05050751336428e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGLN1,Egl nine homolog 1,42119,0.098345647165055,0.00597734136540174,0.0866300580888676,0.110061236241242,3.06641799034233e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.149384311942625,0.00907738322623223,0.13159264081921,0.167175983066041,3.89207058211316e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CMC1,COX assembly mitochondrial protein homolog,39958,0.160398450589551,0.00975517301212827,0.141278311485779,0.179518589693322,4.68789735440183e-60
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP3,Metalloproteinase inhibitor 3,42185,0.22344699911799,0.0136464245943648,0.196700006913035,0.250193991322945,1.09231254323135e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTDH,Protein LYRIC,39657,0.166606512527184,0.0101712313940906,0.146670898994766,0.186542126059602,1.33078758416064e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COCH,Cochlin,39958,0.0802291544592988,0.00490249831724994,0.070620257757489,0.0898380511611087,1.62902469840463e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGBP1,Immunoglobulin-binding protein 1,39934,0.10470943037209,0.00640076650252509,0.0921639280271406,0.117254932717039,1.80133923969073e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.165980300847929,0.0101550731273814,0.146076357518262,0.185884244177597,1.80461489812831e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.10048667107798,0.00615746119665797,0.0884180471325308,0.11255529502343,2.61929075739886e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAG1,Dystroglycan,42185,0.0827093037764171,0.00507116221991711,0.0727698258253796,0.0926487817274547,3.07294543372607e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOLGA3,Golgin subfamily A member 3,39934,0.134918168483489,0.00828890832441673,0.118671908167632,0.151164428799346,6.68417944174762e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EREG,Proepiregulin,41997,0.139320282247185,0.00857220994690706,0.122518750751247,0.156121813743123,7.82182653240742e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAX1BP1,Tax1-binding protein 1,39929,0.107756748255169,0.00662809365527348,0.0947656846908329,0.120747811819505,9.11160036351874e-59
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.176760252672318,0.0108870030693327,0.155421726656426,0.19809877868821,1.00920578030595e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0577572267667877,0.0035610877908888,0.0507774946966457,0.0647369588369298,1.32254739439956e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC13,Mucin-13,41839,0.0913694299386671,0.00563305686205081,0.0803286384890475,0.102410221388287,1.331351038329e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.157225665298166,0.00969302812880501,0.138227330165708,0.176224000430624,1.70652320770694e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0513323674386583,0.00317007095783733,0.0451190283612971,0.0575457065160195,1.97306099033931e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOF,Apolipoprotein F,39990,-0.044580966842544,0.00276410080593179,-0.0499986044221704,-0.0391633292629177,7.02023728935079e-58
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NIT1,Deaminated glutathione amidase,39638,0.0763992628257066,0.00474299369665817,0.0671029951802566,0.0856955304711566,1.02065835997274e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARSB,Arylsulfatase B,42070,0.0954275022500592,0.00593286200339365,0.0837990927234076,0.107055911776711,1.12673744944437e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM13A,Protein FAM13A,39930,0.116769930469461,0.00725642507774725,0.102547337317077,0.130992523621846,1.26227680648802e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0760602821264417,0.00473179191897277,0.066785969965255,0.0853345942876283,1.32545679148009e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT5,ADP-sugar pyrophosphatase,42137,0.0854613738008438,0.00533528364210345,0.0750042178623211,0.0959185297393666,3.20094914302555e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QDPR,Dihydropteridine reductase,42081,0.0720933438563447,0.00450149862847078,0.0632704065445419,0.0809162811681474,3.35903127636746e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.132479045527904,0.00827158157405417,0.116266745642758,0.14869134541305,3.39133294752593e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.0987952430225741,0.00617111026575094,0.0866998669017023,0.110890619143446,3.71954893954384e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PENK,Proenkephalin-A,39736,0.0529388092320477,0.00331047128593476,0.0464502855116156,0.0594273329524798,6.3077256454623e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHACTR2,Phosphatase and actin regulator 2,39934,0.194971426307771,0.01219752776654,0.171064271885352,0.218878580730189,6.84623518404199e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0750841408804649,0.00470428521290512,0.0658637418631709,0.084304539897759,8.05915572721021e-57
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0522762280561517,0.00327944469706645,0.0458485164499014,0.0587039396624019,1.44348294773186e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.112553276885515,0.0070650117203564,0.0987058539136168,0.126400699857414,1.58111310243312e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0734671045223931,0.00461306068069664,0.0644255055882277,0.0825087034565585,1.71796530731451e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MITD1,MIT domain-containing protein 1,42016,0.164198616328987,0.0103280800433211,0.143955579444078,0.184441653213896,2.13052567439316e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.123650942058974,0.00777801477873618,0.108406033092651,0.138895851025297,2.13748098106351e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST13,Hsc70-interacting protein,39736,0.092302382306457,0.00580508779162744,0.0809244102348672,0.103680354378047,2.62325787791395e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELOA,Elongin-A,42070,0.0912221387810712,0.00574807721011258,0.0799559074492506,0.102488370112892,3.29958677871908e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.123179074791651,0.00775621173349605,0.107976899793999,0.138381249789304,3.42843554590739e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0561271814729833,0.00354294571718715,0.0491830078672965,0.0630713550786701,5.05603193260809e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.17841700689994,0.0112632175644654,0.156341100473588,0.200492913326292,6.61982012546444e-56
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBNL,Drebrin-like protein,42185,0.156545764939803,0.00990936206923624,0.1371234152841,0.175968114595506,1.00936363643193e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.152584868687374,0.0096646994467361,0.133642057771772,0.171527679602977,1.47251145351801e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.14284807734975,0.00905943448298481,0.1250915857631,0.160604568936401,1.60945115155085e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDUA,Alpha-L-iduronidase,42262,0.0793375565471751,0.00503916191815872,0.069460799187584,0.0892143139067662,2.30707080752254e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUS,RNA-binding protein FUS,41831,0.0668258741760238,0.00424792303181419,0.058499945033668,0.0751518033183796,2.9157837847704e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.131532628969776,0.0083576327588633,0.115151668762404,0.147913589177148,3.18413806424743e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB27B,Ras-related protein Rab-27B,39958,0.138748368580249,0.00881811351783596,0.121464866085291,0.156031871075208,3.35447549524438e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAO1,Hydroxyacid oxidase 1,42262,0.20765655642261,0.0132136512960502,0.181757799882351,0.233555312962868,3.61159038687473e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,41900,0.129109738145001,0.00821656962841357,0.11300526167331,0.145214214616691,3.83627062519491e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIAE,Sialate O-acetylesterase,42147,0.0779594111551459,0.00496813712503907,0.0682218623900693,0.0876969599202225,5.23938231331811e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.102692449640822,0.00654633934063,0.0898616245331873,0.115523274748457,5.66282952183684e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRKL,Crk-like protein,42143,0.176814407404012,0.0112744780208987,0.154716430483051,0.198912384324974,6.03955157311571e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0484376759426642,0.00309048619645328,0.0423803229976158,0.0544950288877126,8.86801362983655e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IST1,IST1 homolog,39850,0.164987454837388,0.0105273812252142,0.144353787635968,0.185621122038808,8.87651553721145e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDLIM5,PDZ and LIM domain protein 5,39934,0.198584404729037,0.0126760947251067,0.173739259067828,0.223429550390246,9.66614777364826e-55
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0629268165917199,0.00402081080330556,0.055046027417241,0.0708076057661987,1.00273911292577e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNB3,Plexin-B3,42099,0.0802834806320237,0.00513486503008547,0.0702191451730562,0.0903478160909912,1.26681500261612e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STIP1,Stress-induced-phosphoprotein 1,42105,0.106668383869782,0.00683286437611911,0.0932759696925889,0.120060798046976,1.82978591000379e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL3,Angiopoietin-related protein 3,42189,0.0574155896547614,0.00367996898911627,0.0502028504360935,0.0646283288734293,2.08398891798225e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBPL,FK506-binding protein-like,39930,0.0989814118400555,0.00634288841604661,0.0865493505446042,0.111413473135507,2.46754928214708e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.143754219424873,0.00921725839503749,0.125688392970599,0.161820045879146,2.83186254712665e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.147837554144369,0.00948508324047125,0.129246790993046,0.166428317295693,3.29075580693761e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESM1,Endothelial cell-specific molecule 1,42123,-0.0578050760086917,0.00371238646339626,-0.0650813534769484,-0.050528798540435,3.39105282212896e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS8,Galectin-8,42249,0.101246860485217,0.00650666664691563,0.0884937938572622,0.113999927113171,3.93835337089039e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBKS,Ribokinase,41830,0.0824150943456573,0.00529630604873875,0.0720343344901293,0.0927958542011852,4.04861401764475e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD1,Sushi domain-containing protein 1,41900,0.0806710549029034,0.00520204266366091,0.0704750512821281,0.0908670585236788,9.10707649838765e-54
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BID,BH3-interacting domain death agonist,42119,0.109815848447391,0.00709074195532047,0.0959179942149628,0.123713702679819,1.22187096083051e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0459645731757908,0.00296947097176736,0.0401444100711267,0.0517847362804548,1.38153972782043e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D23,TBC1 domain family member 23,42070,0.149065632242903,0.00962993771501441,0.130190954321475,0.167940310164332,1.38212294925381e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0790982863941829,0.00510758513898871,0.069087419521765,0.0891091532666008,1.51326471111116e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL3,C-X-C motif chemokine 3,42129,0.15766267559687,0.0101971826147656,0.137676197671929,0.17764915352181,1.8109083451575e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.124976513694545,0.00808818130186169,0.109123678342896,0.140829349046194,2.11138819105316e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.109975477515012,0.00711487879283196,0.0960303150810613,0.123920639948963,2.36309246539669e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDRKH,Tudor and KH domain-containing protein,41839,0.140542731946921,0.00910170447036966,0.122703391184997,0.158382072708846,2.51408143424417e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGFR,Opioid growth factor receptor,42070,0.0529473171727514,0.00343244627292529,0.0462197224778178,0.059674911867685,3.14193545046793e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0421676385136814,0.00273462611391717,0.0368077713304038,0.0475275056969591,4.29689053834788e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYDGF,Myeloid-derived growth factor,39958,0.163837551213353,0.0106384748676879,0.142986140472685,0.184688961954021,5.56695723511378e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST3,Cystatin-C,42184,0.047105010752382,0.00306525206861922,0.0410971166978883,0.0531129048068757,7.53275799799385e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.174999585527114,0.0113783753173902,0.152697969905029,0.197301201149198,7.60743306866861e-53
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.139954830838491,0.00912068974031575,0.122078278947472,0.15783138272951,1.08975215376044e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON2,Serum paraoxonase/arylesterase 2,41900,0.0576810984376934,0.00375930483063026,0.0503128609696581,0.0650493359057288,1.10499780674564e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCC,Tubulin-specific chaperone C,42016,0.131920043226712,0.00860032186665235,0.115063412368074,0.148776674085351,1.1740287963667e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.0966616163784521,0.00630415897668684,0.0843054647841459,0.109017767972758,1.27523441421014e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.0742214757537335,0.00484910098940029,0.0647172378145089,0.0837257136929581,1.91820192949541e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0756966282039735,0.00495119601865098,0.0659922840074176,0.0854009724005294,2.4928073768431e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.137057003819067,0.00896461120359669,0.119486365860018,0.154627641778117,3.02257015274419e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0799835279708809,0.00523164595460167,0.0697295018998616,0.0902375540419001,3.03470177193875e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL4,C-C motif chemokine 4,42148,0.101677383747982,0.0066567094223274,0.0886302332802205,0.114724534215744,3.08272834882458e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.102264409047316,0.00669872910977802,0.0891348999921511,0.115393918102481,4.39385470383015e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF2,TNF receptor-associated factor 2,42119,0.113163880969755,0.00742964263335396,0.0986017814083808,0.127725980531128,5.90465385095715e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH2D1A,SH2 domain-containing protein 1A,42119,0.0975283730555848,0.00640912850100303,0.0849664811936188,0.110090264917551,7.32053013052037e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0728016921987315,0.00479009263941825,0.0634131106254718,0.0821902737719913,9.89446151461244e-52
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0622982735071437,0.00409945796395287,0.0542633358977961,0.0703332111164913,1.01499219621344e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.117267335806819,0.00771384708216872,0.102148195525769,0.13238647608787,1.12756429315938e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.189653970648648,0.0124962995603969,0.16516122351027,0.214146717787026,1.34480712161023e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.23711353883985,0.0156145862855597,0.206508949720153,0.267718127959547,1.42065214542402e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.200829575251298,0.0132346700633276,0.174889621927175,0.22676952857542,1.42769793800875e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",41900,0.150424213287426,0.00992586247118431,0.130969522843905,0.169878903730947,1.89379061724753e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN2L,Ataxin-2-like protein,39934,0.0779194684426752,0.0051416429808849,0.0678418482001408,0.0879970886852096,2.24935665753512e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0664535569950136,0.00438715329246554,0.0578547365417811,0.0750523774482461,2.5586348604083e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP5,Fatty acid-binding protein 5,42218,0.107797704635528,0.00712427670710049,0.0938341222896114,0.121761286981445,2.6399627605729e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AP2B1,AP-2 complex subunit beta,39649,0.078541457787848,0.00520401140834362,0.0683415954274945,0.0887413201482015,5.83716208772812e-51
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.0905867350484462,0.00602175770722072,0.0787840899422936,0.102389380154599,1.17912251705535e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK10,Kallikrein-10,42138,0.0656793952064723,0.00437155770603645,0.0571111421026408,0.0742476483103037,1.30232978849014e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPC5,Glypican-5,42016,0.090550407825302,0.00602758465189296,0.0787363419075919,0.102364473743012,1.34464305081275e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD207,C-type lectin domain family 4 member K,41832,0.0626709931208532,0.00417293401374654,0.05449204245391,0.0708499437877964,1.45027891948337e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERMAP,Erythroid membrane-associated protein,39657,0.0716208630074362,0.00476738379106355,0.0622767907769516,0.0809649352379207,1.63090871997918e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GTPBP2,GTP-binding protein 2,39649,0.131880693858406,0.00878757600584349,0.114657044886952,0.149104342829859,2.05141234511596e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0451275391188364,0.00301232969901665,0.0392233729087637,0.051031705328909,2.48621961693288e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0946863968474239,0.00632016389066793,0.0822988756217148,0.107073918073133,2.50325357903555e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIP,Gastric inhibitory polypeptide,39638,0.0811738318724088,0.00541418616384246,0.0705620269912776,0.0917856367535401,2.55632386252533e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN3,Ataxin-3,39929,0.0978840440341186,0.00653011555732714,0.0850850175417574,0.11068307052648,2.60254054269257e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.112392115040803,0.00750029817392183,0.097691530619916,0.12709269946169,2.86426004221652e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADD1,Alpha-adducin,39736,0.1114930423342,0.00745581982399012,0.0968796354791798,0.126106449189221,4.49649535709013e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDHD2,Phospholipase DDHD2,39934,0.105727535225198,0.00709305068704978,0.0918251558785808,0.119629914571816,8.93954279661177e-50
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLB,Beta-klotho,41839,-0.119102481005992,0.00800480963946412,-0.134791907899342,-0.103413054112642,1.1385061013154e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGA,Protein O-GlcNAcase,39930,0.11371989180522,0.00763838737600211,0.0987486525482556,0.128691131062184,1.16205668797536e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VNN1,Pantetheinase,39990,0.116410232860404,0.00782400812654262,0.101075176932381,0.131745288788428,1.32540807984729e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,39736,0.13222165554698,0.00888870407702855,0.114799795556004,0.149643515537956,1.42602529747195e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,39735,0.104959618792917,0.00705961932094927,0.0911227649238569,0.118796472661978,1.59508394219545e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIRBP,Cold-inducible RNA-binding protein,39930,0.153328055923874,0.0103170604679577,0.133106617406677,0.173549494441071,1.70956892905946e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0816783397981206,0.00550366098471562,0.070891164268078,0.0924655153281632,2.32029346269678e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0943879265948263,0.00637147924304248,0.081899827278463,0.10687602591119,2.92797749836418e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS1BP3,HCLS1-binding protein 3,39638,0.144832180644083,0.00976869952472038,0.125685529575631,0.163978831712535,2.95219858815449e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YJU2,Splicing factor YJU2,39919,0.0524631224764355,0.00353980776132365,0.0455250992642411,0.0594011456886298,3.10354964796212e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD36,Platelet glycoprotein 4,39657,0.0736038534439756,0.00497780072684668,0.0638473640193561,0.083360342868595,5.25976811634284e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFA,Vascular endothelial growth factor A,42253,0.0893773283522193,0.00606162811850521,0.0774965372399491,0.10125811946449,7.88985699847726e-49
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAT2,Signal transducer and activator of transcription 2,39657,0.123852005809763,0.00840821691280348,0.107371900660668,0.140332110958858,1.19670242297153e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0535733604388258,0.00364150143211897,0.0464360176318726,0.060710703245779,1.27944790487466e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMMD1,COMM domain-containing protein 1,39638,0.0960307269345587,0.00652965109826375,0.0832326107819617,0.108828843087156,1.67366044359486e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GET3,ATPase GET3,39958,0.084897648882847,0.00578401308749252,0.0735609832313617,0.0962343145343324,2.46957154090208e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6AP2,Renin receptor,41843,0.0618213169725801,0.00421527560399107,0.0535593767887576,0.0700832571564026,2.54508289989833e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.0963411383189003,0.00657107276296127,0.0834618357034962,0.109220440934304,2.67383470705836e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.114303505490473,0.00779757883617319,0.0990202509715739,0.129586760009373,2.77477523142317e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASC3,Protein CASC3,39649,0.0677046280623379,0.00462085958364041,0.0586477432784027,0.0767615128462731,3.699876538925e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGKA,Diacylglycerol kinase alpha,39657,0.0866723221064518,0.00592333343078677,0.0750625885821097,0.0982820556307939,4.90560696297483e-48
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA11,Annexin A11,42087,0.103391141488605,0.00709642246820061,0.0894821534509322,0.117300129526279,1.01175474509431e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXJ3,Forkhead box protein J3,39657,0.0705156503458394,0.00484282706674988,0.0610237092950097,0.0800075913966692,1.37251893335209e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF19,Fibroblast growth factor 19,42185,0.120983859448195,0.00831692451832841,0.104682687392271,0.137285031504118,1.396002645506e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.162474052838294,0.0111757643526054,0.140569554707187,0.1843785509694,1.5869585389413e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.123257065098362,0.00849463324318351,0.106607583941722,0.139906546255001,2.41696830444099e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.13518238322365,0.00931853065354115,0.11691806314271,0.153446703304591,2.49308387764941e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHRL,Appetite-regulating hormone,42145,0.128939034793475,0.00888910575046793,0.111516387522558,0.146361682064392,2.53760970496486e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.106778415823278,0.00736356565953945,0.0923458271305809,0.121211004515975,2.68547690249896e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPSE,Heparanase,39866,0.148228021858682,0.0102184150364591,0.128199928387223,0.168256115330142,2.95822558044428e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNMT,Histamine N-methyltransferase,41961,0.0743278237788912,0.00512776750946338,0.0642773994603429,0.0843782480974394,2.96705458263292e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0879083679848578,0.00606699556198605,0.0760170566833652,0.0997996792863505,3.23655215022886e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TWF2,Twinfilin-2,39966,0.132164071660071,0.0091163133300721,0.11429609753313,0.150032045787013,3.30931064264291e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD5,T-cell surface glycoprotein CD5,42239,0.0551436902950326,0.00380865272711542,0.0476787309498864,0.0626086496401788,3.70376812035308e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOM,Apolipoprotein M,42199,0.0439394865761618,0.00303499895259051,0.0379908886290844,0.0498880845232392,3.76246840285606e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPACT,Protein IMPACT,39929,0.0840301819766587,0.00580270751888259,0.0726568752396488,0.0954034887136686,4.19253692235667e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0604329207592847,0.00418142415955377,0.0522373294065593,0.0686285121120101,5.37657718664714e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.100158773802008,0.00693289921677562,0.0865702913371277,0.113747256266888,5.82573224130105e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.112849618378024,0.007804486603727,0.097552824634719,0.128146412121329,5.84746012290683e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,39934,0.118068661516024,0.00817186679259351,0.102051802602541,0.134085520429508,6.71270596147269e-47
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSG,Alpha-2-HS-glycoprotein,39990,0.0412269931748895,0.00285917107714464,0.035623017863686,0.046830968486093,1.00946884232777e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,41843,0.139795867246236,0.00971536224523096,0.120753757245583,0.158837977246888,1.35884857292326e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREH,Trehalase,39966,0.11597514684488,0.00805829215530618,0.10018089422048,0.13176939946928,1.4886142121183e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1S,Complement C1s subcomponent,39979,0.0324865787541834,0.00225837397418291,0.0280601657647849,0.0369129917435819,1.64437745595629e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPP,Lipoma-preferred partner,39575,0.10152095550813,0.00706557461516983,0.087672429262397,0.115369481753863,2.15139719758612e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0727599092644514,0.00506771107359053,0.062827195560214,0.0826926229686888,2.43496980384728e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD226,CD226 antigen,39657,0.0654207586972199,0.00455614885540604,0.0564907069406241,0.0743508104538158,2.44774728125524e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RWDD1,RWD domain-containing protein 1,42249,0.0955614173963195,0.00666723162365365,0.0824936434139584,0.108629191378681,2.94800574752166e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOK1,Docking protein 1,39929,0.210687438505537,0.0146919577351849,0.181891201344574,0.239483675666499,3.10757996954063e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAMP8,Vesicle-associated membrane protein 8,39657,0.134708543158272,0.00941673231252572,0.116251747825722,0.153165338490823,5.2190266512082e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCG2,Secretogranin-2,42193,0.0504445603189182,0.00353362584487814,0.043518653662957,0.0573704669748793,6.66808835675367e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNPY4,Protein canopy homolog 4,42070,0.11484579210562,0.00804507853626337,0.0990774381745443,0.130614146036697,6.74234832481404e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0772194443202232,0.00541095519360011,0.066613972140767,0.0878249164996794,7.14497123586637e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP6,Bone morphogenetic protein 6,41886,0.0611524836661551,0.00428760437602062,0.0527487790891547,0.0695561882431555,8.14817118241244e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.109709781815386,0.00769354100664495,0.0946304414423618,0.12478912218841,8.31691071050909e-46
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFASC,Neurofascin,42296,0.0444226688625477,0.0031212152680279,0.038305086937213,0.0505402507878824,1.21802293575124e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLG4,Disks large homolog 4,39929,0.109938876408104,0.00772256593858566,0.0948026471684763,0.125075105647732,1.3522904722784e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOXO3,Forkhead box protein O3,41843,0.146483303281863,0.0102981358778512,0.126298956961275,0.166667649602452,1.40296884162986e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAX,Protein max,41839,0.161730845070279,0.0113766168722535,0.139432676000662,0.184029014139896,1.5744966122694e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.131036168938999,0.00921577074207945,0.112973258284524,0.149099079593475,1.75598556715679e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0745199493209863,0.00524191955845178,0.0642457869864208,0.0847941116555518,1.83071302111774e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG4,BAG family molecular chaperone regulator 4,39657,0.0769953074939472,0.00541618863534565,0.0663795777686697,0.0876110372192247,1.83771287616918e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MGLL,Monoglyceride lipase,42166,0.132630096279921,0.00934286021428869,0.114318090259915,0.150942102299927,2.05371478971067e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAS6,Growth arrest-specific protein 6,42236,-0.038284417073625,0.00270179444299855,-0.0435799341819022,-0.0329888999653479,2.94278961097415e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0389567857440572,0.0027506456390605,0.0335655202914987,0.0443480511966158,3.27258361156439e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMPR2,GMP reductase 2,39736,0.100764833393702,0.00711182958164517,0.0868256474136771,0.114704019373726,3.53447346219156e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASHC3,WASH complex subunit 3,39929,0.115126314697488,0.00813287846730028,0.0991858729015798,0.131066756493397,4.17266185541285e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TALDO1,Transaldolase,39948,0.066946736948487,0.00473173735519857,0.0576725317322979,0.0762209421646762,4.60885451750293e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPART,Spartin,39736,0.117792825039163,0.00832600112972861,0.101473862824895,0.134111787253431,4.74255458850263e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNLR1,Interferon lambda receptor 1,42119,0.0551332521431264,0.00390275991687006,0.0474838427060611,0.0627826615801917,5.4294200144787e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0571242491311571,0.00404391367019935,0.0491981783375664,0.0650503199247478,5.5491715272059e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH9,Protocadherin-9,39930,0.0512086748341384,0.00362476221425304,0.0441041408942025,0.0583132087740744,6.1867765394836e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.091844063950247,0.00651413539470628,0.0790763585766227,0.104611769323871,7.95222133131017e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FMNL1,Formin-like protein 1,41839,0.0955249542334086,0.0067749887458747,0.0822459762914942,0.108803932175323,8.05055657501372e-45
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL11,Eotaxin,42296,0.0563604906389263,0.00400264926843699,0.0485152980727898,0.0642056832050628,1.02184952480395e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18,Interleukin-18,42069,0.0667977623914009,0.00474798883508157,0.0574917042746411,0.0761038205081608,1.22508675774579e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBXN1,UBX domain-containing protein 1,39736,0.103700920830885,0.00737000016627924,0.0892557205049775,0.118146121156792,1.38446470176627e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEXN,Nexilin,39990,0.105003876408065,0.00746500352590186,0.0903724694972975,0.119635283318833,1.44611777288792e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSC22D1,TSC22 domain family protein 1,39934,0.0993896059891594,0.00706580246931751,0.0855406331492971,0.113238578829022,1.44947374000827e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCAM,Cell surface glycoprotein MUC18,42217,-0.0481571370142218,0.00342837355598718,-0.0548767491839566,-0.0414375248444869,1.65131168550083e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.105685045101825,0.007525942920152,0.0909341969783275,0.120435893225323,1.7478587946219e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TADA3,Transcriptional adapter 3,39919,0.0606697220244953,0.00433437791735923,0.0521743413064712,0.0691651027425194,3.77404822838198e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM17,Splicing factor 45,39934,0.115085298639445,0.00822943196544402,0.0989556119871749,0.131214985291715,4.49536003559945e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CETN2,Centrin-2,41839,0.101964009540586,0.00729671778124538,0.0876624426893446,0.116265576391827,4.61971725162942e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.113929786367868,0.00816035654792335,0.0979354875339378,0.129924085201797,5.49690501553835e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",39934,0.094937229473886,0.00679615830107325,0.0816167592037824,0.10825769974399,5.55672333302042e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.132631611852447,0.00949677576190124,0.114017931359121,0.151245292345774,5.80443015912232e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS2,Trypsin-2,42217,0.0853529619768413,0.00611920488354855,0.0733593204050861,0.0973466035485964,6.45214535726738e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDC,Nuclear migration protein nudC,42296,0.094843266445173,0.00680114031018676,0.081513031437207,0.108173501453139,6.71475182423176e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0779101889116126,0.00558311766313294,0.066967278291872,0.0888530995313531,6.8084241191174e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0859491642807533,0.00616169150980543,0.0738722489215347,0.098026079639972,7.46011853380854e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEPR,Leptin receptor,42145,-0.0468838562582543,0.00336574015594238,-0.0534807069639014,-0.0402870055526072,8.37770246910408e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.14306205470366,0.010270565098128,0.122931747111329,0.163192362295991,8.43581849782641e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0694863420811746,0.00499106369113253,-0.0792688269157943,-0.0597038572465548,9.25293881648864e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53,Cellular tumor antigen p53,41843,0.0663716909795611,0.00476865228628088,0.0570251324984506,0.0757182494606717,9.9592200842572e-44
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICA1,Islet cell autoantigen 1,41913,0.118970008141367,0.00857171419264837,0.102169448323776,0.135770567958958,1.69677477769751e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0526230604033052,0.00379062524394662,0.0451934349251698,0.0600526858814406,1.83741716973204e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0718681340060956,0.00517993207156152,0.061715467145835,0.0820208008663562,2.04716532146511e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RFC4,Replication factor C subunit 4,39919,0.0329479065477202,0.00237504441722713,0.028292819489955,0.0376029936054854,2.10403198459254e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0693299314802736,0.00499722792075448,0.0595353647555948,0.0791244982049524,2.11461029294282e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0675011093376577,0.0048669150916208,0.0579619557580809,0.0770402629172344,2.20144053755482e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0547373136146372,0.00394763575461909,0.0469999475355838,0.0624746796936907,2.30465993345144e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPT1,Angiopoietin-1,42085,0.123998805276202,0.00895017824264444,0.106456455920619,0.141541154631785,2.37244822764824e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,42145,0.119442486106182,0.00862463995708115,0.102538191790303,0.136346780422061,2.5458516398776e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGL1,Fibrinogen-like protein 1,39990,-0.0960907442941583,0.00693748893918287,-0.109688222614957,-0.0824932659733599,2.81460908877952e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HYOU1,Hypoxia up-regulated protein 1,42310,0.0339468078810295,0.00245374526893706,0.0291374671539129,0.0387561486081461,3.07239945181021e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRY2,Protein sprouty homolog 2,41913,0.137691298026985,0.00995490450377873,0.118179685199578,0.157202910854391,3.27365120629031e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRAS,Ras-related protein R-Ras,39649,0.195007863369727,0.0140948335720559,0.167381989568498,0.222633737170957,3.56728891736307e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGF,Pro-epidermal growth factor,42081,0.153884851534821,0.0111453149566597,0.132040034219768,0.175729668849874,4.53220643493595e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CETN3,Centrin-3,39930,0.116414368945479,0.0084260649935474,0.0998992815581265,0.132929456332832,4.55880096888936e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2,Microtubule-associated protein 2,39929,0.0692521883075899,0.00501673877731316,0.0594193803040561,0.0790849963111236,5.3529794370923e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.139249075702303,0.0101052302367734,0.119442824438227,0.159055326966379,7.45548120575205e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F2,Prothrombin,39979,0.0219344714241203,0.00159279664630751,0.0188125899973576,0.025056352850883,8.38538243282681e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.116663945434048,0.00847322593749196,0.100056422596564,0.133271468271532,8.89496258605421e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0633911156606768,0.00460880958044404,0.0543578488830065,0.0724243824383471,9.35225986601214e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFA,Platelet-derived growth factor subunit A,42310,0.105827635144268,0.00769710929417154,0.0907413009276915,0.120913969360844,9.91499715421521e-43
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINE2,Glia-derived nexin,39958,0.0955297443304844,0.00694907130307681,0.0819095645764539,0.109149924084515,1.16270929996076e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRAP2,GRB2-related adapter protein 2,42145,0.189653905060561,0.013823308521232,0.162560220358947,0.216747589762176,1.48620804923274e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0788481592122716,0.00574761999014734,0.0675828240315828,0.0901134943929604,1.52154072439362e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHMP1A,Charged multivesicular body protein 1a,42016,0.116518930138507,0.00850175821635323,0.0998554840344545,0.133182376242559,1.82356121987892e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINC1,Antithrombin-III,39959,0.0212337200573072,0.00155006933081269,0.0181955841689143,0.0242718559457,2.24717823830028e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WDR46,WD repeat-containing protein 46,39919,0.053699553083215,0.00392445706694473,0.0460076172320033,0.0613914889344267,2.77016350644468e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0830035705026725,0.00607127808908403,0.0711038654480678,0.0949032755572772,2.86767314758099e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UROD,Uroporphyrinogen decarboxylase,39736,0.0993306684096852,0.00726068168900733,0.0850997322992308,0.11356160452014,2.90886607755506e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EHD3,EH domain-containing protein 3,39638,0.172922632524718,0.0126538279555549,0.14812112973183,0.197724135317605,3.58674704809039e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0674565470877214,0.00493702063898297,0.0577799866353148,0.077133107540128,3.67017986493224e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53I3,Quinone oxidoreductase PIG3,39513,0.0777009965471854,0.0056868823306107,0.0665547071791885,0.0888472859151824,3.74023278198572e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP10,Caspase-10,41839,0.104156989947427,0.00764573929170749,0.0891713409356801,0.119142638959173,5.61577753412935e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEMIP2,Cell surface hyaluronidase,39657,0.0472641556565793,0.00346964497912916,0.0404636514974862,0.0540646598156725,6.43670970219027e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,A1BG,Alpha-1B-glycoprotein,39979,0.0241173397263902,0.00177098204059863,0.0206462149268169,0.0275884645259635,6.65817128348172e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0594984516592072,0.00437745967043241,0.0509186307051597,0.0680782726132547,8.46200304712346e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNM3,Dynamin-3,39934,0.0802676714471319,0.00590214734417107,0.0686994626525566,0.0918358802417072,8.54567213536888e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0712392047968664,0.00524046051107635,0.0609679021951568,0.0815105073985761,9.22250983754784e-42
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.122120948038145,0.00900399034755099,0.104473126956945,0.139768769119345,1.26328389919594e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNCG,Gamma-synuclein,42016,0.0970538821839592,0.00715908315342286,0.0830220792032503,0.111085685164668,1.35765177236912e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NACC1,Nucleus accumbens-associated protein 1,39919,0.0805257542559883,0.00593805581157542,0.0688871648653004,0.0921643436466761,1.44019416366223e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.119727416082829,0.00883481246198949,0.102411183657329,0.137043648508328,1.44285009694315e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0424038069443088,0.00313124184079217,0.0362665729363561,0.0485410409522614,1.85979171416081e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PF4,Platelet factor 4,39914,0.141264421022031,0.0104541723063703,0.120774243301545,0.161754598742517,2.74854095696014e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCT5,T-complex protein 1 subunit epsilon,41843,0.0655135605499608,0.00485302494733232,0.0560016316531894,0.0750254894467321,2.94917776987081e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RILPL2,RILP-like protein 2,39958,0.143023377989183,0.0105904465823122,0.122266102687851,0.163780653290515,3.04150702430725e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMPER,BMP-binding endothelial regulator protein,39736,0.0333862161046178,0.00247527800859235,0.0285346712077768,0.0382377610014588,3.87601612651639e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTF1,Cardiotrophin-1,41900,0.121998426457734,0.00905536644779602,0.104249908220054,0.139746944695414,4.2225287788416e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0719414279424718,0.00533685665776575,0.0614811888932509,0.0824016669916927,4.2923968245098e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0840961481899584,0.00625015155343849,0.0718458511452189,0.0963464452346978,6.03310015765658e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0461921509743193,0.00343695040187537,-0.052928573761995,-0.0394557281866436,6.43964399388139e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSNL1,Visinin-like protein 1,39929,0.0558502368545036,0.004154128946784,0.047708144118807,0.0639923295902003,6.82109474904923e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMT,Catechol O-methyltransferase,41740,0.119799284531697,0.00892353015284455,0.102309165432122,0.137289403631273,8.00590910346074e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPARC,SPARC,42181,0.100518599048465,0.00748969232181563,0.0858388020977061,0.115198395999223,8.29670244685151e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL7,Interleukin-7,42119,0.0929923692424785,0.00692911114812146,0.0794113113921604,0.106573427092797,8.36278238620638e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0806662331508296,0.00601404192979153,0.0688787109684382,0.092453755333221,9.19509609794917e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF23,Fibroblast growth factor 23,42250,0.0726411857403004,0.00541619731972994,0.0620254389936297,0.0832569324869711,9.3351538438563e-41
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKG1,cGMP-dependent protein kinase 1,39736,0.180932823131012,0.0135297908351908,0.154414433094038,0.207451213167986,1.78548918109889e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMG3,Proteasome assembly chaperone 3,42119,0.0708420286252017,0.00530281731794376,0.060448506682032,0.0812355505683715,1.88626459126664e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESYT2,Extended synaptotagmin-2,39929,0.11940327758844,0.00893615077094888,0.10188842207738,0.1369181330995,2.04299718318523e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LARP1,La-related protein 1,39919,0.0891520454660348,0.00667635003711553,0.0760663993932884,0.102237691538781,2.28481920228473e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMVK,Phosphomevalonate kinase,41832,0.155499480921389,0.0116572392019981,0.132651292085472,0.178347669757305,2.49020441153846e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0490401467854714,0.0036773676147794,0.0418325062605038,0.0562477873104391,2.58180518031883e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0736695465242481,0.00552490229528898,0.0628407380254817,0.0844983550230144,2.99784866861409e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.109480017043596,0.00823404515502584,0.0933412885397451,0.125618745547446,4.35436280119494e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK24,Serine/threonine-protein kinase 24,41839,0.088675114797129,0.00666929572909614,0.0756032951681005,0.101746934426157,4.41063958530319e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0955017226029858,0.00720232922795252,0.0813851573161988,0.109618287889773,7.92643405369457e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0862824091223773,0.00651974744012892,0.0735037041397246,0.09906111410503,9.97636963415496e-40
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0946410983623272,0.00714893750828565,0.0806291808460873,0.108653015878567,1.04752871758631e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.138529926491114,0.0104881592204357,0.11797313441906,0.159086718563168,1.39943120322663e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNDP1,Beta-Ala-His dipeptidase,42217,0.0652156683893755,0.00494755684685026,0.0555184569695489,0.074912879809202,1.95804258234206e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0450440564237525,0.00342016426731361,0.0383405344598178,0.0517475783876871,2.57841740096856e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPON2,Spondin-2,42070,-0.0491119358952647,0.00373951066941443,-0.0564413768073169,-0.0417824949832124,3.69448515884056e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATG4A,Cysteine protease ATG4A,41843,0.0819240278387414,0.00624331054277555,0.0696871391749014,0.0941609165025815,4.32473195198115e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0737020426268386,0.00561523882597865,0.0626961745279205,0.0847079107257568,4.59208347874075e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PQBP1,Polyglutamine-binding protein 1,41843,0.0794341807403825,0.00606756357770374,0.0675417561280831,0.0913266053526818,6.41328392706882e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0793440217379487,0.00606115549364883,-0.0912238865055005,-0.067464156970397,7.25545865628852e-39
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA4D,Semaphorin-4D,42249,0.0420660443674194,0.00322490353683314,0.0357452334352265,0.0483868552996124,1.16858980808265e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPBP,Platelet basic protein,39908,0.119935951054366,0.00919079307324508,0.101921996630806,0.137949905477927,1.21457219218469e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD22,B-cell receptor CD22,42296,0.0595934559518626,0.00457256288630137,0.0506312326947119,0.0685556792090133,1.3501754934483e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0904948327787171,0.00694385724660038,0.0768848725753804,0.104104792982054,1.3609894357795e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NID1,Nidogen-1,42189,0.0502853219137592,0.00386182916596912,0.0427161367484597,0.0578545070790586,1.57779327270425e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNRD2,Protein ZNRD2,39930,0.0973968163008086,0.00748129126068023,0.0827334854298753,0.112060147171742,1.80712031454983e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK13,Kallikrein-13,41839,0.0625798311851661,0.00481331408700222,0.0531457355746417,0.0720139267956904,2.06405248696637e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0791263415058556,0.00608855755867929,0.0671927686908442,0.091059914320867,2.19545657040816e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F12,Coagulation factor XII,39979,0.0574620337500011,0.0044231198535467,0.0487927188370496,0.0661313486629526,2.56650876442158e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.0523656966182412,0.00403353008534469,0.0444599776509656,0.0602714155855168,2.62444833449062e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DFFA,DNA fragmentation factor subunit alpha,42296,0.0929383445045761,0.00716167495738549,0.0789014615881006,0.106975227421052,2.77145807807306e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.0370300772394969,0.00285295528443537,-0.0426218695969903,-0.0314382848820036,2.9851382364488e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RILP,Rab-interacting lysosomal protein,42224,0.0814836606524502,0.00628316316017546,0.0691686608585063,0.0937986604463941,3.10507488982117e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL3,C-C motif chemokine 3,42119,0.082545544766968,0.00636982645919582,0.0700606849069442,0.0950304046269918,3.53405464979403e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED8,Protein TMED8,39930,0.143610671870032,0.0110796744764397,0.12189450989621,0.165326833843853,3.76847460286244e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDT,D-dopachrome decarboxylase,39966,0.0565191423614108,0.0043617997232872,0.0479700149037679,0.0650682698190537,3.9530891591327e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP7,Caspase-7,39929,0.117344464552875,0.00906395586925334,0.0995791110491386,0.135109818056612,4.590186335425e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0278439337986513,0.00215285656297067,0.0236243349352288,0.0320635326620738,5.41069213732682e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.120542016521797,0.00932211668148685,0.102270667826083,0.138813365217511,5.66080128474767e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIABLO,"Diablo homolog, mitochondrial",42107,0.151546495980148,0.0117369847403769,0.12854200588901,0.174550986071287,6.46546066124583e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTF2,Transcription termination factor 2,39649,0.0689436792337368,0.00534021501051518,0.058476857813127,0.0794105006543465,7.39359558825218e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL8,C-C motif chemokine 8,42239,0.0837606296106423,0.00649580017109831,0.0710288612752896,0.096492397945995,8.03080144418834e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARA5,Scavenger receptor class A member 5,42249,0.0421804275363066,0.00327192677858646,0.0357674510502771,0.0485934040223361,8.33870457843266e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.136837387013383,0.0106103167852315,0.116041166114329,0.157633607912437,8.66906477059626e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA1,Carboxypeptidase A1,42310,0.0893705706956789,0.00693725374662188,0.0757735533523,0.102967588039058,9.32651937725699e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4G,C-type lectin domain family 4 member G,42119,0.0462417211795042,0.00359078002454358,0.0392037923313988,0.0532796500276096,9.98751887787736e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0905861715335034,0.00702927552946408,0.0768087914957538,0.104363551571253,9.99991542190528e-38
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.10903558021651,0.00846747356574754,0.0924393320276452,0.125631828405376,1.01442850498995e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPB1,Carboxypeptidase B,42310,0.0856137584223905,0.00665262562569198,0.0725746121960342,0.0986529046487468,1.10902029347083e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLB1,Beta-galactosidase,42016,0.0594183322502387,0.00462278085685802,0.0503576817707969,0.0684789827296804,1.37197012897391e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUB1,NEDD8 ultimate buster 1,42119,0.116090092934555,0.0090322806702788,0.0983868228208082,0.133793363048301,1.37675552032826e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APPL2,DCC-interacting protein 13-beta,39736,0.155679558105667,0.0121052866966789,0.131953196180176,0.179405920031157,1.39021275151865e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0351038867175491,0.0027298875285069,0.0297533071616756,0.0404544662734226,1.39784766194097e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL7,Angiopoietin-related protein 7,42262,0.0506188603087856,0.00394147280146561,0.042893573617913,0.0583441469996582,1.55954027594402e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0369269329073029,0.00287602607456923,0.0312899218011472,0.0425639440134586,1.79273454118503e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.104111448844302,0.00811620573888822,0.0882036855960813,0.120019212092523,2.12375930752036e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMOX2,Heme oxygenase 2,41839,0.0656637410097732,0.00512934105142037,0.0556102325489893,0.0757172494705571,2.67250105633068e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0895134679843971,0.00700084634293569,0.0757918091522432,0.103235126816551,3.25420266022801e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0633243769554622,0.0049673528659425,0.0535883653382149,0.0730603885727095,5.19171116790213e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0507381414538606,0.00398615441713453,0.0429252787962769,0.0585510041114442,7.33569103914395e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0686152307943791,0.00539604848747774,0.0580389757589227,0.0791914858298354,7.79615800758016e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.11602673470436,0.00913149743233994,0.0981289997369738,0.133924469671746,9.72160811324315e-37
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIFBP,KIF-binding protein,42070,0.112374028805816,0.00885207015398137,0.0950239713040128,0.12972408630762,1.02726551828999e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDF2,Growth/differentiation factor 2,42145,0.0480629518132047,0.00378837291174224,0.0406377409061899,0.0554881627202195,1.12903274084218e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FIS1,Mitochondrial fission 1 protein,42125,0.104391003655222,0.00822863240775341,0.0882628841360253,0.120519123174419,1.13915359222368e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,39736,0.162854226379577,0.0128405588653518,0.137686731003488,0.188021721755667,1.31874834415702e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL1,Growth-regulated alpha protein,42117,0.126376609518125,0.00997504679515479,0.106825517799622,0.145927701236629,1.41247523220625e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCB,Tubulin-folding cofactor B,42016,0.135757535083809,0.0107286141774294,0.114729451296047,0.15678561887157,1.72283550415655e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD69,Early activation antigen CD69,42082,0.118708644650189,0.00938878225443465,0.100306631431497,0.137110657868881,1.95197144785966e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.151300860293538,0.0119721512765441,0.127835443791512,0.174766276795565,2.12141533769175e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.114262430838377,0.00904603168937657,0.0965322087271994,0.131992652949556,2.30191014240607e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0665033754401802,0.00526217128321726,0.0561895197250743,0.076817231155286,2.32376260002662e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0899364114141379,0.00711811623443236,0.0759849035946505,0.103887919233625,2.42767384875027e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.102989064023814,0.00816437959439976,0.0869868800187906,0.118991248028838,2.80955129081383e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MENT,Protein MENT,39736,-0.0321060004142237,0.00254894212133437,-0.0371019269720391,-0.0271100738564084,3.92460906359083e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASSF2,Ras association domain-containing protein 2,41843,0.0771344621521982,0.00612759777149698,0.0651243705200642,0.0891445537843323,3.95544056982398e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEP1B,Meprin A subunit beta,42145,0.154564294643546,0.0122905546895754,0.130474807451978,0.178653781835113,4.55858891024765e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGCT,Gamma-glutamylcyclotransferase,39952,0.06414507470501,0.00509860986498453,0.0541517993696403,0.0741383500403796,4.67839123057366e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0738451849387998,0.00588175900668225,0.0623169372857026,0.085373432591897,5.96752135751748e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPB1,Heat shock protein beta-1,41949,0.0942859781598762,0.00751717522110823,0.0795523147265041,0.109019641593248,6.94098892530272e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRDL2,Chordin-like protein 2,42145,0.0614114901365911,0.0049009111237804,0.0518057043339815,0.0710172759392007,8.01903956654592e-36
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL18,C-C motif chemokine 18,42020,0.0941530555636212,0.00752749766829446,0.0793991601337641,0.108906950993478,1.06896854978346e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YWHAQ,14-3-3 protein theta,39736,0.0992946396996128,0.00795213522884346,0.0837084546510796,0.114880824748146,1.52886496779565e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD72,B-cell differentiation antigen CD72,39736,0.0581430800627474,0.00465662956744408,0.049016086110557,0.0672700740149378,1.53744322476515e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,39990,0.0980834151565152,0.00785712866735453,0.0826834429685004,0.11348338734453,1.57103772079389e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRG1,Scrapie-responsive protein 1,39958,0.0365885543571512,0.00293206501160527,0.0308417069344049,0.0423354017798976,1.66566389232978e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEPH,Hephaestin,39958,0.0373558475740297,0.00299387635591962,0.0314878499164272,0.0432238452316321,1.69371359355981e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.132272924397136,0.0106175145496092,0.111462595879902,0.15308325291437,2.19286726944461e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0991063597603669,0.00796002617735063,0.0835047084527597,0.114708011067974,2.38548427325629e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0427580448549363,0.00344080478696033,-0.0495020222373785,-0.036014067472494,2.89650807249896e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0835912025815472,0.00672764341291902,0.070405021492226,0.0967773836708685,2.97453254540468e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRADD,Death domain-containing protein CRADD,41997,0.0994115723070047,0.00800923151012893,0.083713478547152,0.115109666066857,3.50594816946564e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JAM3,Junctional adhesion molecule C,39736,0.0676997266766038,0.00545450905296332,0.0570088889327957,0.0783905644204119,3.85460084846781e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0959933900252009,0.00773953494241872,0.0808239015380602,0.111162878512342,3.94501215949017e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0894322612928608,0.00721297664140236,0.0752948270757122,0.103569695510009,4.15380200906465e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0569269841701834,0.00459248614273057,0.0479257113304314,0.0659282570099353,4.26445569662932e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.124272650720463,0.0100406561294382,0.104592964706764,0.143952336734162,5.4069782843059e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0395538406008149,0.00319704386579564,0.0332876346238554,0.0458200465777744,5.71509249212548e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.036949117040163,0.00299144131971159,0.0310858920535283,0.0428123420267977,7.31963385414178e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,39649,0.105264048034015,0.00852106776010097,0.0885627552242176,0.121965340843813,7.92638518632304e-35
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XCL1,Lymphotactin,42262,0.0719861485468528,0.00585225097449293,0.0605157366368467,0.083456560456859,1.37028165589407e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS1,Galectin-1,42145,0.0461278877890398,0.00375377637399248,0.0387704860960145,0.0534852894820651,1.59662026684532e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS9,Galectin-9,42129,0.0413938329231745,0.00336950616057769,0.0347896008484423,0.0479980649979068,1.66847310810387e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.138121712089747,0.0112378145218172,0.116095595626986,0.160147828552509,1.69776508056562e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0884495701192031,0.00720126257394244,0.074335095474276,0.10256404476413,1.71579921011224e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MATN2,Matrilin-2,42144,0.0390511988155827,0.00317987028457171,0.0328186530578221,0.0452837445733432,1.75309912650701e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F11,Coagulation factor XI,39822,0.0414375816441017,0.00337306602232672,0.0348263722403413,0.048048791047862,1.81866271391659e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0805833321167145,0.00656063838117943,0.0677244808896028,0.0934421833438261,1.87915173795115e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNMA1,Paraneoplastic antigen Ma1,39638,0.0754366357626759,0.00614746465223022,0.0633876050443046,0.0874856664810471,2.16646817853535e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD244,Natural killer cell receptor 2B4,42296,0.0361695474281286,0.00295314248048946,0.0303813881663693,0.041957706689888,2.60881908050614e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0701073265805,0.00572367960608283,0.0588889145525777,0.0813257386084224,2.61905299035382e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BIN2,Bridging integrator 2,42137,0.117134863332798,0.00957523365587247,0.0983674053672879,0.135902321298308,3.13604574909795e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATOX1,Copper transport protein ATOX1,42181,0.0932210416068367,0.00762276413075608,0.0782804239105548,0.108161659303119,3.28063362384556e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0653280489341285,0.00534292660509528,0.0548559127881418,0.0758001850801153,3.40897683940388e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THPO,Thrombopoietin,41900,0.0510815829800016,0.00418109500262712,0.0428866367748524,0.0592765291851507,3.83053200409221e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTUD6B,Deubiquitinase OTUD6B,39930,0.0759755595706758,0.00622163308018703,0.0637811587335093,0.0881699604078424,4.41721883326131e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REEP4,Receptor expression-enhancing protein 4,39934,0.0816697487192809,0.0066912584209262,0.0685548822142656,0.0947846152242962,4.75417179971534e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CERT,Ceramide transfer protein,41839,0.0802884807080521,0.00659149513220125,0.0673691502489376,0.0932078111671665,5.98982535927906e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THTPA,Thiamine-triphosphatase,39897,0.114803429307253,0.0094215468363428,0.0963371975080209,0.133269661106485,6.08518828450955e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0515794428937104,0.00423694769953947,0.043275025402613,0.0598838603848077,6.44333534834176e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACYBP,Calcyclin-binding protein,39713,0.135497280483226,0.0111306390966089,0.113681227853873,0.15731333311258,7.0790775222807e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.118047092956413,0.00969724235383798,0.0990404979428906,0.137053687969935,7.1049927661738e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB33A,Ras-related protein Rab-33A,39575,0.0867555863493648,0.00713016000371859,0.0727804727420764,0.100730699956653,7.65414631154443e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APP,Amyloid-beta precursor protein,42112,0.0862969221616266,0.00710008420532877,0.0723807571191823,0.100213087204071,8.16538289362175e-34
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDC4,Syndecan-4,42145,0.0616275227494906,0.00507805616783588,0.0516745326605322,0.0715805128384489,1.01790061114906e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0410875855632366,0.00338629900954983,0.034450439504519,0.0477247316219543,1.05001079685772e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOD,Apolipoprotein D,39468,-0.0552944225521502,0.0045554285906519,-0.0642230625898279,-0.0463657825144725,1.09513006628452e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSZ,Cathepsin Z,42168,0.0419144657283863,0.00345920205730472,0.035134429696069,0.0486945017607035,1.2833492888563e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYO9B,Unconventional myosin-IXb,41913,0.0857803481453025,0.0070800589313828,0.0719034326397922,0.0996572636508128,1.30937720237329e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA1,Apolipoprotein A-I,39979,-0.0356700087412876,0.00294367024561594,-0.0414396024226949,-0.0299004150598804,1.37294224169633e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.116455939513725,0.0096141543192562,0.0976121970479828,0.135299681979467,1.45172116650181e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAP18,Chromatin complexes subunit BAP18,39929,0.0885357689560321,0.00731394100165975,0.074200444592779,0.102871093319285,1.59839784661949e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARK7,Parkinson disease protein 7,42137,0.0657237873806764,0.00543288596972937,0.0550753308800068,0.0763722438813459,1.62311289880815e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FEN1,Flap endonuclease 1,41843,0.0835586426708638,0.00690733603276805,0.0700202640466385,0.0970970212950892,1.64357990385112e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN4,CCN family member 4,42262,0.0507405736340677,0.00419753534302768,0.0425134043617334,0.0589677429064019,1.80713194288474e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA1,GDNF family receptor alpha-1,42247,0.0370154975504626,0.00306315836373935,0.0310117071575335,0.0430192879433917,1.89909379753563e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0722991332450016,0.00598551165720797,0.060567530396874,0.0840307360931293,2.02503222456071e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD99L2,CD99 antigen-like protein 2,42137,0.0318755990504152,0.00263941066344326,0.0267023541500664,0.037048843950764,2.08025656313667e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD164,Sialomucin core protein 24,42137,0.0349698541214577,0.00289897359160895,0.0292878658819042,0.0406518423610113,2.45999763334429e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM106A,Transmembrane protein 106A,39919,0.0928480760919457,0.00769600310002103,0.0777639100159045,0.107932242167987,2.60459117678659e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMA,Granzyme A,42296,0.04389683716219,0.00364067600353305,0.0367611121952652,0.0510325621291148,2.61640944558623e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL2,C-C motif chemokine 2,41992,0.0671242834481149,0.00556733080872016,0.0562123150630234,0.0780362518332064,2.65579540840759e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,39915,0.113484505005222,0.00940964265318099,0.0950416054049872,0.131927404605457,2.73320522684035e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.12407314464258,0.0102988874924061,0.103887325157464,0.144258964127696,2.96535033332907e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0833106792684761,0.00691198291604151,0.0697631927530347,0.0968581657839175,2.98371074158e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA11,Integrin alpha-11,42119,-0.0438046886214833,0.00363796381320206,-0.0509350976953593,-0.0366742795476072,3.19943573052757e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIF1,Allograft inflammatory factor 1,41843,0.0675253154851195,0.0056132140546345,0.0565234159380359,0.0785272150322031,3.69259869368788e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB9,Serpin B9,42016,0.0423251066616208,0.00352333667433585,0.0354193667799226,0.0492308465433191,4.49868275508337e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STXBP1,Syntaxin-binding protein 1,39934,0.100543231982553,0.00836578326859144,0.0841462967761135,0.116940167188992,4.51802731716883e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0948539869337858,0.00789225169465601,0.07938517361226,0.110322800255312,4.56121158391121e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA12,Serpin A12,41751,0.139491526208113,0.0116218187586437,0.116712761441171,0.162270290975054,5.12432821858165e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L1,Bcl-2-like protein 1,39929,0.128443388224376,0.0106975825111993,0.107476126502425,0.149410649946327,5.191683918689e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSNAX,Translin-associated protein X,39575,0.050575983647367,0.00421657068133285,0.0423115051119546,0.0588404621827794,6.09328205646824e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRLF1,Cytokine receptor-like factor 1,42185,0.0319749699777939,0.00266980816376413,0.0267421459768162,0.0372077939787716,6.90738428674231e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB1,Leukocyte elastase inhibitor,42093,0.114916970053233,0.00960776003202564,0.0960857603904631,0.133748179716004,8.34660008394374e-33
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D5,TBC1 domain family member 5,42119,0.100024777805085,0.00837895395342577,0.0836020280563708,0.1164475275538,1.09976383458351e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.127225881794658,0.0106720198973433,0.106308722795865,0.148143040793451,1.33295819722636e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C3,Complement C3,39445,0.0589292608622185,0.00494235764351192,0.0492422398809351,0.0686162818435018,1.42936184818515e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0685502449243958,0.00575031509004995,0.0572796273478979,0.0798208625008936,1.4379878534226e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PVR,Poliovirus receptor,42249,0.0477567083965099,0.00401307607558076,0.0398910792883716,0.0556223375046482,1.70765278886946e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MESD,LRP chaperone MESD,42137,0.155483126081002,0.0130789132134228,0.129848456182694,0.181117795979311,1.97930312593152e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MIF,Macrophage migration inhibitory factor,42105,0.0854042968418254,0.00718634094450609,0.0713190685905935,0.0994895250930574,2.07281824582465e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,39930,0.106521037954092,0.00895960530094025,0.0889602115642494,0.124081864343935,2.10268819354845e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0610689923820263,0.00513838750472247,0.0509977528727703,0.0711402318912823,2.20878946291284e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB6,Serpin B6,42216,0.0745583965231167,0.00628225016229345,0.0622451862050215,0.0868716068412118,2.50191283113986e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.120678460704849,0.010168679572298,0.100747848743145,0.140609072666553,2.70771853544926e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.087976743208335,0.00741620593031454,0.0734409795849185,0.102512506831752,2.90817757671595e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA3,Annexin A3,42224,0.0883685487879939,0.00745621621503509,0.0737543650065251,0.102982732569463,3.03802562341702e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0853346797199645,0.00719867887573943,0.0712252691235152,0.0994440903164138,3.20720438374551e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.078296386332202,0.00660741870916395,0.0653458456622406,0.0912469270021633,3.33901687762964e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0588096424396765,0.00496293759592728,0.0490822847516591,0.068537000127694,3.37878002853795e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP2,Caspase-2,42119,0.0868102838356443,0.00734263522758203,0.0724187187895835,0.101201848881705,4.28402262252018e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0496866399432691,0.0042091496360869,0.0414367066565388,0.0579365732299995,5.69358761597803e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0593550640000725,0.00502857593148652,0.0494990551743589,0.0692110728257861,5.75641961061649e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0420669904544702,0.00356899766537865,0.035071755030328,0.0490622258786123,6.51680005501881e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.0385716098909684,0.0032736080872948,0.0321553380398706,0.0449878817420662,6.85222082131966e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0467852045026455,0.00397166536481799,0.0390007403876023,0.0545696686176888,7.10170217247149e-32
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIAPIN1,Anamorsin,42181,0.0772580518046821,0.00657821658701321,0.0643647472941362,0.090151356315228,1.07226313904138e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUGT1,Protein SGT1 homolog,41843,0.100699605983951,0.00858052348532005,0.0838817799527234,0.117517432015178,1.19776015700031e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.11433074886279,0.00974975225740642,0.0952212344382731,0.133440263287306,1.43409850996221e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.130841443158283,0.0111665937522492,0.108954919403874,0.152727966912691,1.58105415348366e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0595324674185492,0.00508562050885125,0.0495646512212007,0.0695002836158976,1.69513843721298e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAP,Prolyl endopeptidase FAP,42310,0.0345737076517372,0.00295414531145878,0.028783582841278,0.0403638324621964,1.72746220368307e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NBN,Nibrin,41913,0.068304284312265,0.00583822579847993,0.0568613617472443,0.0797472068772856,1.82774715483683e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSPN,Persephin,42119,0.108676302819406,0.00929020025034452,0.0904675103287308,0.126885095310081,1.85098080740277e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.053880075303127,0.00460371477557035,0.0448567943430091,0.0629033562632449,1.86623330861627e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.115067642688067,0.00984204814988224,0.0957772283142981,0.134358057061836,1.99714978085284e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STXBP3,Syntaxin-binding protein 3,41843,0.0545947963893469,0.00466999661380914,0.045441603026281,0.0637479897524128,2.03256176976194e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC3B,Tetranectin,39726,0.0263296435340642,0.0022560750666665,0.0219077364033978,0.0307515506647305,2.74201102882922e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0999718644077883,0.00858179127231319,-0.116792175301522,-0.0831515535140544,3.25888047845014e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0798870672470914,0.00685824714321035,0.0664449028463991,0.0933292316477837,3.54754353783201e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPI,Glucose-6-phosphate isomerase,39990,0.0596657575645513,0.00513226159964057,0.0496065248292558,0.0697249902998468,4.57197578256856e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL16,C-X-C motif chemokine 16,42295,0.0290843979808073,0.00250338306119087,0.0241777671808732,0.0339910287807414,4.66656165158137e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MICALL2,MICAL-like protein 2,39649,0.0854823849702766,0.0073598369214338,0.0710571046042663,0.0999076653362868,5.25153145211245e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.120834688259384,0.0104071456235189,0.100436682837287,0.141232693681481,5.5002876372922e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACYP1,Acylphosphatase-1,39701,0.0810198650931855,0.00698296147226808,0.06733326060754,0.0947064695788309,6.03508364441329e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX8,Syntaxin-8,42119,0.0596196282413716,0.00514178599588452,0.0495417276894379,0.0696975287933052,6.11074062073815e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.0761274000930781,0.0065740380104708,0.0632422855925553,0.0890125145936009,7.83881660779467e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LACTB2,Endoribonuclease LACTB2,42145,0.0817869918473455,0.00707136584418606,0.0679271147927408,0.0956468689019502,8.55468352012331e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKD2,Polycystin-2,39575,0.0726688253384869,0.0062797928128088,0.0603604314253817,0.0849772192515922,8.63462085883453e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.134114667862822,0.0115919969308576,0.111394353878341,0.156834981847303,8.75309381492434e-31
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.140808899522092,0.0122020277333978,0.116892925164633,0.164724873879552,1.15468495182792e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0795324767493386,0.00689252819747459,0.0660231214822884,0.0930418320163888,1.24488024719575e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL2,ADAMTS-like protein 2,39966,0.042971831486384,0.00372462971499858,0.0356715572449868,0.0502721057277812,1.26832962565275e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0685780166205891,0.00594879115882898,0.0569183859492843,0.0802376472918939,1.42421691476916e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLG,Plasminogen,39742,0.0270453686979326,0.00234739183530697,0.0224444807007309,0.0316462566951343,1.53166461806363e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.0301952191299307,0.00262420333102908,0.0250517806011137,0.0353386576587477,1.69861511530951e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX1,Peroxiredoxin-1,41742,-0.113319283760239,0.00986182296438558,-0.132648456770434,-0.0939901107500428,2.05252037146972e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0711915078822285,0.0061974944995769,0.0590444186630577,0.0833385971013992,2.12354924117758e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0734580913113761,0.00639210701608163,0.0609295615598561,0.085986621062896,2.14686727918179e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.137770865569802,0.0120131903432111,0.114225012497108,0.161316718642496,2.64240258490167e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX4,Syntaxin-4,42070,0.0725229538153442,0.00633273947110491,0.0601107844519786,0.0849351231787098,3.16830143531252e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPI,Mannose-6-phosphate isomerase,42070,0.104508723548361,0.0091388728540173,0.0865965327544873,0.122420914342235,3.82263234287843e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POSTN,Periostin,39966,-0.0464610487476891,0.00406349113291956,-0.0544254913682114,-0.0384966061271668,4.14050014651847e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.092724220243396,0.00811020814566506,0.0768282122778925,0.1086202282089,4.18102458415248e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0487877992676219,0.00426942888937347,0.0404197186444499,0.0571558798907939,4.1829019906333e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.156813450081493,0.0137162870991001,0.129929527367257,0.183697372795729,4.1986122858246e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GMFG,Glia maturation factor gamma,39958,0.0883282418460006,0.0077341130833203,0.0731693802026929,0.103487103489308,4.81154037243391e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2,Complement C2,42199,0.027634595515216,0.00242475777605583,0.0228820702741466,0.0323871207562855,5.92821263683826e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.0932867945166495,0.0081826957376947,0.0772487108707678,0.109324878162531,6.04703913846251e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA4,Protein disulfide-isomerase A4,39966,0.0749672777884828,0.00658195414472351,0.0620666476648247,0.0878679079121409,6.82435547850819e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYBB1,Beta-crystallin B1,39958,0.0808935205918994,0.00710439293343691,0.0669689104423631,0.0948181307414358,7.09556454273164e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0704105656370564,0.00619280779251326,0.0582726623637304,0.0825484689103824,8.13421875954315e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3BP1,SH3 domain-binding protein 1,39930,0.0603517629307771,0.00530735628140562,0.0499493446192221,0.0707541812423321,8.42478811769246e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCOF1,Treacle protein,39958,0.0396041629925969,0.00348558830733863,0.0327724099102132,0.0464359160749806,9.32883453470835e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP2,Retinol-binding protein 2,42070,-0.0950167574805519,0.00836649131577182,-0.111415080459465,-0.0786184345016392,9.36669367036001e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP1,Guanylate-binding protein 1,39911,0.0788675504057502,0.00694270159630151,0.0652598552769993,0.0924752455345012,9.60931329283071e-30
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADM,Pro-adrenomedullin,42262,0.0318701470094559,0.00280971087582264,0.0263631136928435,0.0373771803260682,1.09248825202927e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRG2,Bone marrow proteoglycan,39966,-0.0624195055067935,0.00550600040581563,-0.0732112663021921,-0.0516277447113948,1.2461604685723e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0982879555866227,0.00867661918429179,0.0812817819854108,0.115294129187835,1.38915392095183e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0742272247175836,0.00655706686637164,0.0613753736594952,0.087079075775672,1.41634849548271e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0919908259595833,0.00813944539445283,0.0760375129864558,0.107944138932711,1.84684677840854e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,42181,0.101398017149557,0.00898166559171892,0.0837939525897882,0.119002081709326,2.00099295432276e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.145949831858752,0.0129301361422438,0.120606765019954,0.17129289869755,2.04351261588854e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0642333282945044,0.00568957276752863,0.0530817656701483,0.0753848909188605,2.11862692245994e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0780485611804854,0.00691975882423836,0.0644858338849782,0.0916112884759926,2.2660830445323e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG6,Large proline-rich protein BAG6,41900,0.0446218675122598,0.00396322642599943,0.0368539437173009,0.0523897913072187,2.83739192727527e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRB1,Chymotrypsinogen B,42137,0.0706274743819257,0.00627330391324815,0.0583317987119593,0.082923150051892,2.8401262547427e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0877706313704326,0.00780241370709362,0.0724779005045291,0.103063362236336,3.33567674109691e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFL7,Epidermal growth factor-like protein 7,41843,0.0468640947208388,0.00416816806304026,0.0386944853172799,0.0550337041243977,3.38681003084992e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0637344321280518,0.00566825735656668,0.0526246477091811,0.0748442165469225,3.5668657129153e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRIB,Protein scribble homolog,39638,0.105747100917185,0.00940924567998796,0.0873049793844083,0.124189222449961,3.79176410423226e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JPT2,Jupiter microtubule associated homolog 2,39930,0.105878777277244,0.00944296221525844,0.0873705713353372,0.12438698321915,5.03531746535284e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.0371686510636457,0.00331651424558465,0.0306682831422998,0.0436690189849916,5.34329604103128e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RP2,Protein XRP2,42070,0.0512199754325144,0.00457314498140491,0.0422566112689608,0.0601833395960681,5.46554380601553e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.112757216619275,0.0100692629751484,0.0930214611879844,0.132492972050566,5.58944315104003e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0510186967779833,0.00455367321519138,0.0420934972762082,0.0599438962797584,5.59427222156287e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLF4,Krueppel-like factor 4,39586,0.0487776296439083,0.00435825001483065,0.0402354596148402,0.0573197996729764,6.3947598037231e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0617964233999138,0.00552251751456215,0.0509722890713719,0.0726205577284556,6.47010601774046e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSS,Cathepsin S,39358,0.0291335248562349,0.00260439622688852,0.0240289082515334,0.0342381414609364,6.86869794081271e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCS,Copper chaperone for superoxide dismutase,42016,0.0555829892745459,0.004976048088923,0.0458299350202568,0.0653360435288349,7.65496542470091e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.118158488118223,0.0105841705298903,0.0974135138796383,0.138903462356808,8.66586202390145e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCA,Calcitonin,41997,0.0831723772748011,0.00746101155521368,0.0685487946265823,0.09779595992302,9.84108634608245e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.033891538807685,0.00304067734720257,0.027931811207168,0.0398512664082021,9.95986290278809e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP7,Matrilysin,41881,0.0620535944465701,0.00556698579650451,0.0511423022854213,0.0729648866077189,9.96391329924477e-29
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.129714488384359,0.0116339441591849,0.106911957832356,0.152517018936361,1.03023616015217e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP3,Caspase-3,42310,0.105190982297487,0.00945289311555798,0.0866633117909937,0.123718652803981,1.21701308195197e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0695063688822626,0.00624559752268871,0.0572649977377927,0.0817477400267325,1.21768502905876e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA2,Annexin A2,39492,0.0843124969864329,0.0075784373428425,0.0694587597944616,0.0991662341784042,1.34682582626847e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12A_IL12B,Interleukin-12,42070,0.0917913819624919,0.00826685953936647,0.0755883372653336,0.10799442665965,1.60326829683863e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.145078421962994,0.0130739372537694,0.119453504945606,0.170703338980382,1.72649771493611e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP1,Metalloproteinase inhibitor 1,42032,0.0342886436699418,0.00309206481653337,0.0282281966295364,0.0403490907103472,1.88010233647358e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0418502693264505,0.00377612347012494,0.0344490673250056,0.0492514713278954,2.01282917959681e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0402331719165923,0.00362867155193962,0.0331209756747906,0.0473453681583939,2.01798782322058e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.0325713285247005,0.00294241536849684,0.0268041944024466,0.0383384626469543,2.48149163518312e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.103952487815971,0.00939236199164092,0.085543458312355,0.122361517319587,2.5260617789397e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0394861269698157,0.00357121725842739,0.032486541143298,0.0464857127963334,2.68620121113589e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGR1,Prostaglandin reductase 1,39958,0.0991382085175974,0.00898673264735444,0.0815242125287827,0.116752204506412,3.73760812030686e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0820291723347636,0.007451232625715,0.0674247563883622,0.096633588281165,4.85743516342265e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLN4,Cerebellin-4,42262,0.0375087406106537,0.0034091554192669,0.0308267959888906,0.0441906852324168,4.88140768192876e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.097903536212887,0.00889902089357871,0.0804614552614727,0.115345617164301,4.93575936113177e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G4A,Cytosolic phospholipase A2,42185,0.104194281696533,0.00947519611774083,0.0856228973057613,0.122765666087305,5.21212216714362e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNGR2,Interferon gamma receptor 2,42016,0.0623516908453894,0.00567126222052981,0.051236016893151,0.0734673647976278,5.35825130853938e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTD,Deoxycytidylate deaminase,39736,0.113091848041048,0.0102890422066824,0.0929253253159508,0.133258370766146,5.8455749576482e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRK5,G protein-coupled receptor kinase 5,41900,0.0606511956612472,0.00552357119565428,0.0498249961177648,0.0714773952047296,6.25584950181937e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0515139562856773,0.00468970205388762,0.0423221402600576,0.0607057723112971,6.32798779635567e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.04740612437854,0.00431767769703341,0.0389434760923545,0.0558687726647255,6.62028428504102e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0774419284987761,0.00706043344287283,0.0636034789507454,0.0912803780468069,7.48106476775755e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS3BP,Galectin-3-binding protein,39979,0.0367321684856231,0.0033548943893001,0.0301565754825949,0.0433077614886513,9.25798997162863e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ING1,Inhibitor of growth protein 1,41820,0.0560497062223891,0.00512378628290717,0.0460070851078911,0.0660923273368872,9.85083649650585e-28
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL7,C-C motif chemokine 7,42119,0.0660001487920792,0.00604215723328462,0.0541575206148413,0.077842776969317,1.16419948196039e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0354505303759986,0.00324741050571515,0.0290856057847969,0.0418154549672003,1.25238121055129e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0347901541667715,0.00318833973893364,0.0285410082784616,0.0410393000550815,1.32489873136694e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0437562120351241,0.00400896517812011,0.0358986402860087,0.0516137837842395,1.35416160231387e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OCLN,Occludin,39934,0.051541550710324,0.00475206597476298,0.0422275013997886,0.0608556000208595,2.83159884356758e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1R,Complement C1r subcomponent,39979,0.021908485192136,0.00202037042414558,0.0179485591608107,0.0258684112234613,2.90068989094075e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNAS,Neuroendocrine secretory protein 55,39934,0.100574696053545,0.00928743718964591,0.0823713191618391,0.118778072945251,3.40407239424657e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.11842960342646,0.0109508105850567,0.0969660146797491,0.139893192173171,4.01035333958581e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLNK,B-cell linker protein,39657,0.0485658877667209,0.00449369820033804,0.0397582392940583,0.0573735362393834,4.32887009952933e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.116023380747779,0.0107494491365437,0.094954460440153,0.137092301055404,5.00310925641235e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLMH,Bleomycin hydrolase,42310,0.0358116028262945,0.00331976669442238,0.0293048601052266,0.0423183455473623,5.06886669824938e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BGLAP,Osteocalcin,39966,0.0975628913552274,0.0090482434397328,0.0798283342133511,0.115297448497104,5.62165255060751e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX6,Peroxiredoxin-6,42262,-0.0695082143228525,0.00645105548422226,-0.0821522830719281,-0.0568641455737768,5.81651128321389e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP3,Stromelysin-1,42137,-0.0575266272485386,0.00533930439082181,-0.0679916638545493,-0.0470615906425278,5.86285461680472e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLTA,Clathrin light chain A,41900,0.0540607904259496,0.00502506542113199,0.0442116622005309,0.0639099186513682,6.99237154684581e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKN3,Serine/threonine-protein kinase N3,39757,0.0850490059659098,0.00790808442073766,0.069549160501264,0.100548851430556,7.62439986936605e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLO1,Lactoylglutathione lyase,41900,0.0651683217135024,0.00606619552140436,0.0532785784915498,0.0770580649354549,8.24764165769057e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRGN,Neurogranin,39990,0.106511114733658,0.00992371701641383,0.0870606293814873,0.125961600085829,9.56418131680664e-27
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPLAH,5-oxoprolinase,39638,0.0800587733706159,0.00746221573749983,0.0654328305251163,0.0946847162161156,1.01232143204902e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPPK1,Epiplakin,39638,0.0853051897070241,0.00795966937858987,0.069704237724988,0.10090614168906,1.14338523955762e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.0532370410433123,0.00497360076198959,0.0434887835498127,0.0629852985368119,1.25352783966784e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.06675841232437,0.00623767779056233,0.0545325638548678,0.0789842607938722,1.27349875093211e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.0960006971385908,0.00897585249387588,0.0784080262505941,0.113593368026588,1.43140685361176e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMB1,Laminin subunit beta-1,39638,0.0360021952103195,0.00337359337816514,0.0293899521891158,0.0426144382315232,1.85671507709713e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN9,Septin-9,42070,0.032943012359337,0.00308942728420192,0.0268877348823013,0.0389982898363728,1.92990947413504e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0709158181892298,0.00665072590603218,0.0578803954134067,0.0839512409650528,2.04122097617008e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN6,Dynactin subunit 6,41839,0.0827098459025723,0.00776587671219739,0.0674887275466654,0.0979309642584791,2.21956557750461e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBI,Acyl-CoA-binding protein,42085,0.0889979249422814,0.00836443318424432,0.0726036359011625,0.1053922139834,2.46785146808139e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DXO,Decapping and exoribonuclease protein,39929,0.0517682634122781,0.00487081679808906,0.0422214624880235,0.0613150643365326,2.92717980865785e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBN1,Drebrin,39657,0.0582551468057161,0.00548186465335821,0.047510692085134,0.0689996015262982,2.99063938289129e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TST,Thiosulfate sulfurtransferase,41809,0.0862283241955924,0.00811844275883682,0.0703161763882722,0.102140472002913,3.02750169538637e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM2,Paralemmin-2,39929,0.0442497548368595,0.00416587780864722,0.036084634331911,0.0524148753418081,3.12952584678791e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SWAP70,Switch-associated protein 70,39930,0.0418379714384862,0.00393958573181095,0.0341163834041367,0.0495595594728356,3.19862225061573e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0462222916301053,0.00435768490946968,0.0376812292075448,0.0547633540526659,3.49256227360619e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0232225822344071,0.00218972266262868,-0.0275144386531593,-0.0189307258156549,3.56512402508516e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0708428393523671,0.00668395204121476,0.0577422933515862,0.083943385353148,3.80716751711119e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBCA,Tubulin-specific chaperone A,39736,0.0956608114899124,0.00902887844955982,0.0779642097287751,0.11335741325105,4.18491278859484e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP4,Dipeptidyl peptidase 4,41948,0.0317353002344712,0.00299832448152976,0.0258585842506729,0.0376120162182695,4.46847376648177e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLIT2,Slit homolog 2 protein,41839,0.0587333696788393,0.00555582540962333,0.0478439518759776,0.069622787481701,5.12937903880206e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.038958620347999,0.00369904794665968,0.0317084863725461,0.046208754323452,7.74587576708906e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MIA,Melanoma-derived growth regulatory protein,42181,0.0417460813801759,0.00397202025871705,0.0339609216730904,0.0495312410872613,9.74955321157053e-26
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0355125384175081,0.00340028570692037,0.0288479784319442,0.0421770984030721,1.95986876244222e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0315901658952394,0.00302562578001134,0.0256599393664172,0.0375203924240616,2.12142715682072e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0333196482130537,0.0031938974931537,0.0270596091264725,0.039579687299635,2.2989776293531e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARSA,Arylsulfatase A,42137,0.0505404365184094,0.00484866375028601,0.0410370555678488,0.06004381746897,2.41351634237833e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCN1,Ficolin-1,39978,0.0624245525550686,0.00598841665297451,0.0506872559152386,0.0741618491948987,2.49951440255e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGXT,Serine--pyruvate aminotransferase,42145,0.0858305627233053,0.00824359335131822,0.0696731197547216,0.101988005691889,2.72893240593283e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.0337250159097232,0.0032432618254938,0.0273682227317553,0.040081809087691,3.13492931710395e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0553690207493497,0.00532993703253185,0.0449223441655872,0.0658156973331121,3.680826234245e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNC79,Protein unc-79 homolog,39560,0.0622736127007025,0.00599667708344255,0.0505201256171551,0.0740270997842499,3.80761850267144e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F2R,Proteinase-activated receptor 1,42166,0.0638945260748723,0.00615776746509476,0.0518253018432866,0.075963750306458,3.94876591179087e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CES2,Cocaine esterase,42070,0.0620066564732228,0.00598094202685082,0.0502840101005952,0.0737293028458504,4.33663503082309e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAG3,BAG family molecular chaperone regulator 3,41992,0.0451619177203092,0.0043619270636653,0.0366125406755252,0.0537112947650932,5.00566953394298e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRMD4B,FERM domain-containing protein 4B,39575,0.0782373079843031,0.00755712703454689,0.0634253389965912,0.093049276972015,5.29735471573057e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BDNF,Brain-derived neurotrophic factor,39966,0.0934214829835798,0.00902643311891869,0.0757296740704992,0.11111329189666,5.41610817352598e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMIGO2,Amphoterin-induced protein 2,42070,0.0260352509145868,0.00251655564948715,0.0211028018415919,0.0309676999875816,5.4355935188903e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0789129432489161,0.00763645892856372,0.0639454837489312,0.093880402748901,6.39547453220061e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.0383952342805608,0.0037243845002109,0.0310954406601474,0.0456950279009741,7.9011676031183e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOL1,Apolipoprotein L1,39990,0.0591091326106173,0.00573747681361202,0.0478636780559377,0.0703545871652968,8.83792648045973e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0944020209113888,0.00916941171075245,0.076429973958314,0.112374067864464,9.56661675315529e-25
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0640991426281478,0.00623173074721301,0.0518849503636103,0.0763133348926853,1.00750072641391e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB10,Ras-related protein Rab-10,39958,0.0590673369870734,0.00574736161764454,0.0478025082164901,0.0703321657576567,1.1437435385479e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGRN,Neugrin,39929,0.0247613966173862,0.00241016866219337,0.0200374660394871,0.0294853271952852,1.18731006480828e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLRX,Glutaredoxin-1,42057,0.0612285438847453,0.0059673814211956,0.0495324762992019,0.0729246114702887,1.30742769718152e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA9,Serpin A9,42025,0.0795956646886142,0.00776686558544578,0.0643726081411405,0.0948187212360879,1.48620328679433e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFP,Alpha-fetoprotein,41976,0.0717507503066133,0.00700689955077764,0.0580172271870891,0.0854842734261374,1.61608279764798e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF6,SLAM family member 6,41843,0.042552950078373,0.00415861117392062,0.0344020721774886,0.0507038279792574,1.74928914300175e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0546171936488544,0.0053446915931988,0.0441415981261848,0.0650927891715241,1.9994727402693e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFB,Complement factor B,39794,0.0359883364423856,0.00352366324587275,0.029081956480475,0.0428947164042962,2.21059217439055e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FST,Follistatin,42166,0.0533733897980056,0.0052366314706637,0.0431095921155047,0.0636371874805064,2.62543566095216e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0484944396064923,0.00476528288575159,0.0391544851504192,0.0578343940625655,3.20520649378063e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL24,C-C motif chemokine 24,42166,0.0899840673447688,0.00885117572962421,0.0726357629147054,0.107332371774832,3.42162191383327e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.122654369960508,0.0121158220453163,-0.146401381169328,-0.0989073587516875,5.30093448681451e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0791458174175065,0.00781805265940394,0.0638224342050747,0.0944692006299382,5.301890343171e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0405422866331087,0.00400796030093121,0.0326866844432835,0.0483978888229338,5.96314936106508e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPL14,60S ribosomal protein L14,39638,0.0424582915012024,0.00420024325099426,0.0342258147292537,0.0506907682731512,6.43485359127168e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,39930,0.107461285217811,0.0106365935243716,0.0866135619100424,0.128309008525579,6.76479589852135e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNF,Tumor necrosis factor,41880,0.0394011682968792,0.00390867707913106,0.0317401612217824,0.0470621753719761,8.21238177445121e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPA,Apolipoprotein(a),39775,-0.197933897761869,0.0196284560685295,-0.236405671656187,-0.159462123867551,8.21801622673868e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0578016209089877,0.00573478656243469,0.0465614392466157,0.0690418025713597,8.65977172459078e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0389706210246211,0.00386777519638088,0.0313897816397146,0.0465514604095277,8.97414185299764e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0395944018764854,0.00393543791307686,0.0318809435668548,0.0473078601861161,9.9731525442384e-24
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0386476519356778,0.0038423816602114,0.0311165838816635,0.0461787199896922,1.06638438736778e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.129604658615126,0.0129197562793614,0.104281936307578,0.154927380922675,1.34000649892366e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL15,C-C motif chemokine 15,42310,0.0469343051039959,0.00467918370770593,0.0377631050368923,0.0561055051710995,1.3508335668939e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0448353338159245,0.0044713398748746,0.0360715076611702,0.0535991599706787,1.46017497519088e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0724388115153481,0.00722575057286693,0.0582763403925289,0.0866012826381673,1.4931034660258e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASS1,Argininosuccinate synthase,39575,0.0832857838527259,0.00831182199722653,0.0669946127381619,0.0995769549672899,1.56881019683593e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0424139675475464,0.00423715099176822,0.0341091516036807,0.0507187834914121,1.72413645861516e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSCAM,Down syndrome cell adhesion molecule,39934,0.039058464779837,0.00390347556404651,0.0314076526743059,0.0467092768853682,1.79348679568284e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0488083689850376,0.00487972956959523,0.0392440990286309,0.0583726389414443,1.79866951894648e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFB2,BPI fold-containing family B member 2,39927,0.0658319844744124,0.00659051652318588,0.0529145720889681,0.0787493968598567,2.13017150143984e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPAG1,Sperm-associated antigen 1,39934,0.0626914689768926,0.00627953701981055,0.0503835764180639,0.0749993615357213,2.24895744813727e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMTN,Smoothelin,39897,0.0994473535622081,0.00996358349500886,0.0799187299119907,0.118975977212425,2.30454318477968e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LONP1,"Lon protease homolog, mitochondrial",39638,0.0940045846558082,0.00944066631603031,0.0755008786763888,0.112508290635228,2.933749816461e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.079265140430587,0.00798600976468941,0.0636125612917958,0.0949177195693782,3.8840495895063e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL19,C-C motif chemokine 19,42249,0.120457853576275,0.0121376087358193,0.096668140454069,0.144247566698481,3.90726114136964e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARF1,Scavenger receptor class F member 1,42310,0.0451887507312932,0.00456649732975302,0.0362384159649773,0.0541390854976091,5.18929801910058e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0924287322615685,0.00934200094259263,0.0741184104140869,0.11073905410905,5.48366963157152e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.126767909945496,0.0128334375357588,0.101614372375409,0.151921447515584,6.2009723754972e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDCP1,CUB domain-containing protein 1,42016,0.0594411071107572,0.00602100840593531,0.047639930635124,0.0712422835863905,6.57109719099227e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNAP25,Synaptosomal-associated protein 25,39586,0.0510456332555147,0.00517700980782519,0.0408986940321773,0.061192572478852,7.71332715711214e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.0647602141544888,0.00657215395408175,0.0518787924044886,0.077641635904489,7.88931145860904e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX16,Syntaxin-16,41843,0.0604918980215656,0.00614060799820853,0.0484563063450768,0.0725274896980543,8.11934948374827e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGR,Tyrosine-protein kinase Fgr,41839,0.0622049626485607,0.00631666830368451,0.049824292773339,0.0745856325237823,8.39512722954652e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAP3,Cytosol aminopeptidase,41913,0.0508194357131592,0.00516471680267174,0.0406965907799226,0.0609422806463958,9.07731768584431e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",39929,0.113356962531174,0.0115189711090447,0.0907797791574468,0.135934145904902,9.25795425760552e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NADK,NAD kinase,42145,0.0577769743225881,0.00587383683652703,0.0462642541229952,0.0692896945221811,9.35911054286812e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL26,C-C motif chemokine 26,42119,0.0949990388245604,0.00966427362096842,0.0760570625274623,0.113941015121659,9.97280721799194e-23
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0463737002565566,0.00471936193320677,0.0371237508674714,0.0556236496456419,1.06946352845109e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP170,Centrosomal protein of 170 kDa,39638,0.0814864085533579,0.00831130837614987,0.0651962441361041,0.0977765729706116,1.33445944810223e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS27,Serine protease 27,42107,0.0423022144135581,0.00431759489464903,0.033839728420046,0.0507647004070702,1.3705890531009e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD40LG,CD40 ligand,42296,0.0834352068371362,0.00851919556439041,0.066737583530931,0.100132830143341,1.41997776538518e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL11,C-X-C motif chemokine 11,42249,0.0819651459065108,0.00839220536382438,0.065516423393415,0.0984138684196066,1.85124408225744e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PARD3,Partitioning defective 3 homolog,39757,0.0778398588624518,0.00797716878069295,0.0622046080522936,0.09347510967261,2.09880796905954e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPXM1,Probable carboxypeptidase X1,42181,0.0720368154872785,0.00739346107205724,0.0575456317860464,0.0865279991885107,2.33201945339112e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.028078371445815,0.00288416853955823,0.0224254011082808,0.0337313417833491,2.61976135234999e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHPS,Deoxyhypusine synthase,39919,0.042166090001886,0.00433510448095176,0.0336692852192206,0.0506628947845515,2.83681035473004e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0238826362122793,0.00245829241465121,0.019064383079563,0.0287008893449957,3.07133803806319e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0753793196572502,0.007763126295464,0.0601635921181407,0.0905950471963596,3.24136476803941e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0863491354416766,0.00890065289365937,0.0689038557701042,0.103794415113249,3.51135568893055e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.102173964807198,0.0105347497029355,0.081525855389444,0.122822074224951,3.60424565221936e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX9,Sorting nexin-9,42145,0.0706901732795458,0.00730295759883723,0.0563763763858248,0.0850039701732667,4.33805517984421e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0922707508964468,0.00952880208418368,0.0735942988114468,0.110947202981447,4.34271074364476e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPK1,Thiamin pyrophosphokinase 1,39958,0.0291390389303929,0.00300939738322729,0.0232406200592674,0.0350374578015184,4.34785407840823e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFRP1,Secreted frizzled-related protein 1,41968,0.0447613398319865,0.00462597856309095,0.0356944218483282,0.0538282578156447,4.50143238394412e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BPIFA2,BPI fold-containing family A member 2,39281,-0.115408471453395,0.0119276700219079,-0.138786704696335,-0.0920302382104561,4.71067556993178e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD274,Programmed cell death 1 ligand 1,42016,0.0350959123974041,0.00362919116207919,0.0279826977197289,0.0422091270750793,4.75146093887487e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.047283463637013,0.00489992436055774,0.0376796118903198,0.0568873153837062,5.80865510146207e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH7,Protocadherin-7,39930,0.0362014396636423,0.0037530218344466,0.0288455168681269,0.0435573624591576,6.20902114594123e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPPB,Natriuretic peptides B,41900,-0.145360709277095,0.0150762720320513,-0.174910202459916,-0.115811216094274,6.2876357082462e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0551206525459234,0.005718163830377,0.0439130514383845,0.0663282536534623,6.40437480190529e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12B,Interleukin-12 subunit beta,42296,0.0567748607297945,0.00589263395071917,0.0452252981863849,0.0683244232732041,6.68340364308225e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.0377451027863589,0.0039197189687964,0.030062453607518,0.0454277519651999,7.30949804149724e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXNB2,Plexin-B2,42255,0.025287322901194,0.00263066239003635,0.0201312246167228,0.0304434211856653,8.29841186061503e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TF,Serotransferrin,39979,0.0221531557540175,0.00230549025937004,0.0176343948456522,0.0266719166623828,8.87253518250809e-22
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,42070,0.033807210963352,0.00352423355229548,0.0268997132008528,0.0407147087258511,1.00600244044909e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POMC,Pro-opiomelanocortin,39638,0.0757685561921411,0.00789945245683185,0.0602856293767507,0.0912514830075315,1.05357186072216e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB2B,Ras-related protein Rab-2B,39919,0.0643281000595848,0.00670816430560022,0.0511800980206084,0.0774761020985612,1.06987812315349e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFC1,Cryptic protein,41843,0.0493530835663937,0.00515036271967051,0.0392583726358395,0.0594477944969479,1.11424014783873e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMOTL2,Angiomotin-like protein 2,39882,0.050276591882073,0.00525441983892074,0.0399779289977884,0.0605752547663577,1.31081420369243e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0240019607509762,0.00251018158020093,0.0190820048537824,0.02892191664817,1.35081499276563e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0711542035745486,0.0074451634420541,0.0565616832281225,0.0857467239209746,1.46684637154435e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARFIP1,Arfaptin-1,39934,0.0708020940821768,0.00744473008096962,0.0562104231234763,0.0853937650408772,2.28251780932067e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM1,Intercellular adhesion molecule 1,42126,0.0297527614139625,0.00312997163062786,0.0236180170179319,0.0358875058099931,2.31551298675124e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0248614569205988,0.00261974820591186,0.0197267504370115,0.029996163404186,2.69233544116812e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP3R1,Calcineurin subunit B type 1,42016,0.0412022970660214,0.00434169346594605,0.0326925778727671,0.0497120162592756,2.6966560024562e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0500497544506307,0.0052734073921457,0.0397138759620251,0.0603856329392363,2.7459341878424e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA13,Carbonic anhydrase 13,41967,0.107285123905912,0.0113149138887188,0.0851078926840235,0.129462355127801,2.91650221342808e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0663639773044557,0.00700565422055507,0.0526328950321678,0.0800950595767436,3.17408157476745e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.0453329877607662,0.00479005745619815,0.0359444751466179,0.0547215003749146,3.56490675393523e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSE,Cathepsin E,39736,0.0539871525616365,0.00570663564529428,0.0428021466968597,0.0651721584264133,3.68255750860344e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROK1,Prokineticin-1,42119,0.0506160521372725,0.00535256727477966,0.0401250202787043,0.0611070839958406,3.70473665377703e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LBP,Lipopolysaccharide-binding protein,42217,-0.059564608554337,0.00630125349992754,-0.071915065414195,-0.047214151694479,3.82898785735484e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.0394466851975393,0.00417390341783164,0.0312658344985893,0.0476275358964893,3.90010770056494e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABHD14B,Protein ABHD14B,41976,0.0567335499273176,0.00601209767899887,0.0449498384764799,0.0685172613781554,4.47921383336532e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0473078960255972,0.00501322818853518,0.0374819687760682,0.0571338232751261,4.48391592014226e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSR1,Macrophage scavenger receptor types I and II,42249,0.0479393302349158,0.0050851657193179,0.0379724054250527,0.0579062550447789,4.875955698053e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0410383948973279,0.00435428974447336,0.0325039869981601,0.0495728027964956,5.00982537442505e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF2,Fibroblast growth factor 2,42119,0.0700186412843669,0.00743886513082254,0.0554384656279547,0.084598816940779,5.61392588007217e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP6,Platelet glycoprotein VI,42115,0.0891787896764043,0.00947469110536339,0.0706083951098921,0.107749184242917,5.62623944892805e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0624947342919375,0.00663985675949553,0.0494806150433263,0.0755088535405488,5.65246208656926e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C4BPB,C4b-binding protein beta chain,42181,0.0386497038719848,0.00410713052887873,0.0305997280353825,0.0466996797085871,5.72548954005429e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP5,Platelet glycoprotein V,39736,0.0369958043386168,0.00393466815447516,0.0292838547558454,0.0447077539213881,6.36791904252168e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0633991379664885,0.00674405423302289,0.0501807916697636,0.0766174842632134,6.48571506727374e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0709118313666002,0.00755066485108836,0.0561125282584671,0.0857111344747334,7.04792618518778e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMSB10,Thymosin beta-10,42137,0.0767308946098541,0.00817323546550646,0.0607113530974614,0.0927504361222467,7.07215512357578e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTN,Pleiotrophin,41900,0.0502158615192099,0.00535301027544368,0.0397239613793403,0.0607077616590795,7.58876200402377e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.0398296388721277,0.00425576731346507,-0.0481709428065193,-0.0314883349377362,9.30248553469141e-21
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.0317616984945974,0.00340331407670748,0.0250912029042508,0.0384321940849441,1.19239999159023e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0375114440302242,0.00401827276986477,0.0296356294012893,0.0453872586591592,1.20026780591843e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMMT,MICOS complex subunit MIC60,39919,0.0447805521454531,0.00479849771554005,0.0353754966229946,0.0541856076679116,1.22967094436394e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0485746921615491,0.00520704984469934,0.0383688744659384,0.0587805098571598,1.27138266004142e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERI1,3'-5' exoribonuclease 1,39757,0.0344388748634371,0.00369454048832858,0.027197575506313,0.0416801742205611,1.36182358595075e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTX3,Pentraxin-related protein PTX3,42119,-0.0498638001317394,0.00535379101580575,-0.0603572305227186,-0.0393703697407601,1.42205370649594e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSR,"Glutathione reductase, mitochondrial",39949,0.0228956056621009,0.00246689486415915,0.018060491728349,0.0277307195958529,1.98022656765585e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0591391140910454,0.00638904826181164,0.0466165794978945,0.0716616486841962,2.49509299429962e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAL,Integrin alpha-L,39657,0.0434150074247939,0.00470157684414493,0.0341999168102698,0.052630098039318,3.07814660117705e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA14,Carbonic anhydrase 14,42262,-0.0364259276197086,0.00394791414067178,-0.0441638393354253,-0.028688015903992,3.19708575389265e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0377693517086506,0.00409377770160773,0.0297455474134995,0.0457931560038018,3.22826260297428e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEK,Angiopoietin-1 receptor,42181,0.021953803364684,0.00238057574479361,0.0172878749048885,0.0266197318244795,3.33814526547131e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0308818654140857,0.00335526976760318,-0.037458194158588,-0.0243055366695835,4.02064577005511e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0875207829065768,0.00951011382129772,0.0688809598168333,0.10616060599632,4.09297082780141e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA2,Carboxypeptidase A2,42205,0.0657299122931606,0.00715361123296013,0.0517088342765588,0.0797509903097625,4.55875486831558e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,39820,0.0327009525155156,0.00355823309748814,0.0257268156444388,0.0396750893865923,4.60919642995068e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASAH1,Acid ceramidase,39876,0.0467090958704757,0.00508712049023626,0.0367383397096126,0.0566798520313388,4.97597138837191e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0683141792725778,0.00744438748157203,0.0537231798086966,0.082905178736459,5.0879171788424e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPMT,Thiopurine S-methyltransferase,41843,0.0705013717273049,0.00770109906506273,0.055407217559782,0.0855955258948279,6.23896508525019e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA2,Carbonic anhydrase 2,42103,0.0652977266678212,0.00713405855631107,0.0513149718974515,0.0792804814381909,6.32438765652076e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO2,Roundabout homolog 2,42249,0.0222767487000231,0.00243435880451085,0.0175054054431818,0.0270480919568643,6.43186527340518e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0228232559167135,0.00249665432791166,0.0179298134340067,0.0277166983994204,7.20022572020679e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA6,Carbonic anhydrase 6,42103,-0.0615033101516829,0.00673536183971558,-0.0747046193575254,-0.0483020009458403,7.71006212005544e-20
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.039304743846502,0.00433247724131191,0.0308130884535307,0.0477963992394734,1.35969180299797e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPT,Dermatopontin,42310,0.0247128988976263,0.00273108402106299,0.0193599742163428,0.0300658235789098,1.63823615404294e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDK2,Protein sidekick-2,39736,0.0383121370640275,0.00423289211137984,0.030015668525723,0.0466086056023319,1.65097904823768e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0642171834914954,0.0071028593904177,0.0502955790862767,0.0781387878967141,1.75763968236187e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FADD,FAS-associated death domain protein,42145,0.0741476667442059,0.00820316271302706,0.0580694678266728,0.0902258656617389,1.79433729271234e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM3,Myomesin-3,39736,-0.0942016218548462,0.0104345952984632,-0.114653428639834,-0.0737498150698583,2.03883839319507e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGS10,Regulator of G-protein signaling 10,39934,0.0577927750558842,0.00640275878995637,0.0452433678275697,0.0703421822841987,2.06294227661882e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0314272303224577,0.00348516840821116,0.0245963002423638,0.0382581604025516,2.23374020137171e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPP1,Osteopontin,42286,-0.042652642874714,0.00473338889748802,-0.0519300851137906,-0.0333752006356375,2.30854906670966e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRZB,Secreted frizzled-related protein 3,41973,0.0239047950485144,0.00265647496502335,0.0186981041170687,0.0291114859799602,2.58864945811683e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0350039845475044,0.00389285169952056,0.0273739952164441,0.0426339738785647,2.82678809738868e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0423295291564992,0.00471009300779088,0.0330977468612291,0.0515613114517693,2.94284326355238e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD1C,T-cell surface glycoprotein CD1c,42181,0.0238346145149027,0.00266069974349362,0.0186196430176552,0.0290495860121501,3.73063076339579e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0657180526629625,0.00735164158997681,0.0513088351466079,0.080127270179317,4.4320405544407e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAGED1,Melanoma-associated antigen D1,41843,0.04643825563336,0.00519536935872047,0.0362553316902679,0.0566211795764521,4.46555047719316e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0830794379257085,0.00930358651491647,0.0648444083564723,0.101314467494945,4.81227912214294e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C7orf50,Uncharacterized protein C7orf50,39929,0.0218840712254101,0.00245348292282459,0.0170752446966739,0.0266928977541463,5.3968073457658e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0543655485211395,0.00610076679812464,0.0424080455968152,0.0663230514454638,5.69741897556626e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0932325493200152,0.0104630465117892,0.0727249781569083,0.113740120483122,5.72093058805439e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MZT1,Mitotic-spindle organizing protein 1,41843,0.0503866149790315,0.00565807143660657,0.0392967949632827,0.0614764349947804,6.01233422223939e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DENR,Density-regulated protein,39657,0.0551016990408478,0.00618595020673266,0.0429772366356518,0.0672261614460438,6.03236184407125e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK7,Kallikrein-7,39475,0.0379141154613398,0.00425971788496881,0.029565068406801,0.0462631625158787,6.43438661248965e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREML2,Trem-like transcript 2 protein,42137,0.0329286068128138,0.00370850811878257,0.0256599309,0.0401972827256276,7.57153903107009e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.036879969034657,0.00415714471264861,0.0287319653978657,0.0450279726714482,8.11355554666336e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0409970707318137,0.00462427443101258,-0.0500606486165983,-0.031933492847029,8.54222165854467e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NID2,Nidogen-2,42137,0.0694616622010204,0.00784428869680167,0.0540868563552892,0.0848364680467517,9.39228816249805e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC16A1,Monocarboxylate transporter 1,41839,0.0525775673972885,0.0059382811240159,0.0409385363942173,0.0642165984003597,9.50591105861226e-19
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,39699,0.051659657427687,0.00584415606502704,0.040205111540234,0.06311420331514,1.10596503054847e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTC,Probetacellulin,41843,0.06977536350649,0.00789913597557215,0.0542930569943686,0.0852576700186114,1.14302191628848e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1F,Protein phosphatase 1F,39958,0.0507364569620885,0.00574257979864308,0.039481000556748,0.0619919133674289,1.1464883120004e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNA4,Ephrin-A4,41992,0.0307081604058453,0.0034790058413722,0.0238893089567558,0.0375270118549348,1.21034630453445e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0491887291974805,0.00558650843429341,0.0382391726662654,0.0601382857286955,1.46501417133115e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0338882500137446,0.00386084149439522,-0.0414554993427593,-0.02632100068473,1.91194539518179e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0529900895662387,0.00603765091616655,0.0411562937705522,0.0648238853619251,1.92863153946329e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARB2,Lysosome membrane protein 2,41777,0.0311234001012278,0.00355190799978733,0.0241616604216447,0.038085139780811,2.14195165333606e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRG,Histidine-rich glycoprotein,39925,0.0293385537743014,0.00334900810978426,0.0227744978791243,0.0359026096694786,2.22244395952512e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BST2,Bone marrow stromal antigen 2,42249,0.0480312119607559,0.00548562338200398,0.0372793901320281,0.0587830337894837,2.26164301178722e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTNB,Dystrobrevin beta,39900,0.0428612362757636,0.00489454672953519,0.0332679246858746,0.0524545478656526,2.29138572442147e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0528513684349132,0.00603677142236221,0.0410192964470833,0.0646834404227431,2.33540226369204e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0450122669993347,0.00514389587965922,0.0349302310752026,0.0550943029234667,2.42167749305769e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PER3,Period circadian protein homolog 3,39657,0.115682175911825,0.0132224743429732,0.0897661261995976,0.141598225624053,2.46641937840063e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM4,Intercellular adhesion molecule 4,42119,-0.0494184608397299,0.00565761577766818,-0.0605073877639596,-0.0383295339155003,2.72346222197526e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSL,Cathepsin L1,42145,0.0229745893688228,0.00263162852419896,0.0178165974613928,0.0281325812762528,2.83721964197276e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0393979836635889,0.00452286550994292,0.0305331672641008,0.0482628000630771,3.36903865593547e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL14,C-C motif chemokine 14,42152,0.0378575486774847,0.0043488291706795,0.0293338435029529,0.0463812538520165,3.53195607079767e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCRN1,Secernin-1,42119,0.0517613544853304,0.00596230308597657,0.0400752404368164,0.0634474685338445,4.35117751136552e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0812834682168714,0.00937149989737738,0.0629153284180117,0.099651608015731,4.77119495105697e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0199901139259767,0.00230614880740018,0.0154700622634724,0.0245101655884811,4.88745019834542e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO2,Gamma-enolase,42249,0.0606406906876044,0.00700418278484702,0.0469124924293042,0.0743688889459045,5.34423880094662e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN5,CCN family member 5,42137,0.0353621184904656,0.00408505818499085,0.0273554044478835,0.0433688325330476,5.41120709770888e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS22,Brain-specific serine protease 4,39657,0.0322073254847121,0.00372634070285162,0.0249036977071229,0.0395109532623013,6.22105216978669e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIT,Vitrin,39958,0.035640230223298,0.00413811633061137,0.0275295222152997,0.0437509382312963,8.07871239358698e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0609004487848075,0.00707946295591102,0.0470247013912219,0.0747761961783931,8.83198627601622e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0402570029397262,0.00468282896530507,0.0310786581677283,0.0494353477117241,9.11470077301267e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGMN,Legumain,42185,0.0335880227034433,0.00390760577943986,0.0259291153757412,0.0412469300311454,9.18374715282444e-18
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0452280901384607,0.00527442657740575,0.0348902140467454,0.055565966230176,1.09783240784849e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAA4,Serum amyloid A-4 protein,39979,0.0304099611707701,0.00354701221727337,0.0234578172249143,0.0373621051166259,1.13439634398399e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCAM1,Vascular cell adhesion protein 1,42199,-0.0255511258343251,0.00298254669769836,-0.0313969173618139,-0.0197053343068364,1.17664514813722e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH15,Cadherin-15,42230,0.0637427754743196,0.0074428117683114,0.0491548644084293,0.07833068654021,1.20246945676861e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.06647799785325,0.00776316973284251,0.0512621851768787,0.0816938105296214,1.21592085919594e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.0818017601956368,0.00956771817892968,0.0630490325649346,0.100554487826339,1.36690610054028e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCF2,Neutrophil cytosol factor 2,42097,0.0765054813944916,0.00895431214348774,0.0589550295932556,0.0940559331957276,1.43460230245816e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XRCC4,DNA repair protein XRCC4,41839,0.0339194403693184,0.00397543302201742,0.0261275916461643,0.0417112890924726,1.58992757891291e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL1A1,Collagen alpha-1(I) chain,42310,-0.0215521852947699,0.00252643251972735,-0.0265039930334355,-0.0166003775561043,1.60609061780326e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPR,Nucleoprotein TPR,39575,0.0448281576336653,0.00525637336427037,0.0345256658396954,0.0551306494276352,1.67931726764084e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDHB,Succinate dehydrogenase,39930,0.0602486666892978,0.00706653448511091,0.0463982590984804,0.0740990742801152,1.70813205023393e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGH,Gamma-glutamyl hydrolase,41933,0.0311279967571413,0.00365592066740133,0.0239623922490347,0.0382936012652479,1.85218567359222e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CORO1A,Coronin-1A,41883,0.0812187087324871,0.00954425585532599,0.0625119672560482,0.099925450208926,1.92932575445159e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMS,Spermine synthase,39586,0.0587300942890463,0.00691797625528884,0.0451708608286802,0.0722893277494124,2.34225531071336e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACRBP,Acrosin-binding protein,39919,0.0364873866385278,0.00429929516169235,0.0280607681216108,0.0449140051554448,2.38766585422353e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTN2,Dynactin subunit 2,42070,0.0865232842934696,0.0102082309851343,0.0665151515626063,0.106531417024333,2.57453305091426e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEL1L,Protein sel-1 homolog 1,39638,0.0286801010077672,0.00338382390844444,0.0220478061472161,0.0353123958683183,2.63473958934049e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SF3B4,Splicing factor 3B subunit 4,42070,0.0659989562160239,0.00779178464065335,0.0507270583203434,0.0812708541117045,2.69859382444027e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAT,Catalase,39827,0.0476874377258354,0.00562942761487619,0.0366537596006781,0.0587211158509927,2.73355348076633e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL5,Insulin-like peptide INSL5,39930,0.0933361865323805,0.0110256877537462,0.071725838535038,0.114946534529723,2.86814495139477e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0675963234997347,0.00798609674604857,0.0519435738774795,0.0832490731219899,2.90007634242054e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0637503544288975,0.00753863530508374,0.0489746292309334,0.0785260796268616,3.09914976059135e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0811445093853045,0.00960486296591309,0.0623189779721149,0.0999700407984942,3.32353712264941e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0295730858003097,0.0035015933223776,0.0227099628884496,0.0364362087121698,3.32620112285522e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNM1,Dynamin-1,39930,0.105144970439975,0.012456817141901,0.0807296088418486,0.129560332038101,3.53590223989347e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTA,Lymphotoxin-alpha,42119,0.0363599100901576,0.00431312481129381,0.0279061854600217,0.0448136347202935,3.80167767021549e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APLP1,Amyloid-like protein 1,42145,-0.046062692539952,0.0054669598444526,-0.0567779338350791,-0.0353474512448249,3.94620184506032e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0924924812602669,0.0109896038864007,0.0709528576429216,0.114032104877612,4.27430802991804e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0318342546480863,0.00378465934319626,0.0244163223354216,0.0392521869607509,4.44936206320506e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100P,Protein S100-P,41900,0.0484152412668459,0.00575692522979845,0.037131667816441,0.0596988147172509,4.51806506607469e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BGN,Biglycan,41820,-0.106846877683363,0.0127124666744199,-0.131763312365226,-0.0819304430014998,4.71738465142119e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0390613536256383,0.00465073692387302,0.0299459092548472,0.0481767979964294,5.05547175794381e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD83,CD83 antigen,42119,0.0312041315470221,0.00371822857291415,0.0239164035441104,0.0384918595499339,5.24133120181984e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G15,Phospholipase A2 group XV,42181,0.0248107759755211,0.00295743784853325,0.019014197792396,0.0306073541586463,5.37030970582347e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD84,SLAM family member 5,42119,0.0287979670523053,0.0034329168644529,0.0220694499979776,0.035526484106633,5.39563778539046e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DMD,Dystrophin,39638,0.0464677119671091,0.00554022984411625,0.0356088614726412,0.0573265624615769,5.57806277257286e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0486785715818944,0.00581422929345678,0.0372826821667191,0.0600744609970697,6.20079446975135e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VGF,Neurosecretory protein VGF,39934,0.0271906683058849,0.00324743396592171,0.0208256977326783,0.0335556388790915,6.2781306635621e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0616753249445043,0.0073668755735882,0.0472362488202715,0.0761144010687372,6.34198731034084e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0834235740352259,0.00996851924316152,0.0638852763186294,0.102961871751823,6.50824303630705e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LACRT,Extracellular glycoprotein lacritin,39895,0.0409606898583658,0.00489785853983521,0.0313608871202888,0.0505604925964428,6.83255062482644e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA2,Integrin alpha-2,39736,0.0311215150791952,0.00372586229552222,0.0238188249799716,0.0384242051784187,7.45362724062552e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.0298252657412216,0.00357328138963904,0.0228216342175291,0.0368288972649141,7.69004156748371e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF22,Kinesin-like protein KIF22,39575,0.111386356447871,0.0133698866245869,0.0851813786636812,0.137591334232062,8.95954824422387e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0565140669942857,0.00678403042475005,0.0432173673617756,0.0698107666267958,8.97628259989934e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA1,Carbonic anhydrase 1,41890,0.0505139595044667,0.00606652025247525,0.0386235798096152,0.0624043391993182,9.12184312333304e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3C,Protein FAM3C,42129,0.0272089681832225,0.003269325213935,0.0208010907639099,0.0336168456025351,9.43195561186582e-17
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0511175794779043,0.00615904146288366,0.0390458582106523,0.0631893007451563,1.14466150703212e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP1,Interstitial collagenase,41693,0.0804309185585121,0.00969825418451236,0.0614223403568679,0.0994394967601563,1.20797262936911e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIMAP8,GTPase IMAP family member 8,39560,0.0447367482617386,0.00539888889804327,0.0341549260215738,0.0553185705019035,1.30448774344922e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRD1,Natural killer cells antigen CD94,42296,0.0420468222299786,0.00507672013756727,0.0320964507603468,0.0519971936996105,1.31965249872121e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD2,Sushi domain-containing protein 2,42137,-0.0252399241147168,0.00305221140450804,-0.0312222584675525,-0.019257589761881,1.47117192834869e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD101,Immunoglobulin superfamily member 2,39930,0.0384639836351818,0.00465474610195031,0.0293406812753592,0.0475872859950044,1.57339868259597e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMA4,Laminin subunit alpha-4,42185,0.0304003193105121,0.0036815901691892,0.0231844025789013,0.037616236042123,1.62551669072742e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS7_LGALS7B,Galectin-7,42076,0.0389648356325316,0.00473508158601103,0.0296840757239499,0.0482455955411132,2.06053395422159e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAM,Integrin alpha-M,42137,-0.0279317789545857,0.0033994715309693,-0.0345947431552855,-0.0212688147538858,2.28416712364679e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STK4,Serine/threonine-protein kinase 4,42145,0.0771603770038732,0.00940113976940212,0.0587341430558451,0.0955866109519014,2.45995704277004e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDF1,Endothelial differentiation-related factor 1,39934,0.0586377579473399,0.00714536657753956,0.0446328394553624,0.0726426764393174,2.52535698285201e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAPK2,Death-associated protein kinase 2,39657,0.048823611656563,0.00596071768503983,0.0371406049938849,0.0605066183192411,2.87815021396462e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,39930,0.0216820035237323,0.0026488050129886,0.0164903456982746,0.02687366134919,2.99977948267706e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPL,Periplakin,39657,0.0284165932548888,0.00347501823125792,0.0216055575216233,0.0352276289881544,3.21738507784278e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FXN,"Frataxin, mitochondrial",42262,0.0639444059580923,0.00782231163835052,0.0486126751469253,0.0792761367692593,3.22773187610939e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDGF,Hepatoma-derived growth factor,42243,0.0803514032296851,0.00983281059343143,0.0610790944665595,0.0996237119928107,3.30503285519794e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SBSN,Suprabasin,39954,-0.0312605982992048,0.00382487343716529,-0.0387573502360487,-0.0237638463623608,3.3277520294168e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSC,Dipeptidyl peptidase 1,42123,0.0390120711028861,0.00477569348180703,0.0296517118785443,0.0483724303272279,3.38707354646025e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFA,Protransforming growth factor alpha,42119,0.0397957774665207,0.00487570783965542,0.0302393901007961,0.0493521648322454,3.58333196671914e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17D,Interleukin-17D,41913,0.0299386310485616,0.00367172477760907,0.0227420504844479,0.0371352116126754,3.83924792034567e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C5,Complement C5,39979,0.0131914472942641,0.0016180844260585,0.0100200018191894,0.0163628927693387,3.93769319689228e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGKZ,Diacylglycerol kinase zeta,41913,0.0316012569062658,0.00388974799805329,0.0239773508300814,0.0392251629824503,4.89608815465754e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSNK1D,Casein kinase I isoform delta,39657,0.0562286448178352,0.00692589645448543,0.0426538877670437,0.0698034018686266,5.21563091978406e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0498322356531165,0.00613871244936,0.0378003592523709,0.0618641120538621,5.24980563056577e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR3,Toll-like receptor 3,42296,0.0533481011262047,0.00657951437237653,0.0404522529563467,0.0662439492960627,5.57051008139187e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENAH,Protein enabled homolog,41913,0.0419590481198064,0.00519009258890397,0.0317864666455546,0.0521316295940581,6.78074977432541e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0517590794953605,0.00640919377271594,0.0391970597008372,0.0643210992898837,7.38251562706331e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGA6,Integrin alpha-6,42119,0.0441587707816048,0.00548729961885944,0.0334036635286403,0.0549138780345693,9.15486396668373e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.0293372564034228,0.00364779446794077,0.0221875792462589,0.0364869335605868,9.53199297642477e-16
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1F,V-type proton ATPase subunit F,41820,0.0576976662901178,0.00719103162598289,0.0436032443031914,0.0717920882770443,1.11339653925556e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0541920064597146,0.00675805523039528,0.0409462182081398,0.0674377947112893,1.17256609994465e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDZD2,PDZ domain-containing protein 2,39575,0.0507895460093014,0.00634207055160368,0.0383590877281582,0.0632200042904446,1.27996039308606e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYM,Ketimine reductase mu-crystallin,39586,0.0652228268335986,0.00814754729482265,0.0492536341357462,0.081192019531451,1.31277025437504e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANBP1,Ran-specific GTPase-activating protein,39638,0.0444459177923375,0.0055537339482218,0.0335605992538228,0.0553312363308523,1.3370114754281e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0345780201050034,0.00432439065441642,0.0261022144223472,0.0430538257876595,1.41374952849973e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL15A1,Collagen alpha-1(XV) chain,39966,0.02324017499233,0.00290854086341212,0.0175394349000422,0.0289409150846177,1.4757292671266e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0356993917916791,0.00447738230583003,0.0269237224722523,0.044475061111106,1.67137619783323e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2orf69,UPF0565 protein C2orf69,39649,0.0505875860086436,0.00635349512125838,0.0381347355709772,0.0630404364463101,1.85609035343e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAS2,Growth arrest-specific protein 2,39757,0.0446384074824472,0.00561305440017608,0.0336368208581021,0.0556399941067923,2.00247059771938e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD46,Membrane cofactor protein,42107,0.0245155728528653,0.00308359200513468,0.0184717325228013,0.0305594131829293,2.00711276198523e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_E,,42119,0.0251235406548446,0.00316229159156599,0.0189254491353753,0.0313216321743139,2.09937096384008e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSHB,Thyrotropin subunit beta,42145,0.058165335605514,0.00732586759306494,0.0438066351231067,0.0725240360879213,2.18513842664176e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL3,Insulin-like 3,39929,0.0769246720312304,0.0096976732644843,0.0579172324328411,0.0959321116296196,2.35369986121482e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDA,Cytidine deaminase,39946,0.0406894012547304,0.00513133791954814,0.030631978932416,0.0507468235770447,2.40467730258419e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PON1,Serum paraoxonase/arylesterase 1,39990,-0.0231306960721384,0.00291750463695616,-0.0288490051605725,-0.0174123869837043,2.42982937547451e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA4,Carbonic anhydrase 4,42310,-0.020685146559895,0.00261128105135498,-0.0258032574205508,-0.0155670356992393,2.52738135278051e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAFA5,Chemokine-like protein TAFA-5,42070,0.0313146664669441,0.00395468883537673,0.0235634763496057,0.0390658565842825,2.59410499787159e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANSC1,MANSC domain-containing protein 1,42181,-0.0236306939644689,0.00299103415683108,-0.0294931209118578,-0.0177682670170799,2.99032668965559e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CILP,Cartilage intermediate layer protein 1,39966,0.0468349923600962,0.00595026429323611,0.0351724743453534,0.0584975103748389,3.83488538893731e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.0361453577572652,0.00459807704570484,-0.0451575887668466,-0.0271331267476837,4.09998435054533e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0417048411126091,0.00530876603696138,0.0312996596801648,0.0521100225450534,4.26876929443744e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0620596405823472,0.00793072290209578,0.0465154236942395,0.0776038574704549,5.45087931798375e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0285169769839833,0.00364352327389944,-0.0356582826008262,-0.0213756713671404,5.46345486820896e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIGR,Polymeric immunoglobulin receptor,41987,0.0312160996911199,0.00399363256569015,0.0233885798623672,0.0390436195198726,5.83679855617832e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.0300685810070026,0.00384821160133316,0.0225260862683896,0.0376110757456156,5.97283814451824e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADA,Adenosine deaminase,42296,0.0298138394581349,0.00382221130714264,0.0223223052961354,0.0373053736201345,6.62862012549719e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELOB,Elongin-B,39575,0.0329041373725537,0.00422250952646155,0.0246280187006891,0.0411802560444184,7.15954366828387e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL1,Fc receptor-like protein 1,42145,0.0383577664503054,0.00492966244657423,0.0286956280550199,0.0480199048455909,7.71373536566669e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0399347302353085,0.00513157792234982,0.0298768375075028,0.0499926229631141,7.74904646491049e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDK,Midkine,42129,0.0428451144042913,0.00550743922247091,0.0320505335282483,0.0536396952803343,7.8068576844868e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AK1,Adenylate kinase isoenzyme 1,42145,0.0514154275612147,0.00661840521378619,0.0384433533421938,0.0643875017802356,8.50790245044415e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APRT,Adenine phosphoribosyltransferase,42002,0.0393397014989381,0.0050656698165492,0.0294109886585017,0.0492684143393745,8.69054222228731e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL6A3,Collagen alpha-3(VI) chain,42310,0.0299471093347176,0.00385762567407178,0.0223861630135369,0.0375080556558983,8.87331846198231e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFCAB2,Dynein regulatory complex protein 8,39757,0.0295003019366542,0.00380400444757182,0.0220444532194135,0.036956150653895,9.59804401036925e-15
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0481741779876506,0.00622091178192945,0.0359811908950689,0.0603671650802323,1.03388209080848e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CIT,Citron Rho-interacting kinase,39649,0.0382196959447799,0.00493643955402695,0.0285442744188871,0.0478951174706727,1.06106873323218e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3B,Protein FAM3B,42070,0.0292822491411732,0.00378690882720225,0.0218599078398567,0.0367045904424896,1.12920615472165e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSDE1,Cold shock domain-containing protein E1,39575,0.100391585004657,0.0129811063771949,0.0749486165053546,0.125834553503959,1.13633759213909e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX7,Syntaxin-7,39657,0.0408233831155098,0.00528380613242741,0.0304671230959521,0.0511796431350675,1.20451992147352e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0327381070198627,0.00423772216722037,0.0244321715721107,0.0410440424676146,1.21136045114812e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLIF,Cobalamin binding intrinsic factor,42129,0.0634315393968699,0.00821325359497225,0.0473335623507243,0.0795295164430155,1.21518048752417e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMBS,Porphobilinogen deaminase,42262,0.0334128009915492,0.00432837012144068,0.0249291955535255,0.0418964064295729,1.24885497977565e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBS,Cystathionine beta-synthase,39638,0.0430103802995904,0.00557164828877369,0.0320899496535939,0.0539308109455868,1.26862628510364e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN1,Tetraspanin-1,41900,0.0603472317291456,0.00783917342494928,0.0449824518162451,0.0757120116420462,1.47753336325193e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL1,Angiopoietin-related protein 1,41920,0.0237977672085282,0.00309321295022535,0.0177350698260865,0.0298604645909699,1.53149532555423e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOLA1,BolA-like protein 1,39586,0.0451184923198085,0.00587278164868613,0.0336078402883837,0.0566291443512333,1.69096364950883e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0273168353379812,0.00355654953490831,0.0203459982495609,0.0342876724264014,1.69096552913412e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0524091457732857,0.00682681152948733,0.0390285951754905,0.0657896963710808,1.74304418565752e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSME2,Proteasome activator complex subunit 2,41955,0.0291419953806069,0.00379754135501191,0.0216988143247835,0.0365851764364302,1.78374155802391e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0388673131787617,0.00506747181659353,0.0289350684182384,0.0487995579392851,1.84032628021363e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0991431332696908,0.012926558652578,0.0738070783106379,0.124479188228744,1.86473177255013e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRDL1,Chordin-like protein 1,42166,0.02698653754935,0.00352162457803837,0.0200841533763948,0.0338889217223053,1.93795944484202e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR5,Complement factor H-related protein 5,39864,0.0344008690586445,0.00448965132656469,0.0256011524585777,0.0432005856587113,1.97673356887445e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0250378790395999,0.00327430183674311,-0.0314555106396164,-0.0186202474395834,2.1996138107426e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPO,Erythropoietin,42119,0.0600954607256366,0.00785956732377837,0.044690708771031,0.0755002126802422,2.21024140091455e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL4,ADAMTS-like protein 4,39638,0.0203636924092632,0.00266267742387981,0.0151448446584587,0.0255825401600676,2.21393479337891e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0444393699518408,0.00581557121008262,0.0330408503800789,0.0558378895236028,2.32568152568278e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPME1,Protein phosphatase methylesterase 1,42070,0.0477932361706628,0.00625875203672365,0.0355260821786845,0.0600603901626412,2.38723205776854e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.0661687652009612,0.00867013049840284,0.0491753094240916,0.0831622209778307,2.46959256299463e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1RL,Complement C1r subcomponent-like protein,39958,0.0162141048945315,0.0021243653725303,0.0120503487643721,0.0203778610246909,2.48771976137145e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0439514182060532,0.00577310211240541,0.0326361380657387,0.0552666983463678,2.85288603360638e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB6,Integrin beta-6,41913,0.0252006948156569,0.00331037919915813,0.018712351585307,0.0316890380460069,2.86620571635206e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0553544242974129,0.00727317946831614,0.0410989925395132,0.0696098560553125,2.90459464814502e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPP1,Tripeptidyl-peptidase 1,42057,0.0387955646535237,0.00509914299080006,0.0288012443915556,0.0487898849154918,2.96249596211239e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPA1,Inositol monophosphatase 1,42016,0.0500612199735484,0.00658259002986131,0.0371593435150203,0.0629630964320766,3.03600227617093e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL2A1,Collagen alpha-1(II) chain,39638,0.0644620430426744,0.00848928618704544,0.0478230421160653,0.0811010439692834,3.36924564880015e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPE,Ribulose-phosphate 3-epimerase,39757,0.0584603048308376,0.00771091568783494,0.0433469100826811,0.0735736995789941,3.68676213864511e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.028369547836313,0.00374658740556821,0.0210262365213993,0.0357128591512267,3.90954637561943e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0495823882889244,0.00654966241917094,0.0367450499473494,0.0624197266304995,4.02469318340929e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0329785388972098,0.0043633540428076,0.0244263649733069,0.0415307128211127,4.41431664353288e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGBL1,Integrin beta-like protein 1,39966,0.0320478278878253,0.00424197634248524,0.0237335542565543,0.0403621015190964,4.51235048041917e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HPCAL1,Hippocalcin-like protein 1,42296,0.0597834809051319,0.0079254893901385,0.0442495217004604,0.0753174401098034,4.87449953743116e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN8,Tetraspanin-8,39930,0.0774391197945825,0.0102761120817014,0.0572979401144478,0.0975802994747172,5.22163019884294e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL20,C-C motif chemokine 20,42296,0.0701515882860136,0.00931563179717015,0.0518929499635601,0.0884102266084671,5.36938170347567e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0253550114162104,0.00336696302849064,0.0187557638803687,0.031954258952052,5.37319661176088e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.0179139622098454,0.00237928149368112,-0.0225773539374604,-0.0132505704822304,5.43579238307565e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD302,CD302 antigen,42070,0.0252373560649087,0.00335235290697169,0.0186667443672442,0.0318079677625732,5.46877716230193e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAG3,Lymphocyte activation gene 3 protein,42070,-0.0329180568450106,0.00437533255553606,-0.0414937086538613,-0.0243424050361599,5.66808418274874e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WAS,Wiskott-Aldrich syndrome protein,41913,0.0531899243475115,0.00707047733272126,0.0393317887753778,0.0670480599196452,5.7040729799535e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY75,Lymphocyte antigen 75,42119,0.0313700381413295,0.00417024808250944,0.023196351899611,0.039543724383048,5.71940198944703e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0276275292028467,0.00367341993486098,0.0204276261305192,0.0348274322751742,5.78151013402048e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSTB,Cystatin-B,41959,0.0351184636447689,0.00467009807309009,0.0259650714215123,0.0442718558680255,5.8330739505395e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0928206735989232,0.0123513024200346,0.0686121208556554,0.117029226342191,6.11730002830793e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300LF,CMRF35-like molecule 1,42262,0.0485527736715154,0.00646561823287567,0.0358801619350791,0.0612253854079518,6.30870280894361e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0358701183382853,0.00478039125186866,0.0265005514846227,0.0452396851919478,6.68570762276386e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0536631289524789,0.00715252647846484,0.0396441770546878,0.0676820808502699,6.71773556806951e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBS4,Thrombospondin-4,42189,0.0365906094624147,0.00489170985819066,0.0270028581403611,0.0461783607844684,7.88011420932892e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRP2,Neuropilin-2,42137,-0.0226322109635538,0.00302857699596408,-0.0285682218756434,-0.0166962000514642,8.32626042430617e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UMOD,Uromodulin,42274,-0.0432940742618289,0.00579363578394285,-0.0546496003983569,-0.0319385481253009,8.33335064525896e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK6,Kallikrein-6,42158,0.0248376036710093,0.00332579317148682,0.0183190490548951,0.0313561582871234,8.62775190152983e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0451773976795871,0.00605299449943649,0.0333135284606916,0.0570412668984827,8.93874445047809e-14
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0298164333966943,0.00401105542501304,0.0219547647636687,0.0376781020297198,1.12196832686044e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHGA,Chromogranin-A,39966,-0.0679390839082706,0.00915941733778379,-0.0858915418903268,-0.0499866259262143,1.27941343357103e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH1,Protocadherin-1,42264,0.0164161700461801,0.00221839042377782,0.0120681248155756,0.0207642152767847,1.4409011521648e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0351585879037447,0.00475418668240511,0.0258403820062307,0.0444767938012587,1.51387642008364e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0385488257264489,0.00521591793608889,0.0283256265717147,0.0487720248811832,1.54930129310982e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD93,Complement component C1q receptor,41654,-0.0250195955504376,0.00338683539802833,-0.0316577929305731,-0.018381398170302,1.58928898713967e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKD2,Serine/threonine-protein kinase D2,39575,0.034723406228493,0.00470735077083038,0.0254969987176655,0.0439498137393206,1.7433241963971e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0281409126245632,0.00381677634748525,0.0206600309834921,0.0356217942656343,1.76620154167113e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP9,Caspase-9,39657,0.050706438455549,0.00687651955085481,0.0372284601358736,0.0641844167752244,1.77619714497703e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.030015140064945,0.00407158308335735,0.0220348372215646,0.0379954429083254,1.80303157439409e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0451922951085676,0.00613503492989149,-0.0572169635711549,-0.0331676266459803,1.85635129067523e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMM2,Phosphomannomutase 2,39575,0.047520596445584,0.00646187882313831,0.034855313952233,0.0601858789389351,2.06085484417804e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX6,Syntaxin-6,41843,0.0518865972521987,0.00706989747055139,0.0380295982099179,0.0657435962944794,2.27585269822761e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRCAM,Neuronal cell adhesion molecule,42145,0.0226865692151506,0.003091992418982,0.0166262640739459,0.0287468743563553,2.30512301587402e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RCOR1,REST corepressor 1,41900,0.035254835750988,0.00480501462300526,0.0258370070898977,0.0446726644120783,2.30932991401416e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMD,Osteomodulin,42185,-0.0324021654045998,0.00441989736414221,-0.0410651642383185,-0.023739166570881,2.41392622528815e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTGES2,Prostaglandin E synthase 2,39579,0.0439868478178398,0.00600332871146281,0.0322203235433727,0.0557533720923069,2.51738334721274e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.0319980787148354,0.00436861626726158,0.0234355908310027,0.0405605665986681,2.55990937584896e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.056508767303487,0.00771847631602961,0.0413805537240689,0.071636980882905,2.62360037763043e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRSF1,G-rich sequence factor 1,39486,0.0655321349154122,0.0089655185482368,0.0479597185608681,0.0831045512699563,2.87254109473812e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLC,Galectin-10,42119,-0.0526912079221537,0.00722613938840048,-0.0668544411234186,-0.0385279747208887,3.22956799391705e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN2,Nectin-2,42129,0.0241986485381642,0.00332860487538606,0.0176745829824076,0.0307227140939209,3.79472616156818e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA4,Annexin A4,42088,0.0566642279970901,0.00780091353457768,0.0413744374693178,0.0719540185248623,3.97027072186461e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A12,Protein S100-A12,41910,0.0573633985858397,0.00791055584492401,0.0418587091297887,0.0728680880418908,4.34943151879896e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0295293010192376,0.00407320482072422,0.0215458195706181,0.037512782467857,4.450562546745e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0356006615981193,0.00491899881624155,0.0259594239182859,0.0452418992779527,4.87076923479487e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0206493661018136,0.00285744695156165,0.0150487700767527,0.0262499621268744,5.21846584933342e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0417405164095108,0.00577760998106331,0.0304164008466267,0.0530646319723949,5.35098783126563e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.0290929863396784,0.00403153630730756,0.0211911751773556,0.0369947975020012,5.68156359967334e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB8,Serpin B8,42296,0.0454108351446712,0.00629410071095909,0.0330743977511914,0.057747272538151,5.68412384936127e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECE1,Endothelin-converting enzyme 1,41839,0.0273707627750526,0.00380899543117984,0.0199051317299401,0.0348363938201651,7.03802471241201e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD248,Endosialin,39966,-0.0313480067881432,0.00436252460140031,-0.0398985550068879,-0.0227974585693986,7.10235615549946e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINI2,Serpin I2,39930,0.0447349397487148,0.00622689568521635,0.0325302242056907,0.0569396552917388,7.1870749346436e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRDT,Bromodomain testis-specific protein,39575,0.028277779156218,0.00393958675369934,0.0205561891189673,0.0359993691934687,7.53886792046676e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL8,Interleukin-8,42035,0.0524194301290088,0.00730530878404535,0.0381010249122799,0.0667378353457377,7.58064263876045e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0305570990680374,0.00425889596524383,0.0222096629761595,0.0389045351599153,7.69555885521334e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CENPF,Centromere protein F,39757,0.041628413220206,0.00580696606091509,0.0302467597408124,0.0530100666995996,8.0496062847109e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0387267888861353,0.0054085265648464,0.0281260768190363,0.0493275009532342,8.54708050598936e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAA10,N-alpha-acetyltransferase 10,39575,0.0390881581676919,0.00546039019001109,0.0283857933952701,0.0497905229401136,8.67817033440119e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0365606510763724,0.00511353417977529,0.0265381240840128,0.046583178068732,9.14744877743727e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0254019947010449,0.00355443040437559,-0.032368678293621,-0.0184353111084687,9.44189095834412e-13
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0430809731905099,0.00604264554148217,0.0312373879292048,0.054924558451815,1.07075029447562e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH5,Cadherin-5,42310,-0.0232797898139112,0.00327122017696686,-0.0296913813607662,-0.0168681982670561,1.16162740535386e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0200970459279301,0.0028252755931592,-0.0256345860905221,-0.0145595057653381,1.20248732301059e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.0123546675979989,0.00173745552692675,0.00894925476522245,0.0157600804307753,1.21100913211252e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,F3,Tissue factor,42174,-0.0199839225143587,0.00281485218098816,-0.0255010327890955,-0.0144668122396219,1.31473343084721e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0477476444526754,0.00672821788644174,0.0345603373952496,0.0609349515101012,1.35672708810576e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC10A,C-type lectin domain family 10 member A,42016,-0.0278031360333759,0.00393620551969035,-0.035518098851969,-0.0200881732147828,1.70440840918928e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0335830492011116,0.00475923795603746,0.0242549428072782,0.0429111555949451,1.81124588916963e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300A,CMRF35-like molecule 8,39736,0.0231904105961053,0.00329421039335118,0.016733758225137,0.0296470629670736,2.03919952428793e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MET,Hepatocyte growth factor receptor,42158,-0.0145274558127465,0.0020655564914424,-0.0185759465359737,-0.0104789650895194,2.11535610172556e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0356782376234465,0.00507642828141379,0.0257284381918755,0.0456280370550176,2.21516491298565e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD80,T-lymphocyte activation antigen CD80,39958,0.0259120584908907,0.00369094772063767,0.0186778009584408,0.0331463160233405,2.33791644494905e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX5,Sorting nexin-5,39638,0.0225086581159443,0.00321066208012979,0.0162157604388899,0.0288015557929987,2.51159787721008e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.0178221059649295,0.00255165878830189,0.0128208547398578,0.0228233571900012,2.9906870744793e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPM3,Tropomyosin alpha-3 chain,39575,-0.0347536421624186,0.00498604243874748,-0.0445262853423636,-0.0249809989824735,3.34685867482171e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0508965714207777,0.00732248226080462,0.0365445061896006,0.0652486366519547,3.80103198765856e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSC2,Desmocollin-2,41984,-0.0263348281600334,0.00378908646013742,-0.0337614376219028,-0.0189082186981641,3.81717193566823e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO1,Roundabout homolog 1,42144,0.0179053692756469,0.00258005198466184,0.0128484673857097,0.0229622711655841,4.10147385087871e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BSG,Basigin,42284,0.0156024383196232,0.00224943799531726,0.0111935398488013,0.020011336790445,4.21025013211524e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTN2,Alpha-actinin-2,39575,-0.0481190601397737,0.00695798944859637,-0.0617567194590225,-0.0344814008205248,4.91596114032309e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN3,Calsyntenin-3,39929,0.0225376801114337,0.00325983692444972,0.0161483997395123,0.0289269604833552,4.9740057647634e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0257464003499572,0.00372458116035094,-0.0330465794242451,-0.0184462212756694,4.97681497304866e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.0387992241341458,0.00561466127109545,-0.0498039602254929,-0.0277944880427988,5.05116771588517e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0373161921942673,0.00539996077114187,0.0267322690828292,0.0479001153057054,5.0519780580004e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C7,Complement component C7,39722,-0.0247966580172166,0.00359685517661433,-0.0318464941633807,-0.0177468218710526,5.71897059164549e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0385132660462436,0.00559020685217514,0.0275564606159804,0.0494700714765069,5.85532037605357e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MARCO,Macrophage receptor MARCO,42145,0.0191479530822215,0.00278171895742928,0.0136957839256601,0.0246001222387829,6.09713677726386e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0395598375328143,0.00575110731715807,0.0282876671911845,0.0508320078744441,6.30906242843311e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZBP1,Z-DNA-binding protein 1,39657,0.0306232625225141,0.00445410166575631,0.0218932232576317,0.0393533017873965,6.5195645392593e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFR,Epidermal growth factor receptor,42310,0.0118031513765952,0.00171946442054467,0.00843300111232763,0.0151733016408627,6.96250635668636e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP8,Caspase-8,42224,0.0450869203178055,0.00658004186507407,0.0321900382622604,0.0579838023733507,7.59148473581307e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.019298927718646,0.00281935249163245,0.0137729968350464,0.0248248586022456,8.03339158853923e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSF,Cathepsin F,42181,0.0296780277581379,0.00434113224099887,0.0211694085657801,0.0381866469504957,8.4633793222287e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1A,Protein phosphatase 1A,41843,0.0230612855749876,0.00338050313329411,0.0164354994337311,0.029687071716244,9.37800220541035e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COLEC12,Collectin-12,42123,0.0201039604896687,0.00294949093716818,0.014322958252819,0.0258849627265183,9.75249391059209e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAST,Gastrin,39929,0.0961032981114398,0.0141024215760125,0.0684625518224553,0.123744044400424,9.92761809417914e-12
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0385057315796384,0.00565801512986285,0.0274160219251072,0.0495954412341696,1.05902946009029e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0315614844748676,0.00463950784892804,0.0224680490909687,0.0406549198587666,1.0701496371716e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0428546680316224,0.00631200311994599,0.0304831419165283,0.0552261941467165,1.18376480917826e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRELP,Prolargin,42123,0.0170966498856048,0.00252237554693765,0.012152793813607,0.0220405059576026,1.26905156626775e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPOCK1,Testican-1,42016,0.0189719964892206,0.00281361541151959,0.0134573102826422,0.024486682695799,1.61582810603847e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK4,Dickkopf-related protein 4,41992,0.0334659820198315,0.00496867581191796,0.0237273774284723,0.0432045866111907,1.70161297236749e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGER,Advanced glycosylation end product-specific receptor,42093,0.0297878892226328,0.00442337163672496,0.0211180808146518,0.0384576976306137,1.71501349049936e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0291107291128688,0.00433079908731239,0.0206223629017365,0.0375990953240011,1.88122249117373e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNC,Tenascin,42217,-0.0349413429667281,0.0051995990901763,-0.0451325571834737,-0.0247501287499826,1.88942099002241e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CR2,Complement receptor type 2,42217,0.033754366115445,0.00502350708501507,0.0239082922288155,0.0436004400020745,1.89880141874849e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEO1,RNA polymerase-associated protein LEO1,39934,0.0210627835344889,0.00313625435031415,0.0149157250078731,0.0272098420611046,1.95843053253493e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.0270528881727164,0.00402923313880428,0.01915559122066,0.0349501851247727,1.98430828499749e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXN,Thioredoxin,39854,0.0310839655126286,0.00463041353259846,0.0220083549887356,0.0401595760365216,1.99832772004663e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0294694428634763,0.00440134983563063,0.0208427971856403,0.0380960885413124,2.23545760222843e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGT,Angiotensinogen,39990,0.0156937478048696,0.00234534055167242,0.0110968803235917,0.0202906152861476,2.31320712387624e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0311298913330836,0.00466433444589465,0.0219877958191301,0.0402719868470371,2.58560911163458e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.0236393413052131,0.00354710431424223,-0.0305916657611279,-0.0166870168492984,2.76018463267967e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHI3L1,Chitinase-3-like protein 1,41907,0.0600912640181486,0.00901898339460337,0.042414056564726,0.0777684714715712,2.79317704037282e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0453836101027281,0.00681591612006522,-0.0587428056980559,-0.0320244145074003,2.87216193684744e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGMB,RGM domain family member B,42249,0.0201019894277637,0.00301979516402099,0.0141831909062825,0.0260207879492448,2.90665078487239e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAM2,Neural cell adhesion molecule 2,42137,-0.0192504529443784,0.00290274766090226,-0.0249398383597468,-0.01356106752901,3.44195184875296e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR2,Folate receptor beta,42249,-0.0207139892086769,0.00312933284352445,-0.0268474815819848,-0.014580496835369,3.74388618185687e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0654483465230062,0.00992398123006193,0.0459973433120848,0.0848993497339276,4.44780710935898e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPING1,Plasma protease C1 inhibitor,39959,0.0131456053193556,0.00199566446164128,0.00923410297453873,0.0170571076641725,4.68365412482597e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0292448983836159,0.00444378760203789,0.0205350746836217,0.0379547220836102,4.84276049830273e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA7A,Semaphorin-7A,42272,0.0202357127452943,0.00307622977833952,0.0142063023797489,0.0262651231108398,4.93868085355153e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIMAP7,GTPase IMAP family member 7,39736,-0.0228092308233568,0.00346798114319028,-0.0296064738640097,-0.0160119877827038,5.01227936134511e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPCAM,Epithelial cell adhesion molecule,42125,-0.066247835821619,0.0100792969522677,-0.0860032578480638,-0.0464924137951743,5.12345010755955e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRR3,Small proline-rich protein 3,39929,0.0445986295269472,0.00678968738012567,0.0312908422619009,0.0579064167919935,5.30204636210026e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.021405076023097,0.00326001712066131,0.0150154424666008,0.0277947095795932,5.40229765358281e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4M,C-type lectin domain family 4 member M,39945,-0.0350056755241861,0.00534240602253395,-0.0454767913283526,-0.0245345597200195,5.90642379536342e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.0286682122048997,0.00438047646900739,0.0200824783256453,0.0372539460841542,6.18463864193503e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLYR1,Putative oxidoreductase GLYR1,39919,0.0409022353007172,0.00624925440880343,0.0286536966594624,0.0531507739419719,6.2008619899185e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD6,Programmed cell death protein 6,42145,-0.0496878778699678,0.00759875443777492,-0.0645814365680067,-0.034794319171929,6.41737737268579e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DGCR6,Protein DGCR6,39586,0.0294852540428166,0.00451350382357078,0.0206387865486179,0.0383317215370154,6.74611225748241e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALB2,Calretinin,41839,0.0206748150635958,0.00317236003180272,0.0144569894012625,0.0268926407259291,7.42403563035307e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN4B,Sodium channel subunit beta-4,39638,0.0305646937779347,0.00469137397579251,0.0213696007853814,0.0397597867704881,7.58110619590761e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.0265699997198441,0.00408134666045924,0.018570560265344,0.0345694391743442,7.77490924342703e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST5,Cystatin-D,41846,0.0393223370914758,0.00606160025116618,0.0274416005991901,0.0512030735837615,9.06013416642552e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMPD3,AMP deaminase 3,39929,0.0481275769632908,0.0074246586735143,0.0335752459632028,0.0626799079633788,9.41951912330507e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM2,Myomesin-2,39575,-0.0389054506033019,0.0060045096583473,-0.0506742895336626,-0.0271366116729412,9.60499491688534e-11
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0340952365014025,0.00527387216611812,0.023758447055811,0.044432025946994,1.05619758230369e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0233235976434368,0.00361158296525628,0.0162448950315345,0.0304023002553391,1.09686245404735e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASET2,Ribonuclease T2,42258,0.0186175041186487,0.00288822501742597,0.0129565830844938,0.0242784251528036,1.18697024733864e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.0191618831786393,0.00297557097608453,0.0133297640655137,0.024994002291765,1.2371062759296e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASGR2,Asialoglycoprotein receptor 2,39990,0.0183390143170628,0.00284743163322996,0.012758048315932,0.0239199803181935,1.23837676843744e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0399022441596397,0.00619825174306236,0.0277536707432375,0.0520508175760419,1.2636418412556e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RALY,RNA-binding protein Raly,39919,0.0333476411651427,0.00518696078689956,0.0231811980228196,0.0435140843074659,1.33500694130668e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTB,Lymphotoxin-beta,39919,0.0237720210915624,0.00370904143908956,0.0165022998709469,0.031041742312178,1.52089978120574e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA3,Protein disulfide-isomerase A3,39736,0.0169712476958474,0.00264913750870559,0.0117789381787845,0.0221635572129104,1.55076986149596e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.0259496865027309,0.00405192282144675,0.0180079177726952,0.0338914552327665,1.57247678185064e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0166071898032248,0.00259482377761605,0.0115213351990974,0.0216930444073523,1.60368074541459e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR2,Complement factor H-related protein 2,39904,0.0393419595078531,0.00614880602272441,0.0272902997033132,0.0513936193123929,1.63317221949365e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0581422332595013,0.0091191109576731,0.0402687757824621,0.0760156907365406,1.89006160698868e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0438902014277235,0.00688586334960782,0.0303939092624922,0.0573864935929548,1.91558838235674e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.0260642698588061,0.00409326707920972,-0.0340870733340571,-0.018041466383555,1.99439910602361e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AFAP1,Actin filament-associated protein 1,39736,0.0573012949123924,0.00900961557823325,0.0396424483790553,0.0749601414457296,2.0963841418346e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.0285689548063338,0.00449332149517871,0.0197620446757835,0.037375864936884,2.12130654477643e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHCHD6,MICOS complex subunit MIC25,39919,0.019852988231378,0.00313010232685602,0.0137179876707402,0.0259879887920158,2.34531745809977e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.0141825945329732,0.00223885728376983,0.00979443425678429,0.018570754809162,2.45289690306697e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0480433462781716,0.00759286776245869,0.0331613254637526,0.0629253670925906,2.58828730459171e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYAR,Cell growth-regulating nucleolar protein,41843,0.036331128900974,0.00575137555341949,0.0250584328162718,0.0476038249856762,2.75316805125078e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARF2,Scavenger receptor class F member 2,42249,-0.0192765211325769,0.00306410606430845,-0.0252821690186214,-0.0132708732465323,3.24898453995035e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0189454467326224,0.00301305020194894,0.0130398683368025,0.0248510251284423,3.31778753445672e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0255236093811927,0.00406045685897551,0.0175651139376007,0.0334821048247847,3.36139419535152e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH1,Cadherin-1,41697,0.0271646373339203,0.00432864146700586,0.0186805000585888,0.0356487746092518,3.59364820459257e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD276,CD276 antigen,42123,-0.0242487791937845,0.00387095362941196,-0.031835848307432,-0.0166617100801371,3.85872718545775e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD209,CD209 antigen,42171,-0.0263126687464122,0.0042008105284155,-0.0345462573821066,-0.0180790801107178,3.87262628735749e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0302085080580152,0.0048278689605109,0.0207458848954138,0.0396711312206165,4.0634282776956e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0223998544739107,0.00358188787436301,0.0153793542401592,0.0294203547076622,4.12924816798588e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCT,Secretin,39649,0.0324443049423867,0.00519306623362072,0.0222658951244901,0.0426227147602833,4.3208915265269e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.0342239468034118,0.00548386958584805,0.0234755624151496,0.044972331191674,4.48442409548784e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR15L,Protein GPR15L,39930,0.0419534617349297,0.00672284150339427,0.028776692388277,0.0551302310815825,4.51933916149602e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0168679002171207,0.00271519723727477,0.0115461136320622,0.0221896868021793,5.37074565241425e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRN,Progranulin,42077,0.0167541237291646,0.00270814037877099,0.0114461685867735,0.0220620788715558,6.32630590863102e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0209039102050976,0.00338629380232662,-0.0275410460576578,-0.0142667743525375,6.89132966786264e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EBI3_IL27,Interleukin-27,42247,-0.0203670161361871,0.00329985514871583,-0.0268347322276701,-0.013899300044704,6.92990846382274e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLU,Clusterin,39979,0.0200228948606273,0.00324520754657114,0.0136622880693478,0.0263835016519067,7.06157954260466e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB37,Ras-related protein Rab-37,41913,0.0539813828934051,0.00875652310819056,0.0368185976013516,0.0711441681854586,7.26546026183112e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0339395113596181,0.00551349031465777,-0.0447459523763474,-0.0231330703428889,7.68409898325587e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0355133338487629,0.00577672062890057,0.0241909614161178,0.046835706281408,8.08215162164044e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0255383981542936,0.00415545504590904,0.0173937062643118,0.0336830900442753,8.23477055408149e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0155359678522048,0.00253466397571628,0.0105680264598009,0.0205039092446087,9.06634363139783e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDM1,Nuclear protein MDM1,39649,0.0207526080219416,0.00339310102848565,0.0141021300061097,0.0274030860377735,9.91247643282575e-10
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTRK3,NT-3 growth factor receptor,42249,-0.0139534615468952,0.00228561372114534,-0.0184332644403401,-0.00947365865345036,1.05647941388433e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0380534727352081,0.00623422971394609,0.0258343824958737,0.0502725629745424,1.06301976171854e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AZU1,Azurocidin,41751,0.0494246468419538,0.00811397425478362,0.0335212573025779,0.0653280363813297,1.15122243494842e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0168636478034693,0.00277544114129303,0.011423783166535,0.0223035124404036,1.26539771344289e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSM,Oncostatin-M,42051,0.0451556272007897,0.00744975987653049,0.03055409784279,0.0597571565587895,1.38590588325294e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFB,Vascular endothelial growth factor B,39657,0.0192801736662356,0.00318268234660352,0.0130421162668927,0.0255182310655786,1.42452410726283e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0716278886257815,0.0118261503158366,0.0484486340067418,0.0948071432448212,1.42577706564374e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0338847852992652,0.00559690969396479,0.0229148422990942,0.0448547282994362,1.44937183549506e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SATB1,DNA-binding protein SATB1,39934,0.0190540195602772,0.00315389718316414,0.0128723810812755,0.025235658039279,1.57558889637715e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A13,Protein S100-A13,39657,0.0231848759571147,0.00383762578288586,0.0156631294226584,0.0307066224915709,1.57638973221493e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0351062065681804,0.0058149400370642,0.0237089240955346,0.0465034890408263,1.61684144142274e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CABP2,Calcium-binding protein 2,39649,0.0426067344614086,0.00705812885181701,0.0287728019118473,0.05644066701097,1.62501658816776e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COPB2,Coatomer subunit beta',39575,0.0278897941729285,0.00463704701974884,0.0188011820142207,0.0369784063316362,1.86124975560838e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPHS1,Nephrin,39657,0.0215758967969912,0.00358859466571313,0.0145422512521934,0.0286095423417889,1.88624820461478e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0332535275910006,0.00553343954934746,0.0224079860742796,0.0440990691077217,1.90915063310716e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOB,Apolipoprotein B-100,39990,0.0147470283062292,0.00245704297873894,0.0099312240679009,0.0195628325445576,2.00906447718859e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNU13,NHP2-like protein 1,39575,0.0408024592275593,0.0067982009447413,0.0274779853758664,0.0541269330792523,2.01123948562573e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.0259721921806163,0.00433091848622694,0.0174835919476115,0.0344607924136211,2.06326673130978e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.0180109658087155,0.00300486109445527,0.0121214380635831,0.0239004935538478,2.10001850630019e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0200058921422278,0.00333827034787139,0.0134628822603999,0.0265489020240558,2.12397380109368e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF1C,Kinesin-like protein KIF1C,39575,0.0225019317272117,0.00375761421374495,0.0151370078682716,0.0298668555861518,2.18612170931567e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CX3CL1,Fractalkine,42016,-0.0215548968429822,0.00360124934175212,-0.0286133455528163,-0.014496448133148,2.21373540032061e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300C,CMRF35-like molecule 6,42249,0.0227117168625649,0.00379627753143074,0.0152710129009607,0.0301524208241691,2.25060441043024e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL34,Interleukin-34,41814,0.0235517113851919,0.00394235991212941,0.0158246859574183,0.0312787368129656,2.37438665964723e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKD1,Polycystin-1,39958,0.0174924345669324,0.00293306204983373,0.0117436329492583,0.0232412361846065,2.53647502306853e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GC,Vitamin D-binding protein,39979,0.0165751337640513,0.00278483053858721,0.0111168659084204,0.0220334016196822,2.72799804254588e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWC2,Brorin,41973,0.0262276402591222,0.00441283985605778,0.017578474141249,0.0348768063769955,2.85974639060578e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPH1,Neurexophilin-1,41839,0.0248742592467805,0.00418876297555861,0.0166642838146856,0.0330842346788754,2.95156026167024e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSAP,Prosaposin,39886,0.018274532865689,0.00307710637609691,0.0122434043685391,0.024305661362839,2.95451122922078e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.0174849194294063,0.00295309726343514,0.0116968487930735,0.0232729900657392,3.27965497634268e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBC1D17,TBC1 domain family member 17,41839,0.0275118419406127,0.0046465712863372,0.0184045622193918,0.0366191216618336,3.28135346686203e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX2,Sorting nexin-2,39919,0.0544993363677099,0.00921281834628075,0.0364422124089996,0.0725564603264202,3.40236105384697e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0230466121563491,0.00389834205913858,0.0154058617204375,0.0306873625922607,3.4825038537663e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0250042561562535,0.00423762186465422,0.0166985173015312,0.0333099950109757,3.72947188527872e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB2A2,Mammaglobin-A,39575,-0.0197851736812233,0.00335563046324807,-0.0263622093891895,-0.0132081379732571,3.83129959256255e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA9,Carbonic anhydrase 9,42262,-0.0296265986242301,0.00503145020913507,-0.0394882410341348,-0.0197649562143254,3.99394856210585e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGSF21,Immunoglobulin superfamily member 21,39638,0.0255016808547266,0.0043368775247093,0.0170014009062964,0.0340019608031568,4.21661281811383e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE3,Eosinophil cationic protein,42081,0.068791531540374,0.0117295215474549,0.0458016693073623,0.0917813937733856,4.60155994096812e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LUZP2,Leucine zipper protein 2,39919,0.0284030289769115,0.00484689619793179,0.0189031124289652,0.0379029455248578,4.75639428499659e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.0154593157014378,0.00264091803091357,-0.0206355150420284,-0.0102831163608472,4.91554080356589e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIL1,Nucleotide exchange factor SIL1,39638,0.0206902476389687,0.00353742881827124,0.013756887155157,0.0276236081227803,5.08720305165435e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCN3,CCN family member 3,42299,0.0213947059762955,0.00366043348164633,0.0142202563522687,0.0285691556003223,5.18540824619539e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD14,Monocyte differentiation antigen CD14,41932,0.0259436475664197,0.00444166534809973,0.0172379834841442,0.0346493116486951,5.31070294444578e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA7,Carbonic anhydrase 7,39757,-0.0210956450337777,0.00361671767658573,-0.0281844116798857,-0.0140068783876697,5.60132536490845e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.061035107140007,0.0105262019276702,0.0404037513617734,0.0816664629182406,6.87980662202133e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0219818008862531,0.00379451254697245,0.0145445562941871,0.0294190454783191,7.06381494527394e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0293596799947158,0.00506969213057868,0.0194230834187815,0.03929627657065,7.14679626017611e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACHE,Acetylcholinesterase,39736,0.0213549919211167,0.00369253865525688,0.0141176161568132,0.0285923676854202,7.52277873247242e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0254635472628949,0.00440324456339273,-0.0340939066071446,-0.0168331879186451,7.53554501482277e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL25,C-C motif chemokine 25,42296,0.0305981603188888,0.00529239634488288,0.0202250634829183,0.0409712571548592,7.56369749251821e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.0279977972526055,0.00484532597429947,0.0185009583429785,0.0374946361622325,7.71236297233008e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0406411508663338,0.00703336923643181,0.0268557471629275,0.0544265545697402,7.74338685526029e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFIC,Nuclear factor 1 C-type,39934,0.0284599697752578,0.00492920092400044,0.0187987359642169,0.0381212035862986,7.95622083651475e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0315215183179714,0.00547357574317087,0.0207933098613565,0.0422497267745863,8.65116059104535e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN8,Septin-8,39906,0.0202068142978495,0.00351680679319984,0.0133138729831778,0.0270997556125212,9.38582985430682e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TREML1,Trem-like transcript 1 protein,39990,0.0328070783309203,0.00571186004987733,0.0216118326331607,0.0440023240286798,9.50134410825944e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LXN,Latexin,41960,-0.0424596459350214,0.0073953346848434,-0.0569545019173145,-0.0279647899527284,9.5933810870246e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0237244536956076,0.00413302935076822,0.0156237161681019,0.0318251912231133,9.69919676793917e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0418161873315868,0.00728803662809788,0.0275316355405149,0.0561007391226586,9.80389635423939e-09
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.027632739762031,0.00482255228762724,-0.0370849422457804,-0.0181805372782817,1.02630094608281e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.0371508056661464,0.00648545238548469,0.0244393189905964,0.0498622923416964,1.03557354457658e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP6,Gastrotropin,41881,0.0349572285440289,0.00612168865065991,0.0229587187887355,0.0469557382993223,1.15132139653319e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYZL2,Lysozyme-like protein 2,39560,0.0223482404145989,0.00392223774336905,0.0146606544375955,0.0300358263916022,1.24471014444635e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIM,Vimentin,41900,0.0704423562245923,0.0123727153516404,0.0461918341353771,0.0946928783138074,1.2719463653297e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.0224714537018666,0.00396747150333648,0.0146952095553271,0.0302476978484061,1.50926072732935e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STC2,Stanniocalcin-2,42113,0.0146349437863713,0.00258674669370165,0.00956492026671611,0.0197049673060266,1.56561656030978e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLVRB,Flavin reductase,42137,0.0388385022874311,0.0068671811620006,0.0253788272099099,0.0522981773649523,1.58381525290413e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,XG,Glycoprotein Xg,42261,0.0211023434154366,0.00373140445900963,0.0137887906757777,0.0284158961550955,1.58659844254982e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.0206516184841883,0.00365317553155175,0.0134913944423469,0.0278118425260297,1.60828981106908e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA1,Alpha-1-antitrypsin,39795,-0.00498102483649283,0.000882057359017122,-0.00670985726016639,-0.00325219241281927,1.67197842748084e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0189333157518537,0.00335444066346145,0.0123586120514693,0.0255080194522382,1.6998356945014e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1B,Interleukin-1 beta,41825,0.034304072585708,0.00608407819445092,0.0223792793245842,0.0462288658468318,1.75216117248053e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CR1,Complement receptor type 1,39970,0.0215549195392279,0.00382407462587597,0.014059733272511,0.0290501058059448,1.77532213342964e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB6A,Ras-related protein Rab-6A,42119,0.026976456768943,0.00478805974726871,0.0175918596642963,0.0363610538735896,1.79476437304407e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH3,Cadherin-3,42249,0.0223490818834994,0.00396922053222819,0.0145694096403322,0.0301287541266667,1.83128007307971e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0446323080689182,0.00792696858325308,0.0290954496457421,0.0601691664920942,1.83323749292028e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL3,Myosin light chain 3,39638,-0.0477097167885713,0.00847413733723842,-0.0643190259695586,-0.031100407607584,1.84569770837223e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.0142108096424401,0.00252448760455431,-0.0191588053473666,-0.00926281393751369,1.8464720507937e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.0191221957997559,0.00341210152655218,0.0124344768077136,0.0258099147917982,2.14202193436296e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.040555507507338,0.00725302261208257,0.0263395831876562,0.0547714318270199,2.30463939399548e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A11,Protein S100-A11,42027,0.0278731132168559,0.00498644151278271,0.0180996878518017,0.03764653858191,2.3178681563334e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TK1,"Thymidine kinase, cytosolic",39757,0.028416769311168,0.0050861205271019,0.0184479730780483,0.0383855655442877,2.36277603087328e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JAM2,Junctional adhesion molecule B,42249,0.0164367417690115,0.00294412205265203,0.0106662625458135,0.0222072209922094,2.41050944101485e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.0260827589295958,0.00467653099644998,0.0169167581765538,0.0352487596826378,2.48934703781522e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SDC1,Syndecan-1,42145,0.0242997272803289,0.00436057189671984,0.015753006362758,0.0328464481978998,2.55752777751956e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,42199,-0.0173188968066863,0.00313444480158718,-0.0234624086177972,-0.0111753849955754,3.34878860765107e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX3,Syntaxin-3,39929,0.022666137028715,0.00411158387622543,0.0146074326313132,0.0307248414261169,3.61006003501412e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0465808468509137,0.00847344256944289,0.0299728994148056,0.0631887942870218,3.92842864369749e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0282155223043891,0.00514061160013587,-0.0382911210406554,-0.0181399235681228,4.12003522886808e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENSA,Alpha-endosulfine,39919,0.0313818288493685,0.00571728429120413,0.0201759516386084,0.0425877060601286,4.13068959191695e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBD,Thrombomodulin,42145,0.0174421862447309,0.00318403242468213,0.011201482692354,0.0236828897971079,4.37792671990975e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.0183891231387776,0.00336395365638733,-0.0249824723052968,-0.0117957739722585,4.69010955022336e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMOX1,Heme oxygenase 1,42007,-0.0290274993257324,0.00531093727969891,-0.0394369363939423,-0.0186180622575225,4.69568384586649e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.016375278141177,0.00299793883381212,0.0104993180269053,0.0222512382554488,4.78817936652679e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0163080467613564,0.00298693499148104,0.0104536541780536,0.0221624393446592,4.87011056768994e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.0178544561162801,0.00327160620884557,0.0114421079469428,0.0242668042856174,4.91610043737392e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKK3,Dickkopf-related protein 3,42310,-0.0173324358010605,0.00317714463279952,-0.0235596392813476,-0.0111052323207735,4.97243034097713e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAP,Cartilage-associated protein,39649,0.0289946864031622,0.00532241089953788,0.018562761040068,0.0394266117662565,5.21310568493636e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC16,Mucin-16,42070,0.111578286905213,0.0205738002488167,0.0712536384175319,0.151902935392894,5.95118710789116e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG1A,Lithostathine-1-alpha,42105,-0.0291329402891309,0.00537342255763268,-0.039664848502091,-0.0186010320761709,6.00587791994768e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP13,Collagenase 3,41839,-0.0188624627697753,0.00348256631462583,-0.0256882927464419,-0.0120366327931087,6.19239466088388e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.0381382139497116,0.00705231537307972,0.0243156758184753,0.0519607520809478,6.51058538274022e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPTL4,Angiopoietin-related protein 4,42166,-0.0259617034522843,0.00480643261710646,-0.035382311381813,-0.0165410955227557,6.72193418900183e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSH,Pro-cathepsin H,41865,0.043420119460642,0.00804411530357222,0.0276536534656405,0.0591865854556436,6.86429406035616e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPQ,Carboxypeptidase Q,39960,0.0217475877879588,0.00403755012139762,0.0138339895500194,0.0296611860258981,7.33442293236511e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL3,Fc receptor-like protein 3,41913,0.0309385779615259,0.00577602847411843,0.0196175621522538,0.042259593770798,8.63202904184179e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.0144925679664633,0.0027099848332438,-0.0198041382396211,-0.0091809976933054,9.04381446535145e-08
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST1,Cystatin-SN,38503,0.0612015868596435,0.0114910559032492,0.0386791172892749,0.083724056430012,1.02589132942551e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KEL,Kell blood group glycoprotein,41839,0.0208002234724635,0.00390615784479449,0.0131441540966663,0.0284562928482607,1.02613173605447e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0163452112279163,0.00307027574137773,-0.0223629516810166,-0.0103274707748159,1.03303414684405e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QA,Complement C1q subcomponent subunit A,42230,-0.0128272487272763,0.00241146702422557,-0.0175537240947584,-0.00810077335979414,1.0583052188312e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4D,C-type lectin domain family 4 member D,42119,0.0354632171412359,0.00667800214413467,0.022374332938732,0.0485521013437399,1.11084980207907e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HGFAC,Hepatocyte growth factor activator,39897,0.0154871519671944,0.00291626681640804,0.00977126900703464,0.0212030349273542,1.11333412096877e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.0227210652181512,0.00428108068130077,0.0143301470828017,0.0311119833535008,1.12983825280419e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNG,Interferon gamma,41913,0.0651011609703228,0.0123178393048655,0.0409581959327865,0.0892441260078591,1.27611216145004e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPG,Macrophage-capping protein,42015,0.0335414127260441,0.00634737999744509,0.0211005479310518,0.0459822775210365,1.2816730522763e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0272459758162078,0.00516239073929037,0.0171276899671987,0.037364261665217,1.33250512881902e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTG,Protogenin,42262,0.0139710632398855,0.00264810866621261,0.00878077025410874,0.0191613562256622,1.34150108352861e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFHD1,EF-hand domain-containing protein D1,39934,0.0203686377015614,0.0038801170915924,0.0127636082020403,0.0279736672010825,1.5527836522175e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.0176123907523587,0.00339452440583842,0.0109591229169154,0.024265658587802,2.15790059113179e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLIC5,Chloride intracellular channel protein 5,39649,-0.0176339141191949,0.00339955685938195,-0.0242970455635836,-0.0109707826748063,2.17351296949017e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0212159170373263,0.00410330008339578,0.0131734488738705,0.029258385200782,2.37608869791707e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PVALB,Parvalbumin alpha,42208,0.0619357268147795,0.0120420731517862,0.0383332634372785,0.0855381901922805,2.73736648164575e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPTLC1,Serine palmitoyltransferase 1,39929,0.0214508483943079,0.00417049003043477,0.0132766879346557,0.02962500885396,2.74195740308795e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTP1,Glutathione S-transferase P,41759,-0.0387175504009366,0.00754513297071137,-0.0535060110235309,-0.0239290897783423,2.91597118372701e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UROS,Uroporphyrinogen-III synthase,39649,0.036552341401373,0.00713367571484715,0.0225703370002726,0.0505343458024734,3.04309481198073e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PADI4,Protein-arginine deiminase type-4,41814,0.0404010833802673,0.00788691335865441,0.0249427331973047,0.05585943356323,3.05682060817395e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.0148086550039475,0.00290905826353308,0.00910690080742263,0.0205104092004723,3.6183871578982e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRDX2,Peroxiredoxin-2,39819,0.0330974768306922,0.00651291037066753,0.0203321725041839,0.0458627811572006,3.79842356785572e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0189766565034061,0.00373610991010697,0.0116538810795964,0.0262994319272157,3.84951328821734e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0464514507238264,0.00917751327686256,0.0284635247011758,0.0644393767464771,4.21680906472304e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF7,SLAM family member 7,42119,-0.0324288033744349,0.00644131695133037,-0.0450537845990424,-0.0198038221498273,4.8526631906696e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0141023866715385,0.00280151469819778,0.00861141786307084,0.0195933554800061,4.86939909903854e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0635463696630594,0.012672877079145,0.0387075305879351,0.0883852087381837,5.38924007524218e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VAMP5,Vesicle-associated membrane protein 5,41900,0.0280073257960281,0.00558584624866252,0.0170590671486496,0.0389555844434067,5.40018712098863e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0184189988926978,0.00369814569916988,0.0111706333223248,0.0256673644630708,6.43183329739662e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.0272761562486063,0.00548051090457966,0.0165343548756302,0.0380179576215824,6.55789598088661e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNLY,Granulysin,42137,0.0289209264662151,0.00581688980404815,0.0175198224502808,0.0403220304821495,6.71157229598001e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSV,Cathepsin L2,42200,0.021454156659916,0.00431677571045601,0.0129932762674222,0.0299150370524098,6.77853266159605e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.0163514952520476,0.00329493742873534,0.00989341789172632,0.0228095726123688,7.03906135386357e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0292540445320452,0.00589629594131067,0.0176973044870763,0.0408107845770141,7.10193434194881e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMS1,PMS1 protein homolog 1,39649,0.0264617929198512,0.00533442179063418,0.0160063262102082,0.0369172596294942,7.13314838796175e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPNMB,Transmembrane glycoprotein NMB,41802,0.0155512162674136,0.00313834691017221,0.0094000563234761,0.0217023762113512,7.31419146236234e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDI2,Protein DDI1 homolog 2,39736,0.0399513520042401,0.00807861273489976,0.0241172710438366,0.0557854329646437,7.71269247150182e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0283183257661563,0.00573686470257911,0.0170740709491013,0.0395625805832114,8.06069022190667e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.0102081783386431,0.00207280485211558,-0.0142708758487896,-0.00614548082849658,8.54302923299082e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR2,TGF-beta receptor type-2,42181,0.0181727002992559,0.0036923461746245,0.0109357017969919,0.0254096988015199,8.67927642594673e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0211076611317129,0.004289439855464,0.0127003590150035,0.0295149632484224,8.71869318117378e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MPO,Myeloperoxidase,42137,0.0237836476251377,0.00484957596649846,0.0142784787308008,0.0332888165194747,9.48625488128339e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.0295701331187899,0.00603282153824641,0.0177458029038269,0.0413944633337529,9.64473014743121e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.0124823634232146,0.00254722620139959,-0.0174749267779578,-0.00748980006847144,9.70133217188972e-07
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.0176745447409087,0.00361222091889108,0.0105945917398822,0.0247544977419352,1.00450199574333e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTF4,Neurotrophin-4,41843,0.0199823605809144,0.00408635218982431,0.0119731102888587,0.02799161087297,1.02007082880825e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ODAM,Odontogenic ameloblast-associated protein,41814,0.0283098191929338,0.00581152415977009,0.0169192318397845,0.0397004065460832,1.1213751768148e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PODXL,Podocalyxin,42070,0.00794273346573493,0.00163138830582517,0.0047452123863176,0.0111402545451523,1.1361167553117e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRUNE2,Protein prune homolog 2,39757,0.0151211535332818,0.00311406035367506,0.00901759524007865,0.0212247118264849,1.21548574167031e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0216723080484519,0.00447417541165175,-0.0304416918552893,-0.0129029242416145,1.28732976639844e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYGD,Gamma-crystallin D,39929,0.0510554594595482,0.0105740901870114,0.0303302426930058,0.0717806762260906,1.39465373721127e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM,Paralemmin-1,39859,0.0159402679832852,0.00330217861762628,0.00946799789273774,0.0224125380738327,1.40287718322909e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHCY,Adenosylhomocysteinase,42145,0.034977291412799,0.00724656189139434,0.0207740301056661,0.0491805527199319,1.40298365928315e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD99,CD99 antigen,42137,-0.0103696068127411,0.00214894604960962,-0.0145815410699759,-0.00615767255550621,1.41219180311886e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS3,Galectin-3,42196,0.0154097559025809,0.00319363438824969,0.00915023250161153,0.0216692793035503,1.41418705345563e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0166903829873091,0.00346334687599288,-0.0234785428642552,-0.0099022231103631,1.45736665862443e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK4,Kallikrein-4,42262,-0.0324790523958047,0.00674819095149436,-0.0457055066607337,-0.0192525981308758,1.50270956426885e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0261836262140909,0.00544375026331887,0.0155138756979859,0.0368533767301959,1.52988389038411e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA7,Thyroxine-binding globulin,39979,0.00952560245722268,0.00198048559021256,0.00564385070040606,0.0134073542140393,1.53071632554003e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDHR1,Cadherin-related family member 1,41839,0.0214649582310139,0.00446497086640546,0.0127136153328592,0.0302163011291686,1.54576783008582e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG3,Desmoglein-3,42196,0.018199851659505,0.00378767560115144,0.0107760074812482,0.0256236958377618,1.56390065919195e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.0179169946776171,0.00372990760054523,0.0106063757805484,0.0252276135746857,1.57508092889971e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STAM,Signal transducing adapter molecule 1,39919,0.0186858566745501,0.00390236873778343,0.0110372139484945,0.0263344994006056,1.70299844360226e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRSS53,Serine protease 53,39929,0.0196927385526641,0.00411946453824437,0.0116185880577051,0.0277668890476231,1.77136568088114e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCN2,Transcobalamin-2,42286,-0.0155772275775835,0.00326218015640432,-0.021971100684136,-0.00918335447103107,1.81481052208275e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.0221659486895093,0.00465573083508654,0.0130407162527397,0.0312911811262789,1.94615977586067e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL2,Fc receptor-like protein 2,42229,0.0256798763974268,0.00539753133720759,0.0151007149764999,0.0362590378183537,1.97812067410647e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUC2,Mucin-2,39966,0.0474629221509168,0.0100070887041321,0.0278490282908179,0.0670768160110157,2.13210845658672e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.0145027450186853,0.00305939005070189,-0.0204991495180609,-0.00850634051930956,2.15436788761355e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP12,Macrophage metalloelastase,42146,0.0279146566621233,0.00589381585978103,0.0163627775769524,0.0394665357472941,2.19903791632753e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.0138772190129744,0.00293521809657634,0.00812419154368475,0.019630246482264,2.2920851945798e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGR2,Anterior gradient protein 2 homolog,41740,0.0510757911255427,0.0108252823762542,0.0298582376680844,0.072293344583001,2.40398185768079e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAFB2,Scaffold attachment factor B2,39934,0.0138272049906555,0.00293775112314343,0.00806921278929442,0.0195851971920167,2.54701002315277e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.0169679832594842,0.00361297038553198,0.00988656130384157,0.0240494052151269,2.67886431338314e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTSB,Cathepsin B,42153,-0.0256293640722731,0.00547314301629796,-0.0363567243842171,-0.0149020037603291,2.85796833858694e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUCA2A,Guanylin,42083,-0.0177714426379912,0.00379624815932478,-0.0252120890302677,-0.0103307962457146,2.87813696562814e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0317982229131676,0.00679998323554008,0.0184702557715091,0.0451261900548262,2.95638072559939e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0284458377350392,0.0060991399531374,0.0164915234268899,0.0404001520431886,3.13239615800247e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH12,Protocadherin-12,39934,0.0127989349601347,0.00274906451814605,0.00741076850456842,0.0181871014157009,3.26481242170757e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0191409154379314,0.00411354202092299,0.0110783730769223,0.0272034577989404,3.30004678658963e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF16,Fibroblast growth factor 16,39657,0.0232341115850161,0.00501445690112501,0.0134057760588111,0.0330624471112212,3.63774013819449e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0380172879997707,0.00820911025628768,0.0219274318974469,0.0541071441020946,3.6789614152966e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOSB,Protein fosB,41839,0.0192078182578958,0.00415270857629352,0.0110685094483605,0.0273471270674311,3.77470168352679e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICOSLG,ICOS ligand,42070,0.00952790417996529,0.00206128448043231,0.00548778659831795,0.0135680217616126,3.8300661292035e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA12,Carbonic anhydrase 12,42070,-0.0162491407870576,0.00352861380381346,-0.023165223842532,-0.00933305773158324,4.16312048238359e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0174487532241287,0.00379465728656541,0.0100112249424604,0.0248862815057969,4.30688015436024e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PROCR,Endothelial protein C receptor,39575,-0.0171738265054714,0.00373483928927957,-0.0244941115124594,-0.00985354149848346,4.30761041140461e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0515832051737007,0.0112215539181686,0.0295889594940902,0.0735774508533111,4.33674751752398e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0260039395857119,0.00566820807103108,0.014894251766491,0.0371136274049329,4.52991177868017e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFHR4,Complement factor H-related protein 4,39945,0.0360086505669573,0.00788879109208569,0.0205466200264693,0.0514706811074452,5.05868097399167e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEO1,Neogenin,39934,0.0111134536623292,0.00243568377872074,0.00633951345603652,0.0158873938686218,5.10145582142627e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2,Apoptosis regulator Bcl-2,39930,0.0262716306200843,0.00575806117870355,0.0149858307098254,0.0375574305303433,5.10590780534086e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLASP1,CLIP-associating protein 1,39560,0.0369619018349669,0.00810779544639514,0.0210706227600324,0.0528531809099013,5.20012822684538e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD55,Complement decay-accelerating factor,41714,0.0129437831976092,0.00284216762808346,0.00737313464656563,0.0185144317486528,5.30605199036867e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.0169592349799867,0.00372395614519582,0.00966028093540291,0.0242581890245705,5.30773211899724e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.021945223307407,0.00481980726088844,0.0124984010760657,0.0313920455387483,5.34174274802054e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0255275344998301,0.00561066059292124,0.0145306397377045,0.0365244292619557,5.42486984401098e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN4,Contactin-4,42137,-0.0115086813404992,0.00253432527168122,-0.0164759588729944,-0.00654140380800405,5.6438452195162e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCC,Netrin receptor DCC,39649,0.0109020625150882,0.00241308662316703,0.00617241273368084,0.0156317122964956,6.31066217643428e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.0130669839132207,0.00289673857225357,0.00738937631160367,0.0187445915148377,6.50897137792551e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL21,C-C motif chemokine 21,42185,0.0185582921413652,0.00412706907688404,0.0104692367506724,0.0266473475320579,6.95798421626332e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THY1,Thy-1 membrane glycoprotein,42249,0.0141043347583378,0.0031512265534874,0.00792793071350245,0.0202807388031731,7.67335292262212e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ULBP2,UL16-binding protein 2,42016,0.0189705111294283,0.00424465962379399,0.0106509782667921,0.0272900439920646,7.91315547087192e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN1,Nectin-1,39657,0.0159025633133688,0.00355889513013999,0.00892712885829438,0.0228779977684432,7.95904159141029e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NELL2,Protein kinase C-binding protein NELL2,42185,0.0139285856072852,0.00312251173151515,0.00780846261351554,0.0200487086010549,8.23486573261605e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG4,Regenerating islet-derived protein 4,42144,0.0244900821220813,0.00549810824303867,0.0137137899657255,0.0352663742784371,8.48516767016175e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIPF,Gastric triacylglycerol lipase,39638,0.0301957130743106,0.00678284549550046,0.0169013359031297,0.0434900902454915,8.5998505669591e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL9,C-X-C motif chemokine 9,42185,0.0311401436997784,0.00700620905968148,0.0174079739428027,0.0448723134567541,8.87324660450962e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,39929,0.115665194552439,0.0260260845671015,0.0646540688009205,0.166676320303958,8.90563674934288e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOBR,Apolipoprotein B receptor,39638,-0.0205848700341322,0.00463394164499482,-0.029667395658322,-0.0115023444099423,8.99127056790039e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.0253579697855793,0.00571674288457604,-0.0365627858393483,-0.0141531537318103,9.24814602983628e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0915205252518656,0.0207012012213148,0.0509461708580887,0.132094879645643,9.90017731087056e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB44,Ras-related protein Rab-44,39919,0.021407486383312,0.00484246975780202,0.0119162456580201,0.030898727108604,9.92621400941863e-06
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0303328340397078,0.00688552063384568,0.0168372135973703,0.0438284544820454,1.06604151087052e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.027021465761769,0.00614019223875029,0.0149866889738184,0.0390562425497196,1.08719904746648e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.0140342597817348,0.00319581645688258,0.00777045952624494,0.0202980600372247,1.13654766400596e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP3,Dual specificity protein phosphatase 3,41839,0.04040287910364,0.00927241210214625,0.0222289513834333,0.0585768068238466,1.32655615134923e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0409850254974789,0.00941435705415587,0.0225328856713334,0.0594371653236244,1.3521979787703e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMB,Granzyme B,42119,0.0318452926962098,0.00732198346682734,0.0174942051012282,0.0461963802911914,1.37590991894908e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.0141446830107047,0.00326059445824798,0.00775391787253871,0.0205354481488708,1.44804667955078e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VEGFD,Vascular endothelial growth factor D,42275,-0.0180328901205562,0.00416152138615356,-0.0261894720374172,-0.00987630820369521,1.47976539628185e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE1,Ribonuclease pancreatic,39990,0.0115447246930473,0.00266550735779249,0.00632033027177406,0.0167691191143206,1.49599020818716e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.0330410161751021,0.00764832274208911,0.0180503036006074,0.0480317287495968,1.5735491163396e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00855179217008791,0.00198030332759599,0.00467039764799978,0.012433186692176,1.58477614413713e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPARCL1,SPARC-like protein 1,42169,-0.0127175909395596,0.0029472772728569,-0.0184942543943591,-0.00694092748476009,1.60710702235721e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP4,Guanylate-binding protein 4,41839,0.0228312830503551,0.00529475420191579,0.0124535648146002,0.0332090012861101,1.62913136569655e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRTN,Neurturin,41913,0.0230288504242718,0.00534704766677551,0.0125486369973918,0.0335090638511518,1.66793624435268e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,42145,0.00813369118665942,0.00189151387811128,0.00442632398556132,0.0118410583877575,1.71918999732514e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERC2,ERC protein 2,39649,0.0340924189358885,0.00795890652041298,0.0184929621558791,0.049691875715898,1.85485951204298e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSR,Insulin receptor,39657,0.0078350521259825,0.00184830294604451,0.00421237835173526,0.0114577259002297,2.26288926571712e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.0142937509861717,0.00337794593099897,-0.0209145250109297,-0.00767297696141373,2.34033089410375e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0325746712410497,0.00770267321700573,0.0174774317357184,0.0476719107463809,2.36615933413966e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.0193989024935528,0.00459848436157088,0.0103858731448738,0.0284119318422317,2.47513921586521e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YAP1,Transcriptional coactivator YAP1,39929,0.0125526031450988,0.00297701434492505,0.00671765502904573,0.0183875512611519,2.5004219685632e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.025577364669379,0.00608300573653972,0.0136546734257612,0.0375000559129969,2.63408632579594e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDH17,Protocadherin-17,42145,0.016926350152725,0.00403767595458127,0.00901250528174568,0.0248401950237042,2.78136778371696e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRISP3,Cysteine-rich secretory protein 3,39889,-0.0123273479146019,0.0029410859475407,-0.0180918763717817,-0.00656281945742217,2.79317084335937e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECM1,Extracellular matrix protein 1,39720,0.0164929318529943,0.0039376200494451,0.00877519655608186,0.0242106671499066,2.82904160462218e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.0200150450420391,0.00477962050652603,0.0106469888492481,0.0293831012348302,2.84129886556019e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN2,Ataxin-2,39586,0.0476051347511088,0.0114394069731333,0.0251838970837675,0.0700263724184502,3.18567605235842e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA1,Annexin A1,39699,0.0199497183832467,0.00479478149064609,0.0105519466615804,0.029347490104913,3.19643748236078e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPE,Carboxypeptidase E,42134,-0.0174922999447995,0.00421434903385269,-0.0257524240511508,-0.00923217583844827,3.33557223744996e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF5,Fibroblast growth factor 5,41913,-0.0152615639042171,0.00367892949838561,-0.0224722657210529,-0.00805086208738134,3.36928703322636e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGB1A1,Uteroglobin,42165,0.0239299631854573,0.00577818019629205,0.0126047300007249,0.0352551963701897,3.47227932951454e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARG1,Arginase-1,42015,0.0225496520759141,0.00544979101112787,0.0118680616941035,0.0332312424577248,3.52930445746691e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0157205784183526,0.00380117828015198,-0.0231708878474505,-0.00827026898925468,3.55977800435785e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0211708897112425,0.00512420204055733,-0.0312143257107349,-0.0111274537117501,3.62495147177408e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AOC3,Membrane primary amine oxidase,42217,-0.0131660758171393,0.00319671933480287,-0.019431645713353,-0.00690050592092572,3.83397221151223e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.0165003776561882,0.00400855751160423,-0.0243571503789324,-0.00864360493344388,3.87839639805533e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHB4,Ephrin type-B receptor 4,42310,-0.0112531965064883,0.00273472732539684,-0.0166132620642661,-0.00589313094871044,3.89570253118498e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRG3,Proteoglycan 3,39966,-0.0220642559077606,0.00536890571926406,-0.0325873111175181,-0.011541200698003,3.99062705511388e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPEP1,Dipeptidase 1,41997,-0.0203218844133213,0.00495362304958926,-0.0300309855905163,-0.0106127832361264,4.11253993410934e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD1,Bromodomain-containing protein 1,39757,-0.0134615936943778,0.00328191762374602,-0.01989415223692,-0.00702903515183558,4.12954790138982e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BOC,Brother of CDO,41900,-0.0102113131098377,0.00250635095032394,-0.0151237609724726,-0.00529886524720273,4.64456410144228e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIF,Leukemia inhibitory factor,41839,0.0219305407290667,0.00540584000317925,0.0113350943228353,0.032525987135298,5.00298811468818e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHB6,Ephrin type-B receptor 6,41997,0.0143318713166409,0.00353494304306875,0.00740338295222613,0.0212603596810556,5.05597080161004e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBPMS,RNA-binding protein with multiple splicing,39657,0.0281884896892003,0.00695569220231839,0.0145553329726563,0.0418216464057443,5.10028240565544e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK14,Kallikrein-14,42262,-0.0202164869527749,0.00499477368896459,-0.0300062433831455,-0.0104267305224043,5.20465405520617e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,QSOX1,Sulfhydryl oxidase 1,39767,0.0174047922076601,0.00430226753757379,0.00897234783401549,0.0258372365813048,5.25645963288876e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B2M,Beta-2-microglobulin,39979,0.013281692838009,0.00328468113845538,0.00684371780663646,0.0197196678693815,5.30004866407891e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDN1,Endothelin-1,39638,0.0128138441253119,0.00317103575682896,0.00659861404192713,0.0190290742086967,5.3607058464031e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMNB2,Lamin-B2,39929,0.012486120991186,0.00309432975478787,0.00642123467180173,0.0185510073105702,5.49231827889534e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0160061240218249,0.00396700650627551,0.00823079126952488,0.0237814567741249,5.50112514433749e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHISA5,Protein shisa-5,39966,0.0112965416627884,0.0028008499889718,0.00580687568440364,0.0167862076411731,5.53691559783191e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.0124975773768269,0.00310258012689928,0.00641652032810429,0.0185786344255495,5.65896982088129e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0168380130562033,0.00418368795996603,0.00863798465466985,0.0250380414577367,5.74333397834948e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD59,CD59 glycoprotein,41638,0.0102198763788217,0.00254580382860618,0.00523010087475361,0.0152096518828898,5.99305774944334e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.01596713008987,0.00397805989706457,0.00817013269162347,0.0237641274881166,6.00766734713306e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL9A2,Collagen alpha-2(IX) chain,39757,0.0193047556966598,0.00481224438511588,0.00987275670183266,0.0287367546914869,6.07044554870649e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP9,Fatty acid-binding protein 9,42119,0.0243794364094659,0.00608496636122476,0.0124529023414654,0.0363059704774665,6.1954421662391e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAX,Apoptosis regulator BAX,41814,0.0396386924306744,0.00990816918746515,0.0202186808232427,0.0590587040381061,6.35245012066821e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WIF1,Wnt inhibitory factor 1,42262,-0.0144984327581676,0.00362887810012392,-0.0216110338344105,-0.00738583168192472,6.49530425714441e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0447365737815569,0.011199118845414,0.0227863008445454,0.0666868467185684,6.52096241981639e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0353791538110538,0.00886588470732253,0.0180020197847016,0.0527562878374059,6.63649676604809e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A14,Protein S100-A14,39934,0.0222871006635865,0.00558514219950885,0.0113402219525492,0.0332339793746238,6.63696976087e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEPD,Xaa-Pro dipeptidase,39990,0.0113470714160098,0.00284418507769156,0.00577246866373431,0.0169216741682852,6.66078657834387e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C9orf40,Uncharacterized protein C9orf40,39930,0.033383644753737,0.00839029753281944,0.0169386615894109,0.0498286279180631,6.96838589578066e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSPB6,Heat shock protein beta-6,42262,0.0174205017379381,0.0043861705779414,0.00882360740517293,0.0260173960707032,7.17310530856792e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EGFLAM,Pikachurin,39930,0.0132360380710225,0.00333558843372608,0.00669828474091938,0.0197737914011256,7.28863342404311e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OLFM4,Olfactomedin-4,39347,0.0529663353272391,0.0133695036847194,0.0267621081051891,0.0791705625492891,7.48900169824881e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.0446891937458129,0.0113363433886675,0.0224699607040245,0.0669084267876013,8.11754956241832e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPESP1,Sperm equatorial segment protein 1,39958,0.0142444730834074,0.0036197815703084,0.0071497012056029,0.0213392449612118,8.36315120458077e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPA4,Carboxypeptidase A4,39518,0.0186492442156397,0.00474545623228252,0.00934815000036599,0.0279503384309135,8.54996336570548e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.0183825938263132,0.0046788105106481,0.0092121252254429,0.0275530624271835,8.58391712953513e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINI1,Neuroserpin,39713,0.0122678349902725,0.00312372372547448,0.00614533648834251,0.0183903334922025,8.64199898069355e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0165606096041289,0.00422483573829867,0.00827993155706346,0.0248412876511943,8.91352283851908e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM3,Intercellular adhesion molecule 3,42310,-0.0114374954140603,0.00291956470137013,-0.0171598422287458,-0.00571514859937485,8.98932157214267e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRH,Corticoliberin,41830,0.0361881460384315,0.00925603709292754,0.0180463133362935,0.0543299787405694,9.28794464670373e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0103344155104857,0.00264388073159972,0.00515240927655028,0.0155164217444212,9.32913533712402e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.0151059838247833,0.00386960885857481,-0.02269041718759,-0.0075215504619767,9.52765776499729e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCP1,Plastin-2,39966,0.0201762986287518,0.00516867908793586,0.0100456876163975,0.0303069096411061,9.53316372125018e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0322438285229195,0.00826200624309997,0.0160502962864436,0.0484373607593955,9.5705292484629e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CENPJ,Centromere protein J,39757,0.0295497562752818,0.00757995975601027,0.0146930351535017,0.044406477397062,9.73950207695633e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMNB1,Lamin-B1,39908,0.0256920906917605,0.00659372839739477,0.0127683830328668,0.0386157983506543,9.81782430532438e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.00931426624637111,0.00239276165639808,0.00462445339983087,0.0140040790929114,9.96169337655701e-05
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSTL3,Follistatin-related protein 3,42084,0.0136632998184537,0.00352976433613298,0.00674496171963308,0.0205816379172743,0.000108953648150897
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD1,Programmed cell death protein 1,42232,0.0174943112441464,0.00452153046196034,0.00863211153870414,0.0263565109495887,0.000109740550705938
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL15,Interleukin-15,42119,0.0137453684557755,0.00355576196003136,0.00677607501411402,0.020714661897437,0.000111307223496676
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGA,Fibrinogen alpha chain,39735,0.0129836444364815,0.00335915926856164,0.00639969227010069,0.0195675966028623,0.00011165273551265
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.0108764685138857,0.00281461976950083,-0.0163931232621074,-0.0053598137656641,0.00011206129826261
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0156153096560268,0.00404871615575525,0.0076798259907465,0.0235507933213071,0.000115509346784873
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REN,Renin,42145,-0.0337087484865986,0.00874831270493682,-0.0508554413882748,-0.0165620555849224,0.000117135455762945
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWF,von Willebrand factor,42310,-0.0307290653624271,0.00798409722850209,-0.0463778959302912,-0.015080234794563,0.000119244194376147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD3,Extracellular superoxide dismutase,39990,-0.0251798819432373,0.00655013461406562,-0.0380181457868059,-0.0123416180996687,0.000121615075551193
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18BP,Interleukin-18-binding protein,42217,0.0130033090055583,0.00338293483114974,0.00637275673650484,0.0196338612746118,0.000121696751095939
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNPEP,Aspartyl aminopeptidase,39929,0.0235763923476265,0.00614222532893552,0.0115376307029129,0.0356151539923401,0.00012450571967409
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK8,Kallikrein-8,41668,0.0151574846459646,0.00395504434171246,0.00740559773620823,0.0229093715557211,0.000127470984625585
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,METAP1,Methionine aminopeptidase 1,41839,0.0119829321034105,0.00313549255082682,0.00583736670378996,0.0181284975030311,0.000133137724729116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCGN,Secretagogin,41913,-0.0182968113286029,0.00479396199529635,-0.0276929768393837,-0.00890064581782203,0.00013589553014777
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.0235694428924937,0.00618083384473635,0.0114550085568104,0.0356838772281769,0.00013785571617244
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD300E,CMRF35-like molecule 2,42232,0.017163919949457,0.00450590443879185,0.00833234724942497,0.025995492649489,0.00014002534348015
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA11,Serpin A11,42310,-0.0171546015385689,0.00450396302213902,-0.0259823690619614,-0.00832683401517641,0.000140263583303178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.012895856401119,0.00338759761339067,0.00625616507887332,0.0195355477233648,0.000141526444172453
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTPN,Myotrophin,41900,0.0133324681346096,0.00350306680244719,0.00646645720181312,0.0201984790674061,0.000141899003466776
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.0146526891976567,0.00385865693987973,0.00708972159549239,0.0222156567998209,0.000146887171223883
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0367882349079122,0.00968900182269809,0.017797791335424,0.0557786784804005,0.00014715120646601
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRIM26,Tripartite motif-containing protein 26,39560,0.0234072904446887,0.00619728716347678,0.0112606076042742,0.0355539732851032,0.000159553974207391
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGFR4,Fibroblast growth factor receptor 4,39736,0.0213590980550698,0.00565881645880886,0.0102678177958044,0.0324503783143352,0.000161173171752978
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA5,Protein disulfide-isomerase A5,39560,0.0250448419680029,0.00665260450211755,0.0120057371438525,0.0380839467921533,0.000167642132152363
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE6,Ribonuclease K6,39937,0.0131029041877012,0.0034813265205361,0.00627950420745042,0.019926304167952,0.000168216741242915
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.018727627484159,0.00497995803918102,0.00896690972736422,0.0284883452409538,0.000170387231744298
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0229832033581344,0.00613167726551351,0.0109651159177279,0.0350012907985408,0.000178970899449741
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0210935805961214,0.0056304638521054,0.0100578714459948,0.0321292897462479,0.000180201193749408
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANPEP,Aminopeptidase N,42187,0.0110140170922981,0.00294010452094009,0.00525141223125555,0.0167766219533407,0.000180325194026609
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDRG1,Protein NDRG1,41839,0.0266219863186401,0.00712948200997059,0.0126482015790978,0.0405957710581825,0.000189199747802798
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC12A2,Solute carrier family 12 member 2,39575,-0.0106203891415076,0.00284909635584266,-0.0162046179989592,-0.00503616028405597,0.000194256954727269
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP112,Centrosomal protein of 112 kDa,39575,0.0178383016087957,0.00478926493245002,0.0084513423411937,0.0272252608763978,0.000196571865238543
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GZMH,Granzyme H,41900,0.0314863452358191,0.00848447845621527,0.0148567674616372,0.048115923010001,0.00020724070225059
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.0118980299609742,0.00321430855398929,0.00559798519515519,0.0181980747267932,0.000215127383424891
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUCA1,Tissue alpha-L-fucosidase,42212,0.0333498703192181,0.00902153562795869,0.0156676604884191,0.0510320801500172,0.000219281486678384
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.0169695887139375,0.00460462355911798,-0.0259946508898087,-0.00794452653806624,0.000229499967711532
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN2,Prefoldin subunit 2,41839,0.021951629088489,0.0059588215781874,0.0102723387952417,0.0336309193817363,0.000230618673362573
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.00951537763468431,0.00258604148346592,0.0044467363270911,0.0145840189422775,0.000234579688912684
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.0162433714630611,0.00441687302393119,0.00758630033615597,0.0249004425899662,0.000236380069771727
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.0107590159729404,0.00292621576004519,0.00502363308325183,0.016494398862629,0.000237299336495166
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SNX18,Sorting nexin-18,39930,0.0173354453078553,0.00472041359684421,0.0080834346580407,0.02658745595767,0.000241349296578286
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,0.0245892602323109,0.0066960075511274,0.0114650854321012,0.0377134350325206,0.000241553285845397
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAM,Basal cell adhesion molecule,42137,-0.00970646199695291,0.00264778995244651,-0.0148961303037481,-0.00451679369015776,0.000247438998278556
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.0160552073830655,0.00440169486927239,0.00742788543929161,0.0246825293268394,0.000265979967355209
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0191964282287856,0.00526533619771859,-0.029516487176314,-0.00887636928125716,0.000267544098491055
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.0115744779748826,0.00318731304871376,0.0053273443994036,0.0178216115503615,0.000283138469175108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN3,Neuronal-specific septin-3,39934,-0.0305855360015567,0.00844662911158012,-0.0471409290602537,-0.0140301429428596,0.00029470763921094
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FMR1,Synaptic functional regulator FMR1,41843,0.0141056645682181,0.00390041166008156,0.00646085771445824,0.021750471421978,0.000299774646554164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THBS2,Thrombospondin-2,42137,0.0150502924800837,0.00416641350262946,0.00688412201492991,0.0232164629452374,0.000304603783627199
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD3,Bromodomain-containing protein 3,39575,0.0184621758539713,0.00512346839894071,0.0084201777920475,0.0285041739158951,0.000315407431318623
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RCC1,Regulator of chromosome condensation,39919,0.0202663730438233,0.00562689730889791,0.00923765431838336,0.0312950917692632,0.000317501888205876
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,0.0165539620981027,0.00459955871982778,0.00753882700724023,0.0255690971889651,0.000320543320425095
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.0130830604077084,0.00364610992695811,0.00593668495087046,0.0202294358645463,0.000334117805188438
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM5,Intercellular adhesion molecule 5,42145,0.0177722619986343,0.00496232069412816,0.00804611343814311,0.0274984105591255,0.000342900436619659
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM25,Transmembrane protein 25,39934,-0.0180540556037069,0.00505465603528384,-0.0279611814328632,-0.00814692977455056,0.000356050021893318
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.0139488796078931,0.00391579944203394,0.00627391270150657,0.0216238465142796,0.000369300287947877
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.013251891497994,0.00373149148823931,0.00593816818104492,0.020565614814943,0.00038454528426153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROBO4,Roundabout homolog 4,39638,-0.00698481738157291,0.00196904371839784,-0.0108441430696327,-0.00312549169351315,0.000390794102473245
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.0286531357986162,0.00807884371784647,0.0128186021116371,0.0444876694855952,0.000391678291753085
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF5,Eukaryotic translation initiation factor 5,39575,0.0162514492278074,0.00459091131879581,0.0072532630429676,0.0252496354126472,0.000401908415617358
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0231741978049912,0.00657142052308452,0.0102942135797455,0.0360541820302369,0.000422488800185625
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.0103993625804231,0.00296363216213546,0.00459064354263765,0.0162080816182086,0.000451249978571473
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.0196469454737388,0.00560136900150734,0.00866826223078443,0.0306256287166932,0.000454106329868469
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPA2,Replication protein A 32 kDa subunit,39657,0.0117077428065912,0.00334002286121276,0.00516129799861414,0.0182541876145682,0.000457919733287784
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.013951391613079,0.00398477439990514,0.0061412337892649,0.0217615494368931,0.000464988849366344
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.027291854650491,0.00780181647572317,-0.0425834149429084,-0.0120002943580736,0.000470310361291125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0174243360180626,0.00498141748146795,0.00766075775438544,0.0271879142817398,0.000470795071497562
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOH,Beta-2-glycoprotein 1,42137,-0.0137919558876562,0.00394724879924713,-0.0215285635341805,-0.00605534824113178,0.000477240086984572
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.0189535588706867,0.00543144261110256,0.00830793135292566,0.0295991863884477,0.000485318399710383
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST7,Cystatin-F,42148,0.0354901521655496,0.0101840631257496,0.0155293884390804,0.0554509158920187,0.00049393017382125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17RA,Interleukin-17 receptor A,42137,0.0166774683399593,0.0047860555803836,0.00729679940240744,0.0260581372775112,0.000494440605778069
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLMP,CXADR-like membrane protein,42262,0.00831204368272629,0.00238696295567449,0.00363359628960428,0.0129904910758483,0.000498741268190037
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPON1,Spondin-1,42144,0.0122421569209929,0.00351788943230101,0.00534709363368297,0.0191372202083029,0.00050304388504961
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALB1,Calbindin,42070,0.0169391508170065,0.00487978061300303,0.00737478081552052,0.0265035208184924,0.00051958095902478
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.011220284513751,0.003238222301609,-0.0175672002249046,-0.00487336880259734,0.000531948326552289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRPB1,Signal-regulatory protein beta-1,42100,0.0178312688881568,0.00515291676748139,0.00773155202389327,0.0279309857524203,0.000540995615769276
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0144484483537396,0.00419204760303089,0.00623203505179908,0.0226648616556802,0.000569382432478527
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDK1,Cyclin-dependent kinase 1,39560,0.0135521002273129,0.00393839406189328,0.00583284786600205,0.0212713525886237,0.00058168278994622
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.0116713926753773,0.00339534319276646,0.00501652001755509,0.0183262653331996,0.00058897143978307
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HCG22,Protein PBMUCL2,39575,-0.0215381532043311,0.00626568643424685,-0.0338188986154549,-0.00925740779320723,0.000589338793357606
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",39586,0.0309391131955688,0.0090564405411066,0.0131884897349998,0.0486897366561377,0.000637186222640144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0236678168789494,0.00694093176275744,0.0100635906239448,0.0372720431339539,0.000652148952474566
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGN,Mimecan,42137,0.0158718911965336,0.00466490420798633,0.00672867894888034,0.0250151034441868,0.000669890245820454
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.0245115235326903,0.00721942678158589,0.010361447040782,0.0386616000245987,0.000687754876792288
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.0203749203110729,0.00600580338492173,0.00860354567662631,0.0321462949455195,0.000694851203044865
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP3,"Fatty acid-binding protein, heart",39958,0.0199120237885467,0.00586937453197859,0.00840804970586862,0.0314159978712247,0.000694869477041837
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0148297802606099,0.00437306946144507,-0.0234009964050422,-0.00625856411617752,0.00069842820853995
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0158071582114744,0.00466535540486439,-0.0249512548050086,-0.00666306161794015,0.000705537325783732
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.0132700812114391,0.00392597875147843,0.00557516285854137,0.0209649995643368,0.000727125569264519
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.0130665386624895,0.00386611643750702,-0.0206441268800033,-0.00548895044497576,0.00072753267079746
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.0203852854161012,0.00603959784570999,0.00854767363850958,0.0322228971936927,0.000739903765877089
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,41960,0.0110653495118173,0.00327915053425284,0.00463821446468169,0.0174924845589528,0.000741720782616508
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP1,Caspase-1,41839,0.0250228836644505,0.00744087430390443,0.0104387700287978,0.0396069973001032,0.000773480969345552
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0257005589308802,0.00767567597652004,-0.0407448838448595,-0.0106562340169009,0.000815703722205972
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD27,CD27 antigen,42181,-0.0154095069591758,0.00460538139498032,-0.0244360544933372,-0.00638295942501432,0.000822150662706699
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,L1CAM,Neural cell adhesion molecule L1,42181,0.0107044380597687,0.00320118537267145,0.00443011472933269,0.0169787613902048,0.000828334991293093
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PI3,Elafin,41966,0.0202347069706132,0.00606350669186255,0.00835023385456257,0.0321191800866637,0.000848794183152944
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNPY2,Protein canopy homolog 2,41900,0.0218229077335217,0.00656573547733385,0.00895406619794733,0.034691749269096,0.000890535038940885
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMOD1,Leiomodin-1,39934,-0.0124259419134608,0.00374216246824646,-0.0197605803512239,-0.00509130347569775,0.000901322814289667
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SULT1A1,Sulfotransferase 1A1,42249,-0.0458818069646188,0.0138609270788094,-0.0730492240390853,-0.0187143898901524,0.000934862675614044
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RSPO1,R-spondin-1,42016,0.0121429230821668,0.00367636603152975,0.00493724566036846,0.0193486005039651,0.000959172285297512
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.0104639326897707,0.00317584155991223,0.00423928323234276,0.0166885821471987,0.000987262538007017
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRAL,GDNF family receptor alpha-like,39574,-0.022466377494784,0.00682077695838902,-0.0358351003332264,-0.00909765465634147,0.000991504472195024
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.0208319292715721,0.00634724343859145,0.00839133213193285,0.0332725264112113,0.00103318961190897
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATXN10,Ataxin-10,41839,0.0259937655899013,0.00792191551257669,0.010466811185251,0.0415207199945516,0.0010361637821117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDS,Iduronate 2-sulfatase,42296,0.00325408414872991,0.000992059366297909,0.001309647790786,0.00519852050667381,0.00104018235023181
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP152,Centrosomal protein of 152 kDa,39560,0.0148524085686339,0.0045394201195259,0.00595514513436317,0.0237496720029047,0.00107167756989055
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,39757,0.0184977107503244,0.00566567046273773,0.00739299664335842,0.0296024248572903,0.00109842125070951
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL2L15,Bcl-2-like protein 15,39657,0.0199105337764745,0.00610849106898023,0.00793789128127326,0.0318831762716758,0.00111952141750926
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUK1,Guanylate kinase,39575,-0.0141235009297723,0.00434228572838113,-0.0226343809573993,-0.00561262090214527,0.0011472009347815
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPH3,Neurexophilin-3,39657,0.0105048166817075,0.00323734247286367,0.00415962543489475,0.0168500079285203,0.00117845765533496
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALCAM,CD166 antigen,42310,0.00688263576846566,0.00212261553269831,0.00272230932437696,0.0110429622125544,0.00118758446906861
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.0133852196091647,0.00413537785580564,0.00527987901178561,0.0214905602065437,0.00121183348253469
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A16,Protein S100-A16,41814,-0.0211767237867322,0.00657501056538395,-0.0340637444948847,-0.00828970307857966,0.00128147426350395
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.0130179889408578,0.0040428471829531,-0.0209419694194459,-0.00509400846226969,0.00128561083382454
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AHNAK2,Protein AHNAK2,39638,0.0107994300752244,0.00336250347188442,0.00420892327033096,0.0173899368801179,0.0013231978279557
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.0109814364002481,0.00342488512161599,0.00426866156188076,0.0176942112386154,0.00134807597980153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.029888839211751,0.00932234518136776,0.0116170426562702,0.0481606357672318,0.00134906317335724
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALPP,"Alkaline phosphatase, placental type",42070,0.0359897549125065,0.0112389932311105,0.0139613281795299,0.058018181645483,0.00136688588195564
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17C,Interleukin-17C,41913,-0.0244734449795312,0.00765150433387978,-0.0394703934739356,-0.00947649648512684,0.00138461133753948
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_DRA,,42060,-0.0125397360251166,0.00392742542699659,-0.0202374898620299,-0.00484198218820331,0.00141193237320374
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.00997721074377601,0.00312519309821806,0.00385183227126861,0.0161025892162834,0.00141427694829548
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD7,T-cell antigen CD7,39636,0.0154184757734262,0.00483004867390332,0.0059515803725757,0.0248853711742767,0.00141589997200375
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.0189972543519173,0.00598201190675612,0.00727251101467529,0.0307219976891593,0.00149866715645061
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00663421011843461,0.00209046068868649,-0.0107315130682601,-0.00253690716860909,0.00150980603239966
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MILR1,Allergin-1,41913,-0.0174892691055009,0.00552087522472282,-0.0283101845459576,-0.00666835366504414,0.00153921108974304
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLH1,Glutamate carboxypeptidase 2,39657,0.0357492319413973,0.0112895484244093,0.013621717029555,0.0578767468532396,0.00154663187176104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.0118433909301246,0.00374745518030779,0.00449837877672139,0.0191884030835279,0.00157904952491436
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL12,Stromal cell-derived factor 1,41913,0.0134463063990613,0.00426233719334521,0.00509212550010469,0.0218004872980179,0.00161032183275251
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITM2A,Integral membrane protein 2A,42119,-0.0211253629384609,0.00670121213437395,-0.0342597387218339,-0.00799098715508798,0.00162249871426125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TERF1,Telomeric repeat-binding factor 1,39657,-0.00987410883408005,0.0031370434137787,-0.0160227139250863,-0.00372550374307379,0.00165063031274234
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100G,Protein S100-G,39934,-0.0166055196185626,0.00527674731647216,-0.026947944358848,-0.00626309487827715,0.00165425561521907
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.0164656670627733,0.00524270344377135,0.00618996831298143,0.0267413658125651,0.00168923951873231
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYTL1,Cytokine-like protein 1,39966,0.00863310684411546,0.00275520233447975,0.00323291026853514,0.0140333034196958,0.00173242535644646
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.0112433330176821,0.00358968913108026,-0.0182791237145994,-0.00420754232076475,0.00174005408415021
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL36G,Interleukin-36 gamma,39624,0.0226363404938682,0.00724702018313307,0.00843218093492738,0.036840500052809,0.00179153991686012
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.0246098622204611,0.00788550328491862,0.00915427578202059,0.0400654486589016,0.00180679323782668
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.0170164318389724,0.00545406512733908,0.0063264641893878,0.027706399488557,0.00181344975695487
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP1,DNA topoisomerase 1,39930,0.0405131830600895,0.0130198293937036,0.0149943174484304,0.0660320486717487,0.00186505929577009
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,39951,-0.00497535245688443,0.00160551642976767,-0.00812216465922906,-0.0018285402545398,0.00194708140863942
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP7,Retinoid-binding protein 7,39930,0.0208187298455298,0.00674076721919336,0.00760682609591078,0.0340306335951488,0.00201669316971942
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPS10,40S ribosomal protein S10,39575,-0.013909022018201,0.0045047994226239,-0.0227384288865438,-0.00507961514985815,0.00202282677820499
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MST1,Hepatocyte growth factor-like protein,39854,0.0224504131290639,0.00727523162249541,0.00819095914897293,0.0367098671091549,0.00203450762362885
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLA2G1B,Phospholipase A2,42299,-0.0147388850050261,0.00480553867940614,-0.0241577408166621,-0.00532002919339007,0.0021659551689693
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00687878394814088,0.00224625881589222,-0.0112814512272896,-0.00247611666899213,0.00220153328784205
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00993389708506196,0.00325323472262291,0.00355755702872105,0.0163102371414029,0.00226693161423974
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.00935616637310232,0.0030696411563366,0.00333966970668259,0.0153726630395221,0.00230924110612272
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QL2,Complement C1q-like protein 2,39657,0.0141455149206461,0.00464606368868222,0.00503923009082897,0.0232517997504633,0.00233519636239833
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAN,Neurocan core protein,42249,0.0123015843701712,0.00404115667101394,0.00438091729498388,0.0202222514453585,0.0023384120327484
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,0.0189126722238944,0.00622364181345914,0.00671433426951448,0.0311110101782743,0.00237941080990351
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6L2,Seizure 6-like protein 2,42070,-0.0079150889085016,0.0026092491235201,-0.013029217190601,-0.0028009606264022,0.00242216132035063
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKAP4,Cytoskeleton-associated protein 4,42247,0.00926481114161664,0.00305968407366991,0.00326783035722362,0.0152617919260097,0.00246614430466586
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMOD4,Tropomodulin-4,39560,-0.013061773859151,0.00432317087887361,-0.0215351887817433,-0.00458835893655873,0.00252238257568896
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,42119,0.0119423586738322,0.00396118229425125,0.00417844137709977,0.0197062759705647,0.00257585939405268
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,0.0100720870693757,0.00334496259988104,0.0035159603736089,0.0166282137651426,0.00260765246308897
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGA,Glycoprotein hormones alpha chain,42137,-0.0200852263038805,0.00667372611165026,-0.033165729482715,-0.00700472312504601,0.00262076150459845
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTSL5,ADAMTS-like protein 5,39958,-0.0130294206086343,0.00433117092120093,-0.0215185156141881,-0.0045403256030805,0.00263297479917929
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP8,Neutrophil collagenase,42224,0.0232036897723246,0.00772001162857865,0.00807246698031041,0.0383349125643387,0.0026549219221823
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.0328138405213118,0.010918648030079,-0.0542143906602666,-0.0114132903823569,0.00265916281944637
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLPS,Colipase,42115,0.0239047225926011,0.0079562983996465,0.00831037772929394,0.0394990674559082,0.0026650267181838
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRLB,Fc receptor-like B,41843,0.0199225922494136,0.00665585496354461,0.00687711652086614,0.032968067977961,0.00276539020848049
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA2,GDNF family receptor alpha-2,42070,0.00672629769709672,0.00225157361005746,0.00231321342138409,0.0111393819728093,0.00281889876444132
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP164,Centrosomal protein of 164 kDa,41913,0.0200642664181314,0.00671835860941231,0.00689628354368328,0.0332322492925795,0.00282719842381069
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,41839,0.0123408791630733,0.00413396431870857,0.00423830909840454,0.0204434492277421,0.00283872985347758
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SRPX,Sushi repeat-containing protein SRPX,39958,-0.0124112565410174,0.00416072589282501,-0.0205662792909544,-0.00425623379108034,0.0028608682305222
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NLGN2,Neuroligin-2,39586,-0.0150426357419464,0.00504715107357132,-0.0249350518461462,-0.0051502196377466,0.00288482655211308
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ASPN,Asporin,39958,0.00893941836834148,0.00300424430487663,0.00305109953078328,0.0148277372058997,0.00293035159572737
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCP2,Non-specific lipid-transfer protein,41843,0.0238451164304429,0.00801416097239129,0.00813736092455601,0.0395528719363299,0.00293160939877922
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRK1,NKG2-D type II integral membrane protein,39929,0.0151064277504582,0.005084934040082,0.00513995703189753,0.025072898469019,0.00297628313373368
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.014374415270835,0.00484209285509756,-0.0238649172668262,-0.00488391327484378,0.00299643453849667
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,39090,0.0181170536810682,0.00610688568284233,0.00614755774269724,0.0300865496194392,0.00301732490919021
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA4,Ephrin type-A receptor 4,39736,0.00934079058850532,0.00315294876902309,0.00316101100122007,0.0155205701757906,0.00305740041513853
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.0197987954365052,0.00669095876991393,-0.0329130746255365,-0.00668451624747388,0.00309260149632981
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17A,Interleukin-17A,41877,-0.0136554686352342,0.00463195808447564,-0.0227341064808065,-0.00457683078966196,0.00320291867307588
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF3,Trefoil factor 3,42143,-0.0114571619560054,0.00388989629698893,-0.0190813586981037,-0.0038329652139071,0.0032312327561676
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX5,Syntaxin-5,39657,0.0126368025734364,0.00429158962664292,0.00422528690521626,0.0210483182416565,0.00324097385977808
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.0147791329113895,0.00502413955623518,-0.0246264464416104,-0.00493181938116854,0.00327177651316632
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.0156172942022408,0.00531520758060931,0.0051994873442466,0.0260351010602351,0.00330758802940682
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.0115018988213806,0.00391912916387923,0.0038204056601773,0.0191833919825839,0.00334438601389912
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINA6,Corticosteroid-binding globulin,39979,0.00488165763804772,0.00166412173692687,0.00161997903367104,0.00814333624242439,0.00335860638845346
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN1,Calsyntenin-1,41839,0.0160369863217997,0.00547375570309103,0.00530842514374127,0.0267655474998581,0.00339763818455431
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLL4,Delta-like protein 4,39638,0.0278567903546052,0.00951984247753109,0.00919789909864427,0.0465156816105661,0.00343849732945932
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,39929,0.0217938983569448,0.00745664710480108,0.00717887003153465,0.0364089266823549,0.00347643605580958
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0243054241891325,0.00832103270783221,-0.0406146482964836,-0.00799620008178139,0.00349638625299034
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.0112323355197826,0.00384592389466571,0.0036943246862378,0.0187703463533274,0.00349965284993824
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.0175609176728805,0.006031299717502,0.00573957022657663,0.0293822651191845,0.00360270523106166
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MB,Myoglobin,42310,-0.0176087501479478,0.0060501520586403,-0.0294670481828828,-0.00575045211301277,0.00361473174257537
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PREB,Prolactin regulatory element-binding protein,41913,0.00890499303728379,0.00306097602085173,0.0029054800364144,0.0149045060381532,0.00362953873409391
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCUN1D2,DCN1-like protein 2,39560,-0.0250606250107967,0.00861618785883083,-0.0419483532141051,-0.00817289680748825,0.0036383671958054
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.0253591115804534,0.00874327850838364,0.0082222857040215,0.0424959374568854,0.0037340709875239
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NTF3,Neurotrophin-3,42119,0.0107639348803672,0.00371702630647817,0.00347856331966994,0.0180493064410644,0.00378744078435961
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RYR1,Ryanodine receptor 1,39575,-0.0105475659222205,0.00364268622371924,-0.0176872309207102,-0.00340790092373076,0.00379246239437981
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC6A,C-type lectin domain family 6 member A,41843,0.0147106943187718,0.00511711733037247,0.0046811443512418,0.0247402442863019,0.00404926141060982
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF3,Granulocyte colony-stimulating factor,41913,0.014841811659424,0.005181148031546,0.00468676151759388,0.0249968618012542,0.00418216182436269
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRR4,Proline-rich protein 4,39652,-0.0218994730507832,0.00766747971445759,-0.0369277332911201,-0.00687121281044632,0.00429611812642356
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC1A,C-type lectin domain family 1 member A,41900,-0.0104919834058769,0.00367499743877595,-0.0176949783858777,-0.00328898842587601,0.00431083580702365
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP290,Centrosomal protein of 290 kDa,39757,0.016293956618871,0.0057228193124926,0.00507723076638549,0.0275106824713565,0.00441874999242206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNL1,Thioredoxin-like protein 1,39570,0.0312392529923916,0.0109818313766206,0.00971486349421529,0.0527636424905679,0.00445452642803637
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK15,Kallikrein-15,39900,0.0160391725917398,0.0056771107178204,0.00491203558481184,0.0271663095986678,0.00473287562061822
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.0119104254394683,0.00421670120441761,0.00364569107880982,0.0201751598001269,0.00474128352171516
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD200,OX-2 membrane glycoprotein,42119,-0.00822196432106279,0.00293648265290429,-0.0139774703207552,-0.00246645832137038,0.00511851897827279
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNMA2,Paraneoplastic antigen Ma2,39586,0.0134233237993969,0.00480355229978443,0.00400836129181936,0.0228382863069743,0.00520769421483783
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.0186950461489585,0.00669296439787547,-0.0318132563687944,-0.00557683592912257,0.00522723269482529
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF1,Macrophage colony-stimulating factor 1,42185,0.00812243441433412,0.00291239842613536,0.00241413349910881,0.0138307353295594,0.00529583777421504
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0210633716677563,0.00755863701179356,0.00624844312464093,0.0358783002108717,0.0053327094213118
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JCHAIN,Immunoglobulin J chain,41913,-0.0183303443578839,0.00661603486636426,-0.0312977726959579,-0.00536291601980997,0.00560317888179506
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.0113968968085559,0.00411839055244983,0.00332485132575422,0.0194689422913576,0.00565993724238583
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HRAS,GTPase Hras,39750,0.0293442831639659,0.0106939529428635,0.00838413539595339,0.0503044309319784,0.00607912814937227
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.0159039554167569,0.00580582252341701,-0.0272833675626543,-0.00452454327085957,0.00616677845227698
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.0157347615267712,0.00577645461024185,0.00441291049069717,0.0270566125628452,0.00645910381881161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EXTL1,Exostosin-like 1,39575,0.013988309033071,0.00513560785816716,0.00392251763106341,0.0240541004350787,0.00646399486567965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SERPINB5,Serpin B5,41900,0.0142960519017174,0.0052507327857854,0.00400461564157802,0.0245874881618568,0.00648396515439211
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.0190139669846016,0.00699411150796144,0.00530550842899718,0.032722425540206,0.00656675264665979
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0339258927033473,0.0125026017540542,0.00942079326540102,0.0584309921412935,0.00666608910411493
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTX1,Neuronal pentraxin-1,42137,0.0121902661256635,0.00450513357036521,0.00336020432774765,0.0210203279235793,0.00682128468526954
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYO6,Unconventional myosin-VI,39934,0.0109097438806127,0.00403699078159008,0.00299724194869614,0.0188222458125293,0.00689341686619351
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0117848371403711,0.00439568242776236,-0.0204003746987853,-0.00316929958195683,0.0073491472116659
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH6,Cadherin-6,42145,-0.0112346900837872,0.00419681450145924,-0.0194604465066473,-0.00300893366092705,0.00743837581224899
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG1B,Lithostathine-1-beta,42310,-0.0164678504990312,0.00615324604784726,-0.0285282127528118,-0.00440748824525057,0.00745314464731675
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00788177050104078,0.00295121287765342,-0.0136661477412415,-0.00209739326084007,0.00758056156590558
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB39B,Ras-related protein Rab-39B,39575,0.026599134840272,0.00996243586504469,0.00707276054478446,0.0461255091357596,0.0075975880649249
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARTN,Artemin,41913,0.013014439541836,0.00487978451616952,0.00345006189014377,0.0225788171935283,0.00766216886037633
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPLX2,Complexin-2,39560,-0.00879926514146548,0.0033098165937146,-0.0152865056651461,-0.00231202461778487,0.00785950513214748
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.015429568974547,0.00581376551627732,0.00403458856264342,0.0268245493864505,0.00796450355673635
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSAP,Gamma-secretase-activating protein,41843,0.024135249427915,0.00909698737582514,0.00630515417129772,0.0419653446845323,0.00798505646606967
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKCQ,Protein kinase C theta type,41913,0.0121891133803177,0.00461713148969,0.00313953566052527,0.0212386911001101,0.00830087353652851
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA6C,Semaphorin-6C,39657,0.00734051297035951,0.00278453391584845,0.00188282649529656,0.0127981994454225,0.00839641066119029
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTR,Methionine synthase,39575,0.0185308493944755,0.00704897220040908,0.00471486388167367,0.0323468349072773,0.00857878386360073
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR101,Probable G-protein coupled receptor 101,39586,-0.0163764872741938,0.00627377664124555,-0.0286730894910351,-0.00407988505735257,0.00905836058188425
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,42223,0.011550194028333,0.00442827939694876,0.00287076641031347,0.0202296216463526,0.00910977214228772
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0188865589492496,0.00726974818664091,0.00463785250343345,0.0331352653950658,0.00938990766045078
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP4,Bone morphogenetic protein 4,41992,-0.0132279430987568,0.00510801462791108,-0.0232396517694625,-0.00321623442805105,0.00961790154378347
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ID4,DNA-binding protein inhibitor ID-4,39757,-0.0117029920356852,0.00452997446102771,-0.0205817419792996,-0.00282424209207092,0.00979418025972764
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DSG4,Desmoglein-4,42018,0.0132868225350808,0.00516717844264013,0.00315915278750613,0.0234144922826554,0.0101398366493697
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.00915142675492861,0.00356956311162614,0.00215508305614138,0.0161477704537158,0.0103660389085495
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CST6,Cystatin-M,41864,0.0137500130837937,0.00536742650529359,0.00322985713341827,0.0242701690341691,0.0104255307459993
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0115618063855044,0.00451445815436233,-0.0204101443680546,-0.00271346840295426,0.0104483365669534
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.0106152103331383,0.00414565945701575,0.00248971779738744,0.0187407028688892,0.0104632025281738
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD109,CD109 antigen,42137,-0.00939202398834001,0.00368116426918409,-0.0166071059559408,-0.00217694202073919,0.0107408320483691
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.0154403023731388,0.00606770893270936,-0.0273330118812492,-0.00354759286502847,0.0109516645487447
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC13A1,Solute carrier family 13 member 1,39919,0.0164983455883475,0.00648367633384838,0.00379033997400469,0.0292063512026903,0.0109535450768426
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSTN2,Calsyntenin-2,42296,-0.0109752935725408,0.00431858747491969,-0.0194397250233834,-0.00251086212169819,0.011051623640632
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXDC2,Plexin domain-containing protein 2,39929,0.00751310103444068,0.0029579829780344,0.00171545439749325,0.0133107476713881,0.0111003723433718
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0192200724899483,0.0075674753400654,0.00438782082342011,0.0340523241564765,0.0111017481080847
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.0109314588964865,0.00431029870435947,-0.019379644357031,-0.00248327343594193,0.0112223199867325
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LEG1,Protein LEG1 homolog,39398,-0.0192905348239845,0.00762739683068586,-0.0342402326121288,-0.00434083703584021,0.0114492933851544
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAV,Integrin alpha-V,42262,-0.00451969300150787,0.00179287389324131,-0.00803372583226084,-0.0010056601707549,0.0117161088619573
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPC1,Glypican-1,42262,0.00802577487400555,0.00318784578717829,0.00177759713113612,0.014273952616875,0.0118265123010427
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OPTC,Opticin,42070,-0.0122953665357583,0.00489517251906672,-0.0218899046731291,-0.00270082839838758,0.0120255939219364
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PKLR,Pyruvate kinase PKLR,42143,0.0168518247830492,0.0067214494265178,0.00367778390707428,0.030025865659024,0.0121817861806782
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NELL1,Protein kinase C-binding protein NELL1,42181,0.0113841938989498,0.00454432877661356,0.00247730949678721,0.0202910783011124,0.0122517997262657
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0185760661257219,0.00741546582223454,0.00404175311414225,0.0331103791373016,0.0122555412582537
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK11,Kallikrein-11,42062,0.00868133301397922,0.00347938026096225,0.00186174770249321,0.0155009183254652,0.0126047482140175
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOX9,Transcription factor SOX-9,39649,0.00744087240501125,0.00298480650848753,0.0015906516483757,0.0132910931616468,0.012684399492031
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.0230624036360741,0.00925267172235136,0.00492716706026542,0.0411976402118827,0.0126988043533817
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0144844734311512,0.00584607888728278,0.00302615881207692,0.0259427880502254,0.0132378631162944
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INHBB,Inhibin beta B chain,39736,0.0138567166307165,0.00563732024388271,0.00280756895270634,0.0249058643087266,0.0139851705144626
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42070,0.0212529418889349,0.00866577436138511,0.00426802414062006,0.0382378596372497,0.0141987375665923
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.0148111299324417,0.00605006770609629,0.00295299722849293,0.0266692626363904,0.0143742647643721
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CXCL14,C-X-C motif chemokine 14,41913,0.0150972493569196,0.00617131595797633,0.00300147007928594,0.0271930286345532,0.0144436018079011
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.018239623829057,0.0074654315830572,0.00360737792626484,0.0328718697318491,0.0145727719896673
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,0.0104523924700923,0.00427994358188438,0.00206370304959895,0.0188410818905857,0.0146115847210808
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42310,0.00817145713675152,0.00335298196542479,0.00159961248451893,0.0147433017889841,0.0148193765996136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.0138837065454156,0.00570547903786216,-0.0250664454596254,-0.00270096763120573,0.0149734331540341
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP7,Dipeptidyl peptidase 2,42054,0.0164695348909885,0.00677860127202498,0.0031834763978195,0.0297555933841574,0.0151269826309781
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACE,Angiotensin-converting enzyme,39990,-0.00708050820636,0.00291513555841643,-0.0127941739008562,-0.00136684251186379,0.0151610014219755
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RALB,Ras-related protein Ral-B,39657,0.00776961067852361,0.00319987497250619,0.00149785573241148,0.0140413656246357,0.0151940794142757
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMIGO1,Amphoterin-induced protein 1,39649,0.0132692034204715,0.00547890931845003,0.00253054115630942,0.0240078656846335,0.0154568818918443
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAL,Galanin peptides,42185,-0.0172973927057109,0.00718392877650179,-0.0313778931076544,-0.00321689230376737,0.0160626465579326
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCTPP1,dCTP pyrophosphatase 1,42145,0.0082119520518864,0.00341517065097585,0.00151821757597373,0.0149056865277991,0.0162056821853393
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS1,"Nitric oxide synthase, brain",41839,-0.0152388609212303,0.00634783241741342,-0.0276806124593606,-0.0027971093831,0.0163801379954042
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM171B,Protein FAM171B,39919,0.00687424214660132,0.00286679237576423,0.00125532909010342,0.0124931552030992,0.0165060786129816
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY6D,Lymphocyte antigen 6D,42041,0.0102784344937981,0.00428838559788554,0.00187319872194243,0.0186836702656538,0.0165521852754762
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0131701528712539,0.00553372220346706,-0.0240162483900494,-0.00232405735245847,0.017327426287259
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTXR,Neuronal pentraxin receptor,42145,0.00874815384648644,0.00368129288139389,0.00153281979895441,0.0159634878940185,0.017497225544786
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGA4,Pepsin A-4,39990,0.0191862808244601,0.00808796102901411,0.0033338772075924,0.0350386844413277,0.0176989176957017
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0380495563934482,0.0160674618276794,0.00655733121119668,0.0695417815756998,0.0178933831800704
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.0115240012704982,0.00487011870924307,0.00197856860038177,0.0210694339406146,0.0179854661713435
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.00928745957273059,0.00393726821170082,0.00157041387779698,0.0170045052676642,0.0183481121769522
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42095,0.00975562862266166,0.00414310423592691,0.00163514432024491,0.0178761129250784,0.0185535806228927
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.00797872598582181,0.00339281147163454,0.00132881550141812,0.0146286364702255,0.0187045331314859
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.0132789283288092,0.00566784729176526,0.00216994763694929,0.0243879090206691,0.0191516899490759
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD86,T-lymphocyte activation antigen CD86,39930,0.00764700592599631,0.00327956768200051,0.00121905326927531,0.0140749585827173,0.0197333059060211
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0194817460353121,0.00836394143318044,0.00308842082627842,0.0358750712443457,0.0198635327876935
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACAN,Aggrecan core protein,41994,0.00683720979207304,0.00294881676732682,0.00105752892811248,0.0126168906560336,0.0204301797231429
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,-0.00680738304846667,0.00293781589681361,-0.0125655022062213,-0.00104926389071199,0.0205128159911547
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP2,Guanylate-binding protein 2,41913,0.0151562559156076,0.00654742417440081,0.00232330453378202,0.0279892072974332,0.0206366854177938
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,APOA4,Apolipoprotein A-IV,39979,0.00855598109661473,0.00371462889693234,0.00127530845862734,0.0158366537346021,0.0212787555676057
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPN1,Epsin-1,39757,0.0107162412735337,0.00466868988604259,0.00156560909689024,0.0198668734501772,0.0217319813829226
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.013487452681012,0.00587843139493045,0.00196572714694834,0.0250091782150757,0.0217859336670544
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.0103742703104454,0.00452401006696719,-0.0192413300417011,-0.00150721057918969,0.0218571258360109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYT1,Synaptotagmin-1,39929,0.00990920767250046,0.00432364000071406,0.0014348732711009,0.0183835420739,0.0219315768695491
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC11A,C-type lectin domain family 11 member A,42118,-0.0119774421202621,0.00523526594522793,-0.0222385633729088,-0.00171632086761533,0.022162305809736
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MERTK,Tyrosine-protein kinase Mer,42296,0.0060798334697794,0.00266178467082538,0.000862735514961658,0.0112969314245971,0.0223797580677412
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",39575,0.0135978110817033,0.00595726869076804,0.00192156444779793,0.0252740577156086,0.0224754608504423
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.00974062221134685,0.00428520769421344,0.0013416151306885,0.0181396292920052,0.0230399834037128
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.073241429828741,0.0323129400585527,0.00990806731397779,0.136574792343504,0.0234286572656815
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.0211401174164646,0.00932863534329533,0.00285599214360578,0.0394242426893235,0.0234614520753755
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00955418387617521,0.0042174128413162,-0.017820313045155,-0.00128805470719546,0.0235067475527978
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPHA2,Glycoprotein hormone alpha-2,39930,-0.0106607442098817,0.00471162380033021,-0.0198955268585289,-0.0014259615612345,0.023676273437715
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFAP,Glial fibrillary acidic protein,41820,0.0110758217738374,0.00492039088374173,0.0014318556417036,0.0207197879059712,0.0244016143651998
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00948292382784576,0.00421494278728233,0.00122163596477239,0.0177442116909191,0.0244790738759869
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TTN,Titin,39575,-0.016773921976843,0.00747300864231382,-0.0314210189157781,-0.0021268250379079,0.0248136041649862
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN2B,Sodium channel subunit beta-2,39649,-0.00683402640644745,0.00304698222670094,-0.0128061115707813,-0.000861941242113614,0.0249240653390386
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NME1,Nucleoside diphosphate kinase A,39657,-0.00530550526284828,0.00236751499746818,-0.00994583465788592,-0.000665175867810645,0.025048465649141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL3A1,Collagen alpha-1(III) chain,39966,0.00569892730648114,0.00254596750928325,0.000708830988285978,0.0106890236246763,0.02521340341822
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPR158,Probable G-protein coupled receptor 158,39934,0.00831961673724503,0.00374105193447492,0.000987154945674176,0.0156520785288159,0.0261767578645598
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0296572614241706,0.0133661887567794,0.00345953146088305,0.0558549913874582,0.0265153786780003
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.0104558294299037,0.00471338381404722,0.00121759715437116,0.0196940617054363,0.0265489734599734
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELENOP,Selenoprotein P,39979,0.00541331193811711,0.00244156759045897,0.000627839460817525,0.0101987844154167,0.0266328000441206
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,42119,0.0116602754595956,0.00526083289338551,0.00134904298856003,0.0219715079306312,0.0266785505777859
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOC,Myocilin,42137,-0.0106732543827332,0.00482536617678401,-0.0201309720892299,-0.00121553667623659,0.026989825998646
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.0136587018160964,0.00620391178396069,-0.0258183689126594,-0.00149903471953349,0.0277123549392529
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.00568593120055292,0.00258328914925632,0.000622684468010525,0.0107491779330953,0.0277499307576722
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00720239704196349,0.003272544681421,-0.0136165846175486,-0.000788209466378339,0.0277670029497604
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIF20B,Kinesin-like protein KIF20B,39586,0.0177464541518971,0.00807213678178098,0.0019250660596064,0.0335678422441878,0.0279354932608997
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42189,-0.00706638432505655,0.00322977654228484,-0.0133967463479348,-0.000736022302178257,0.0286948470606591
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.0137897823486768,0.00632055129889086,0.00140150180285072,0.0261780628945029,0.0291462212052409
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD5L,CD5 antigen-like,39925,0.0112509095248313,0.00518270498183502,0.00109280776043469,0.021409011289228,0.0299627128637828
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.016557348777831,0.00763866963125281,-0.0315291412550865,-0.00158555630057554,0.0302128493144971
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALM3,Paralemmin-3,39575,0.0177260675767585,0.00818407264668861,0.00168528518924883,0.0337668499642682,0.0303385673391082
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMBN,Ameloblastin,41913,-0.00636925431942005,0.00295349913102404,-0.0121581126162272,-0.000580396022612928,0.03106160995789
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPS,Calcyphosin,39929,0.02209948702063,0.0102531622459133,0.00200328901864004,0.04219568502262,0.0311529080216914
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NINJ1,Ninjurin-1,41843,0.0126271621404462,0.00586691346089616,0.0011280117570897,0.0241263125238026,0.0313943738669096
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALPI,Intestinal-type alkaline phosphatase,39657,0.0290854164321383,0.0135285566351743,0.00256944542719669,0.0556013874370798,0.0315825699220628
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCND2,G1/S-specific cyclin-D2,39757,0.00859278972735044,0.00400717440584531,0.000738727891893628,0.0164468515628072,0.0320262862897725
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.00853669425655235,0.00398406138752012,-0.0163454545760918,-0.000727933937012913,0.032154047400228
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00679285908057382,0.00317618887855023,-0.0130181892825323,-0.000567528878615361,0.0324833901471136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,-0.00615547460776888,0.00288603319379787,-0.0118120996676127,-0.000498849547925059,0.0329550959991393
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0133487119792637,0.00629072308904974,0.00101889472472621,0.0256785292338012,0.0338588739547309
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIPK2B,Divergent protein kinase domain 2B,39736,0.00685161982904133,0.00322942322308012,0.000521950311804306,0.0131812893462784,0.0338913998656461
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEX101,Testis-expressed protein 101,39649,0.0141073454208506,0.00665314345957151,0.00106718424009048,0.0271475066016108,0.0339942930762768
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.00898238198498247,0.00424367636171916,0.000664776316012909,0.017299987653952,0.0343077609317794
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMG4,Proteasome assembly chaperone 4,39657,0.0127702945676626,0.00603766269131556,0.000936475692684135,0.0246041134426411,0.0344432493118892
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00718763676605123,0.00340417513543429,-0.0138598200315024,-0.000515453500600021,0.0347589193962726
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.007705501498417,0.00365160004423266,0.000548365411720979,0.014862637585113,0.0348660086996903
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.0149419904310787,0.00710088396942726,-0.0288597230111561,-0.00102425785100128,0.0353755507901219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,0.0101390210418296,0.00482413462651959,0.000683717173851222,0.019594324909808,0.0355994315725202
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,0.00972337558866858,0.00462943282566899,0.000649687250357359,0.0187970639269798,0.0357177014485908
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0214877678486174,0.0102770351411022,0.00134477897205705,0.0416307567251778,0.0365642339339928
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MKI67,Proliferation marker protein Ki-67,39657,0.00917314478602784,0.00439208801412477,0.000564652278343306,0.0177816372937124,0.0367700532184178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MUCL3,Mucin-like protein 3,39560,-0.00958937359644204,0.00460147861471059,-0.0186082716812748,-0.000570475511609271,0.0371854042429104
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA1549,UPF0606 protein KIAA1549,39757,0.0153883835853992,0.0073860370560531,0.000911750955535079,0.0298650162152632,0.0372336140196763
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSAB1,Tryptase alpha/beta-1,42281,0.0117058721079384,0.00562102383317267,0.000688665394919959,0.0227230788209568,0.0373138942158294
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB2,Integrin beta-2,42079,-0.00645659491752475,0.00310151636768691,-0.0125355669981911,-0.000377622836858413,0.0373837428369156
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0189080257754913,0.00909823141818936,-0.0367405593551425,-0.00107549219584019,0.0377095407130405
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH4,Myosin-4,39575,-0.0102622646443935,0.00494484438658385,-0.0199541596420978,-0.000570369646689137,0.0379776855884038
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN1,Contactin-1,42310,-0.00594932570725847,0.00288082793879873,-0.011595748467304,-0.000302902947212949,0.0389280931001967
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.00642708223604193,0.00311420526812884,-0.0125309245615745,-0.000323239910509402,0.0390563136223765
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RSPO3,R-spondin-3,42262,0.00624620631387517,0.00303132895594446,0.000304801560224026,0.0121876110675263,0.0393648348516319
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CFD,Complement factor D,39979,0.00450357547065939,0.00218604151032141,0.000218934110429427,0.00878821683088936,0.0394067994548965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.0155032025058423,0.00755178794686408,0.000701698129988663,0.0303047068816958,0.0401034224411463
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGM2,Phosphoglucomutase-2,39649,0.0134454801224085,0.00655655044352511,0.000594641253099316,0.0262963189917177,0.0403202708846435
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.00763887616876857,0.00373394506490179,0.000320343841561069,0.0149574084959761,0.0407959339843086
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLL1,Delta-like protein 1,42181,-0.00677171947884647,0.00331072768506921,-0.0132607457415821,-0.000282693216110823,0.0408359434524675
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLIN3,Perilipin-3,42145,0.00942371871207247,0.00461910373602988,0.000370275389453894,0.018477162034691,0.0413535744629854
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GM2A,Ganglioside GM2 activator,39733,0.00847306048253941,0.00415930665573584,0.000320819437297171,0.0166253015277816,0.0416603274829038
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3GL3,Endophilin-A3,39690,0.0186381671082934,0.00919656959886408,0.000612890694519832,0.036663443522067,0.0427227753650741
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNA1,Ephrin-A1,42113,0.00642628807039068,0.00317641680497288,0.000200511132643833,0.0126520650081375,0.0430799170206224
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,-0.0130911851270681,0.00647339829027922,-0.0257790457760154,-0.000403324478120826,0.0431647575429489
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.0164852023478338,0.0081735191380634,0.000465104837229481,0.032505299858438,0.0437256940880848
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,S100A3,Protein S100-A3,39919,0.00926102807454842,0.00460932106495613,0.0002267587872344,0.0182952973618624,0.044540079542619
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC4A1,Band 3 anion transport protein,39966,0.0103120367025264,0.00514164998720664,0.000234402727601397,0.0203896706774514,0.0449237743274234
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD82,CD82 antigen,39757,-0.00896561145237934,0.00447232489403483,-0.0177313682446876,-0.000199854660071068,0.0450206395020122
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAU,Urokinase-type plasminogen activator,42137,-0.00617455764464599,0.00308135409840297,-0.0122140116775158,-0.000135103611776161,0.0451064985085771
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEDD9,Enhancer of filamentation 1,39657,0.00731882722881154,0.00365393073603218,0.000157122986188467,0.0144805314714346,0.045201536516046
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSC1,Hamartin,39657,0.0159122461163274,0.00798544567296416,0.000260772597317604,0.0315637196353371,0.0463236708567163
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.0104232430967747,0.00523741605860349,0.000157907621911865,0.0206885785716375,0.046599166090837
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.0132647519143022,0.00667875520566564,0.000174391711197534,0.0263551121174069,0.0470457648017475
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN5,Contactin-5,42170,0.0079287912479628,0.00399400035830966,0.000100550545675857,0.0157570319502497,0.0471450589290115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEB,Nebulin,39575,-0.00852456536518063,0.00429537235288101,-0.0169434951768274,-0.000105635553533854,0.0472146463070826
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUP50,Nuclear pore complex protein Nup50,39575,-0.00675623935762849,0.00342301452124492,-0.0134653478192685,-4.71308959884417e-05,0.0484330760710313
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00486440997420238,0.00246478581950214,3.34297679781825e-05,0.00969539018042658,0.0484515083103778
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOC2B,Double C2-like domain-containing protein beta,39649,0.00781678278999661,0.00396446279126663,4.64357191140219e-05,0.0155871298608792,0.0486672868881056
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVI2B,Protein EVI2B,39560,-0.00849903326550859,0.00431484070822571,-0.016956121053631,-4.19454773861894e-05,0.0488954729136612
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENOPH1,Enolase-phosphatase E1,39919,0.0112839194995292,0.00575653539568552,1.11012398554093e-06,0.0225667288750728,0.0499977498084514
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSBP1,Heat shock factor-binding protein 1,39638,0.0203658595491436,0.0103936267885426,-5.64895639996663e-06,0.0407373680546871,0.0500844805646077
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,39930,0.0101856476665212,0.00520015597616687,-6.6580467658825e-06,0.0203779533798083,0.050170123230748
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCL28,C-C motif chemokine 28,42075,0.0124595220559681,0.00636318987846912,-1.23301058313485e-05,0.0249313742177676,0.0502433097054072
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB118,Beta-defensin 118,39586,0.0120046162432562,0.00615369913570221,-5.66340627201345e-05,0.0240658665492325,0.0511066177769383
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.0051667413474465,0.00264978484463312,-2.68369480344198e-05,0.0103603196429274,0.0512166140266263
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEBP1,Heme-binding protein 1,41900,-0.0109237921443011,0.00560992595124123,-0.0219192470087339,7.16627201317564e-05,0.0515286964485643
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNG,Uracil-DNA glycosylase,39919,0.00736325784420614,0.00380314661981818,-9.09095306374967e-05,0.0148174252190498,0.0528807812341508
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNL1,Interferon lambda-1,41839,0.00950354038841328,0.00491110175362904,-0.00012221904869964,0.0191292998255262,0.0529976139285883
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CAPN3,Calpain-3,39919,-0.00814658180473155,0.00421251218735132,-0.0164031056919401,0.000109942082477039,0.0531501914997063
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.0065384158254834,0.00338924727428254,-0.0131813404830772,0.000104508832110389,0.0537360116781034
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FRMD7,FERM domain-containing protein 7,39649,0.00707863715910653,0.0036714109680638,-0.000117328338298528,0.0142746026565116,0.0538754097366974
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNGR1,Interferon gamma receptor 1,42185,0.00446744846259653,0.00233384842552045,-0.000106894451423552,0.00904179137661662,0.0556158212096464
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.0106499158985649,0.00556460636744807,-0.000256712581633328,0.0215565443787631,0.0556627234686793
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPM1B,Protein phosphatase 1B,39657,0.012738179352063,0.00665715669436221,-0.000309847768886942,0.0257862064730129,0.0557154399214467
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.0172978898162349,0.00904248225949,-0.000425375412365526,0.0350211550448353,0.0557794455170855
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1R1,Interleukin-1 receptor type 1,42113,-0.00490655515066037,0.00257396686212502,-0.0099515302004254,0.00013841989910466,0.0566424564282141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.017507072516776,0.0091941505500145,-0.000513462561252408,0.0355276075948044,0.0569114240454953
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.00809295613615822,0.00425081219427746,-0.016424548036942,0.000238635764625593,0.0569544001208645
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00604168735499424,0.00317651923631969,-0.000184290348192359,0.0122676650581808,0.0571992659303531
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD48,CD48 antigen,42166,0.00629488553263976,0.00331644879970909,-0.000205354114790058,0.0127951251800696,0.0577067340591778
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL1A,Interleukin-1 alpha,41913,0.0118492515719815,0.00624780706951115,-0.000396450284260394,0.0240949534282233,0.0579095507326522
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYH7B,Myosin-7B,39560,-0.00875468184357124,0.00463150885393937,-0.0178324391972924,0.000323075510149935,0.0587516928582991
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0079818353167304,0.00422818749736264,-0.0162690828115612,0.000305412178100371,0.059079161207147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00914091506750383,0.00484759800437915,-0.000360377021079307,0.018642207156087,0.0593628441396642
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACRV1,Acrosomal protein SP-10,39657,0.021572456044898,0.0114707237322016,-0.000910162470217128,0.0440550745600131,0.06004533727731
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBA,Lysosomal acid glucosylceramidase,39649,0.0112573098262149,0.0059897954071018,-0.000482689171704617,0.0229973088241344,0.060214180140528
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL5,Interleukin-5,41913,0.028018140415267,0.0149147618846036,-0.00121479287855612,0.0572510737090901,0.0603276649592832
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.00748523715632843,0.00399666547565425,-0.000348227175953888,0.0153187014886108,0.0611081571610698
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DHODH,Dihydroorotate dehydrogenase,39575,0.00938337506241877,0.00501368558867145,-0.000443448691377276,0.0192101988162148,0.0612951405365603
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIP1,Huntingtin-interacting protein 1,39575,0.00663245851032442,0.00355547927034214,-0.000336280859546172,0.013601197880195,0.0621493610153994
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C8B,Complement component C8 beta chain,39979,0.00607891921819258,0.00326453840620386,-0.000319576057966992,0.0124774144943521,0.0626137927834977
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDNRB,Endothelin receptor type B,39657,0.00880490298041945,0.0047292735086809,-0.000464473096595116,0.018074279057434,0.0626595405513352
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.0167961519805085,0.00904176994956003,-0.0345180210816462,0.000925717120629128,0.0632500859470532
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HSP90B1,Endoplasmin,41774,0.0127215893554336,0.00686832914313212,-0.00074033576510533,0.0261835144759726,0.0640179979579203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPHS2,Podocin,39657,-0.0203270878897834,0.0109961045320817,-0.0418794527726635,0.00122527699309679,0.0645463596565593
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.0163197311457563,0.00883740802977318,-0.0336410508841117,0.00100158859259913,0.0648221880132378
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLSPN,Claspin,41820,0.00708161069178321,0.00383982998025695,-0.00044445606952042,0.0146076774530868,0.0651689135948369
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.00795805085070343,0.00431537785426307,-0.000500089743652194,0.016416191445059,0.065193211499992
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AIF1L,Allograft inflammatory factor 1-like,39638,0.0112695603292001,0.00612677572112881,-0.000738920084212412,0.0232780407426125,0.0658839565670694
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA8,Carbonic anhydrase-related protein,39657,0.00526511350478922,0.00287491700440018,-0.000369723823835127,0.0108999508334136,0.0670682449413583
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.0122997263160892,0.00672291779763394,-0.000877192567273283,0.0254766451994518,0.0673483531874892
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00642209534464409,0.00352222781787847,-0.00048147117839771,0.0133256618676859,0.068284408027748
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR1,Folate receptor alpha,42110,0.00579849183374321,0.00318218058877601,-0.000438582120257767,0.0120355657877442,0.0684504422724405
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSHB,Follitropin subunit beta,39638,-0.00805054296703996,0.00442952311248112,-0.016732408267503,0.000631322333423039,0.0691716702852033
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PMCH,Pro-MCH,39575,-0.0161619529737975,0.00890564817375448,-0.0336170233943563,0.00129311744676126,0.0695822360129472
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.0116530916078886,0.00642526656549362,-0.000940430860478863,0.0242466140762561,0.0697611966173336
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.0114913763086152,0.00634408835854916,-0.000943036874141124,0.0239257894913716,0.0701136994350598
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR1,Toll-like receptor 1,39657,0.00521724970684076,0.00288825430830025,-0.00044372873742774,0.0108782281511093,0.0708880791816693
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FH,"Fumarate hydratase, mitochondrial",39586,0.0159749610468738,0.00888612912916651,-0.00144185204629259,0.0333917741400401,0.0722454665008172
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.00882941431573688,0.00492500874246172,-0.0184824314509618,0.000823602819488085,0.0730315600939901
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FZD8,Frizzled-8,39586,0.00827445132500995,0.00465037275822656,-0.000840279281114116,0.017389181931134,0.0752167127796483
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0242340663298129,0.0136377795525166,-0.00249598159311972,0.0509641142527455,0.0755944206322298
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DBH,Dopamine beta-hydroxylase,39978,0.0217964998963275,0.0122998667683679,-0.00231123896967356,0.0459042387623286,0.076405983673385
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSN,Gelsolin,39943,-0.00361839567789712,0.00204412014260966,-0.00762487115741205,0.00038807980161781,0.076729305887771
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.0155986358886211,0.00881257861384239,-0.0328712899717522,0.00167401819451,0.0767479105164218
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAB6B,Ras-related protein Rab-6B,41839,0.00902508858885723,0.00511669567950998,-0.00100363494298233,0.0190538121206968,0.0777801357190216
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.0087293929647318,0.00495064920099047,-0.0184326653986731,0.000973879469209521,0.0778804767237577
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RTKN2,Rhotekin-2,39575,-0.00967421451446615,0.00549564593721713,-0.0204456805514117,0.00109725152247943,0.0783777445060335
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC12A,C-type lectin domain family 12 member A,39657,0.00385289123715332,0.00220228027867547,-0.000463578109050605,0.00816936058335724,0.0802322221348822
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,-0.00408257618040032,0.00233439107531513,-0.00865798268801798,0.000492830327217337,0.0803390912679667
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL5,Fc receptor-like protein 5,42137,-0.0111535715947842,0.00638058506945395,-0.0236595183309139,0.00135237514134557,0.0804783144718724
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAN,Brevican core protein,42016,0.00649371759414284,0.0037245772817917,-0.000806453878168896,0.0137938890664546,0.0812731052213574
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.00677557319631928,0.00390767275343169,-0.000883465400406827,0.0144346117930454,0.0829610510944733
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B4,Protein ATP1B4,39560,-0.00782056799917923,0.00452266465848138,-0.0166849907298027,0.00104385473144427,0.083802403149694
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00879738209888448,0.00508945237887151,-0.00117794456370368,0.0187727087614726,0.0839166115490359
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MATN3,Matrilin-3,41992,-0.0061448364469822,0.00356155176078082,-0.0131254778981126,0.000835805004148207,0.0844918796504354
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00476997746913346,0.00276585584385516,-0.0101910549230896,0.000651099984822654,0.0846287209699523
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,39934,0.0073992571048258,0.00429165373121111,-0.00101238420834798,0.0158108984179996,0.084716348837255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.00909691968449213,0.00527910176173647,-0.0194439591374956,0.00125011976851136,0.0848815440490604
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAG,S-arrestin,39586,-0.00962797365767433,0.00564627921946169,-0.0206946809278192,0.00143873361247057,0.0881874370416071
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0161893050645763,0.00950090027537646,-0.0348110696043142,0.00243245947516157,0.0884137363073284
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR4,Toll-like receptor 4,39657,0.0051831447821581,0.00306363129114003,-0.000821572548476363,0.0111878621127926,0.0907064788342731
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OTOA,Otoancorin,39586,-0.0095653466556229,0.00567427499318654,-0.0206869256422685,0.00155623233102271,0.0918744791591368
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AREG,Amphiregulin,42070,0.00711069996503751,0.00422420914450885,-0.00116874995819983,0.0153901498882749,0.0923361399173458
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0126376568693963,0.00751410091323456,-0.00208998092054342,0.027365294659336,0.0926194935044516
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VCAN,Versican core protein,42249,-0.00544811295272101,0.00324560099891627,-0.0118094909105969,0.000913265005154872,0.093250086742679
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGLC2,Immunoglobulin lambda constant 2,39963,-0.00461504009978498,0.0027631742367873,-0.0100308616038881,0.000800781404318121,0.0949083091289192
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.0057333546135573,0.00343445024761529,-0.0124648770988833,0.000998167871768673,0.0950684952090169
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GKN1,Gastrokine-1,41538,0.00510668057834799,0.0030642350805082,-0.000899220179448088,0.0111125813361441,0.0956294483680747
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0165198149197592,0.00992651211864763,-0.00293614883279016,0.0359757786723086,0.0960987036014592
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIRREL1,Kin of IRRE-like protein 1,39586,-0.0100109610460847,0.0060274805540417,-0.0218248229320065,0.00180290083983703,0.0967647808364381
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCARB1,Scavenger receptor class B member 1,41839,0.00992063100661584,0.00600217882746591,-0.00184363949521734,0.021684901508449,0.0983874900224377
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00612498152342954,0.00372776582522771,-0.0134314025408759,0.00118143949401678,0.100396994603297
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.00830703019693893,0.00505690216352626,-0.0182185584374504,0.00160449804357254,0.100471371720774
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0121425120926486,0.007425686041858,-0.00241183254939309,0.0266968567346903,0.102029639434736
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ELAVL4,ELAV-like protein 4,39586,0.0144367012007746,0.00885235732505305,-0.00291391915632936,0.0317873215578786,0.102954590937943
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC44A4,Choline transporter-like protein 4,39649,-0.0121165958071744,0.00743323533001248,-0.0266857370539988,0.00245254543965011,0.10311799695297
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,41430,0.00739001638027182,0.00453694618204279,-0.00150239813653206,0.0162824308970757,0.103368787241024
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EP300,Histone acetyltransferase p300,39657,0.0054124191961754,0.0033229234011798,-0.001100510670137,0.0119253490624878,0.103381204362017
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.00529669615267575,0.00325627918995012,-0.00108561105962648,0.011679003364978,0.103843448565073
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA4C,Semaphorin-4C,42070,-0.00488510478304044,0.003004053195226,-0.0107730490456834,0.00100283947960252,0.103936633769255
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTO1,Protein LTO1 homolog,41913,0.00724764442608025,0.00445959312116074,-0.0014931580913948,0.0159884469435553,0.104147744198476
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAD2,Glutamate decarboxylase 2,39657,-0.0079397857456173,0.00488932901503283,-0.0175228706150816,0.00164329912384705,0.104425467151927
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM3D,Protein FAM3D,39930,0.01528016798296,0.00944853231565744,-0.0032389553557286,0.0337992913216486,0.105862920035174
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCN,Decorin,41900,-0.00400597211461628,0.00248115590742838,-0.0088690376931759,0.000857093463943344,0.106429994191844
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RAP1A,Ras-related protein Rap-1A,39657,-0.012026211530502,0.00746356699138126,-0.0266548028336092,0.00260237977260528,0.107138046868297
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DRAXIN,Draxin,42016,0.00739395683028724,0.00458892174646437,-0.00160032979278292,0.0163882434533574,0.107146077380065
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STX1B,Syntaxin-1B,39649,0.00698455376007688,0.00433766423828982,-0.00151726814697116,0.0154863756671249,0.107380412709039
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PZP,Pregnancy zone protein,39979,0.00573191132080313,0.00358377009054856,-0.00129227805667206,0.0127561006982783,0.109757691109741
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.00861919532173505,0.00539792955887313,-0.0191991372571264,0.00196074661365628,0.110348087657108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL4,Interleukin-4,41913,0.0162641824387155,0.0101906809703867,-0.0037095522632424,0.0362379171406735,0.110515692341459
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00514839969283792,0.00322590610629726,-0.00117437627550472,0.0114711756611806,0.110523459424472
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00531822816838593,0.00333702041137111,-0.00122233183790143,0.0118587881746733,0.111025725153372
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0127816293091917,0.00802515494756569,-0.00294767438803706,0.0285109330064204,0.111256371797683
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,0.00900561824316212,0.00565498005785605,-0.00207814267023572,0.02008937915656,0.11129784505915
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM25,RNA-binding protein 25,39560,-0.00804197728692254,0.00505636880385883,-0.0179524601424858,0.00186850556864076,0.111758884879721
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MANSC4,MANSC domain-containing protein 4,39575,0.0116610389134859,0.00733487879754616,-0.00271532352970456,0.0260374013566764,0.111907203212167
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRR5,Proline-rich protein 5,39657,0.00807967692039941,0.0050922562046617,-0.00190114524073753,0.0180604990815363,0.112618367975633
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS5,Transmembrane protease serine 5,41946,-0.00659747263140454,0.00416051738678959,-0.0147520867095121,0.00155714144670306,0.112823422699324
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GPA33,Cell surface A33 antigen,42070,0.0228368577148549,0.0144272184464918,-0.00544049044026912,0.0511142058699789,0.11346752026854
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNNI3,"Troponin I, cardiac muscle",41900,0.0143323386926112,0.00905617550039893,-0.00341776528817071,0.0320824426733931,0.113535550757827
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.0117936873360266,0.0074677510068198,-0.00284310463734018,0.0264304793093934,0.11429965775048
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.0117985887439298,0.00748536279811763,-0.0264698998282403,0.00287272234038081,0.115003590474921
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.00850434014600185,0.00544466486452853,-0.0191758832804778,0.00216720298847406,0.118326202089666
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGMA,Repulsive guidance molecule A,42249,-0.00541418880296051,0.00346979333457006,-0.0122149837387178,0.0013866061327968,0.118693790997969
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF7,Fibroblast growth factor 7,39560,-0.0130429557050044,0.00839316639192294,-0.0294935618331734,0.00340765042316455,0.120213997021464
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCDHB15,Protocadherin beta-15,39919,-0.00668432577737892,0.0043024983731053,-0.0151172225886653,0.00174857103390746,0.120309797400883
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00606425674776709,0.00391059089678228,-0.0137290149054604,0.00160050140992618,0.120995893364427
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SELL,L-selectin,39979,0.00389142432811892,0.00251503398421539,-0.00103804228094325,0.00882089093718108,0.121827141366588
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHAD,Chondroadherin,39736,0.00779571318015565,0.00506363413797414,-0.00212900973027366,0.017720436090585,0.123698722894105
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00488463475334861,0.00317626978930501,-0.00134085403368921,0.0111101235403864,0.124108447823994
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGFL4,Insulin growth factor-like family member 4,39657,0.0118610143864175,0.00771442784957865,-0.00325926419875664,0.0269812929715917,0.12419694186116
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,39575,0.0165390862717131,0.0107699176755214,-0.00456995237230888,0.037648124915735,0.124647096557505
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FABP1,"Fatty acid-binding protein, liver",42123,0.0156298395336769,0.0102612642938305,-0.00448223848223093,0.0357419175495848,0.127734941197864
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LIFR,Leukemia inhibitory factor receptor,42119,-0.00394797323023895,0.00259323282338207,-0.0090307095640678,0.0011347631035899,0.127928838225516
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NECTIN4,Nectin-4,42181,-0.00550674001931621,0.00362628787093136,-0.0126142642463417,0.00160078420770925,0.128896264009793
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0066867696082773,0.00440850699608512,-0.00195390410404953,0.0153274433206041,0.129348195417297
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIRREL2,Kin of IRRE-like protein 2,41839,0.00653052565596751,0.00430698886961463,-0.00191117252847716,0.0149722238404122,0.129476868422096
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00855406016410564,0.0056425382159476,-0.0196134350673629,0.00250531473915165,0.129549368027609
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK3,Prostate-specific antigen,39966,0.0187387842650837,0.0123632918950039,-0.00549326784912394,0.0429708363792913,0.129628300392525
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFRC,Transferrin receptor protein 1,42200,0.00612353165855724,0.00404203021080827,-0.00179884755462697,0.0140459108717414,0.129804672942376
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD5,Sushi domain-containing protein 5,39695,-0.00563111033897892,0.00371891000077366,-0.0129201739404953,0.00165795326253745,0.130007914699591
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL4,Myosin light chain 4,39638,0.00835877323385101,0.00556723004733681,-0.00255299765892915,0.0192705441266312,0.133274514592204
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TUBB3,Tubulin beta-3 chain,39586,-0.00462171667920904,0.0030910794553092,-0.0106802324116151,0.00143679905319699,0.134896490174033
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00873973661283435,0.00585017060547996,-0.00272659777390637,0.0202060709995751,0.135223095257758
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00709756560616685,0.00475906490992708,-0.0164253328296239,0.00223020161729023,0.135890098470043
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.0094059506421343,0.00635055085509471,-0.00304112903385133,0.0218530303181199,0.138602351838767
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRRT3,Proline-rich transmembrane protein 3,39638,0.00617201682079207,0.00418012311346375,-0.00202102448159689,0.014365058123181,0.139834068279203
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPK13,Mitogen-activated protein kinase 13,39560,0.00694954631188544,0.00471195202029274,-0.00228587964788833,0.0161849722716592,0.140274529918154
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYMP,Thymidine phosphorylase,42070,0.0105572369727648,0.00717504444841384,-0.00350585014612633,0.0246203240916559,0.141210983556071
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,41900,0.00757390615513724,0.00515819624971037,-0.00253615849429508,0.0176839708045696,0.142039736102825
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.00973993038619593,0.00664247783915664,-0.0227591869509429,0.00327932617855108,0.142592555905819
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHPK,Sedoheptulokinase,39757,-0.00632449056229546,0.00431423209167166,-0.0147803854619719,0.002131404337381,0.142687436482267
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF2,Trefoil factor 2,42166,0.00920963459296373,0.0063033769129395,-0.0031449841563977,0.0215642533423252,0.144021147295091
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH23,Cadherin-23,39929,-0.00420422989418487,0.00288876250809785,-0.00986620441005665,0.0014577446216869,0.145593453653981
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RGS8,Regulator of G-protein signaling 8,41913,-0.00999015894800515,0.00689940601529664,-0.0235129947379866,0.00353267684197626,0.147647934955084
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF9,Fibroblast growth factor 9,39539,0.00643536848589122,0.00445002908444876,-0.00228668851962835,0.0151574254914108,0.148166372501216
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.00602954926267836,0.00418408230100894,-0.00217125204729916,0.0142303505726559,0.14959385687599
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.00425876416888447,0.00297423658503895,-0.00157073953779187,0.0100882678755608,0.152200291223288
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,0.00533298792938905,0.00374802412092372,-0.00201313934762143,0.0126791152063995,0.154794025545468
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,YY1,Transcriptional repressor protein YY1,39657,0.00427756360222781,0.00301039503417382,-0.00162281066475288,0.0101779378692085,0.155365021894022
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMA1,Proteasome subunit alpha type-1,41843,0.00705898081786094,0.00500021697311145,-0.00274144444943749,0.0168594060851594,0.15805152738322
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.0052979836452133,0.00375327370345718,-0.00205843281356278,0.0126544001039894,0.158106453148414
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.00502602818662053,0.003563296214138,-0.012010088766331,0.00195803239308994,0.158420121210034
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRXN3,Neurexin-3,39649,0.00547951515676542,0.00388500242603594,-0.00213508959826502,0.0130941199117959,0.158441573034719
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP9,Matrix metalloproteinase-9,42125,0.00907214510649789,0.006455255155214,-0.00358015499772155,0.0217244452107173,0.159928581147497
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRC1,Macrophage mannose receptor 1,39990,0.00430216426928246,0.00306641214681294,-0.00170800353847091,0.0103123320770358,0.160645261228772
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD177,CD177 antigen,42123,-0.0194755255138104,0.013896303829759,-0.0467122810201381,0.00776122999251728,0.161090660431452
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VNN2,Vascular non-inflammatory molecule 2,42070,0.00714482348990799,0.00510176710420701,-0.00285464003433774,0.0171442870141537,0.161398487263832
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSG1,Tryptase gamma,39657,0.00395950028477206,0.00282776542714887,-0.00158291995243972,0.00950192052198384,0.161474810937401
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00865626514161719,0.00618741514313833,-0.0207835988221683,0.00347106853893393,0.161837784331669
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2RB,Cytokine receptor common subunit beta,39657,-0.00642106399599298,0.00459067592967255,-0.0154187888181512,0.00257666082616522,0.161925419928108
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0056563481150979,0.00404502669194687,-0.0135846004313138,0.00227190420111798,0.162032037790964
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.0109169821536068,0.00781432969040595,-0.0262330683468025,0.00439910403958882,0.162427796924689
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEX33,Testis-expressed protein 33,39757,-0.00581313711308163,0.00416294281184781,-0.0139725050243033,0.00234623079814007,0.16262158189845
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYOM1,Myomesin-1,39586,0.00736833795406411,0.00528842991081959,-0.00299698467114228,0.0177336605792705,0.163559075905868
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP6V1D,V-type proton ATPase subunit D,42070,0.00389583110543552,0.00279984988169388,-0.00159187466268449,0.00938353687355553,0.164114156200564
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.00809786656496067,0.00584392317163231,-0.01955195598136,0.00335622285143866,0.165869516428806
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANGPT2,Angiopoietin-2,42262,-0.00557444323042298,0.00402816882270498,-0.0134696541229247,0.00232076766207877,0.166422297628268
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.00752195677525761,0.00544768525022039,-0.00315550631517435,0.0181994198656896,0.167380079666447
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,H2AP,Huntingtin-interacting protein M,39560,-0.00748763879227467,0.00544065324952731,-0.0181513191613482,0.00317604157679885,0.168775791157663
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBX2,Chromobox protein homolog 2,39575,-0.00585186733004295,0.00426015125707298,-0.014201763793906,0.00249802913382009,0.169584944278461
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCRL6,Fc receptor-like protein 6,42119,0.0101810490401516,0.00741281781618435,-0.00434807387956969,0.024710171959873,0.169638857889356
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADA2,Adenosine deaminase 2,42096,-0.00649311232773427,0.0047322443253336,-0.0157683112053881,0.00278208654991959,0.17005512188479
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.00607350688787116,0.00443250912748116,-0.00261421100199191,0.0147612247777342,0.170646212912378
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00374632009227484,0.00273715899752321,-0.00911115172742032,0.00161851154287064,0.171123570673449
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00642902444147094,0.00471911861244183,-0.0156784969218569,0.00282044803891506,0.173119848987631
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00500191590998878,0.00367182372206876,-0.0121986904052436,0.002194858585266,0.173149187114588
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00612946791688193,0.00450330250895356,-0.00269700500066705,0.0149559408344309,0.173503651425149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.0111491333952737,0.00819619091404734,-0.00491540079625913,0.0272136675868065,0.173763662665753
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL4A4,Collagen alpha-4(IV) chain,39743,-0.00785524294358543,0.00578451047430863,-0.0191928834732303,0.00348239758605949,0.174497887655288
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NXPE4,NXPE family member 4,39575,-0.00464717537003315,0.00345314247455804,-0.0114153346201669,0.00212098388010061,0.178400782671761
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSB,Lupus La protein,41839,0.00850047508325741,0.00636069374939957,-0.00396648466556575,0.0209674348320806,0.181439276193522
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00694405770694681,0.0052200500445115,-0.00328724038029572,0.0171753557941893,0.183457281470123
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.00387166564033603,0.00291288404968327,-0.00183758709704317,0.00958091837771523,0.183820216862991
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFAP2A,Transcription factor AP-2-alpha,39586,0.00854018995121561,0.00642661906067239,-0.00405598340770228,0.0211363633101335,0.183915962243551
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRL,Prolactin,42249,0.0105412551538223,0.00793888474269464,-0.00501895894185921,0.0261014692495038,0.184266225785158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMMD9,COMM domain-containing protein 9,39919,0.00571052178698011,0.00430459746379713,-0.00272648924206227,0.0141475328160225,0.184664509161341
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC4C,C-type lectin domain family 4 member C,42119,0.00693744942340564,0.00523711394670239,-0.00332729391213103,0.0172021927589423,0.185302911591443
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNPO1,Transportin-1,39757,0.00507325463342113,0.00382978331400346,-0.00243312066202565,0.0125796299288679,0.185302944458965
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTA4H,Leukotriene A-4 hydrolase,42262,-0.00847515549178653,0.00642622934213128,-0.0210705650023639,0.00412025401879078,0.18724538086531
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNN,Tenascin-N,39966,0.00614100697389087,0.00466773784113265,-0.00300775919472913,0.0152897731425109,0.188325440478554
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00657047705833674,0.00500286371222944,-0.00323513581763295,0.0163760899343064,0.189094782436223
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00869459793674078,0.00662671424490995,-0.0216829578567643,0.00429376198328273,0.189529366957361
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COMP,Cartilage oligomeric matrix protein,42042,0.00469282463889291,0.00359341510955034,-0.00235026897582576,0.0117359182536116,0.191591514169914
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6L,Seizure 6-like protein,42181,0.00387022491844989,0.00296891254830122,-0.00194884367622049,0.00968929351312028,0.192397782879927
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BMP10,Bone morphogenetic protein 10,39736,0.00396508366658477,0.00305273865632101,-0.0020182840998044,0.00994845143297394,0.194018474754969
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBN2,Fibrillin-2,39649,0.008425041133133,0.00649024433992566,-0.00429583777312131,0.0211459200393873,0.194277161014186
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00399791806318222,0.00308145806651679,-0.0100375758735551,0.00204173974719068,0.194516107773838
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANK2,Ankyrin-2,39575,-0.00976480806452492,0.00754385229178049,-0.0245507585564147,0.00502114242736484,0.195552435153431
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.0054963232397922,0.00426199886257344,-0.0138498410104361,0.00285719453085175,0.19721271589467
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FBLN2,Fibulin-2,39966,-0.00447294354498993,0.00346926694320536,-0.0112727067536724,0.00232681966369257,0.19731827726673
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEMA3G,Semaphorin-3G,39736,0.00633330769900423,0.0049146904272821,-0.0032994855384687,0.0159661009364772,0.197547137718557
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBP1,Retinol-binding protein 1,39649,0.0097738402974733,0.00758817915701463,-0.00509899085027537,0.024646671445222,0.197760755795871
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EXOSC10,Exosome component 10,39575,-0.00808224880670467,0.00629152214572569,-0.020413632212327,0.00424913459891768,0.198950350751593
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCAM1,Neural cell adhesion molecule 1,42217,0.00451129153116129,0.00352931233058257,-0.00240616063678055,0.0114287436991031,0.201188267764407
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAYN,Layilin,41997,-0.00493551921558344,0.00386239750661791,-0.0125058183285546,0.00263477989738767,0.201328610473057
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FDX1,"Adrenodoxin, mitochondrial",39575,0.00866973944568604,0.00679813644702986,-0.00465460799049249,0.0219940868818646,0.202226114846525
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOS,Proto-oncogene c-Fos,39539,-0.00492353895236914,0.00389881114665721,-0.0125652087998173,0.00271813089507899,0.20667689681659
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RETN,Resistin,42105,0.00585620111001423,0.00463797106880082,-0.00323422218483537,0.0149466244048638,0.206731602708952
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LAMA1,Laminin subunit alpha-1,39575,-0.00703705607057091,0.00557833542989773,-0.0179705935131705,0.00389648137202864,0.207156479790729
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,41913,0.00811972661974988,0.00644222522075339,-0.00450703481292676,0.0207464880524265,0.207550217235954
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.00674751052474961,0.00536054356255472,-0.00375915485785764,0.0172541759073569,0.208152187127721
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OBP2B,Odorant-binding protein 2b,41979,-0.00771619859787468,0.00618194788734407,-0.0198328164570691,0.0044004192613197,0.211986107993945
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.00888719886142958,0.00712020466752089,-0.0228428000097705,0.00506840228691136,0.211996823352347
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.00433814158339044,0.00347617650691135,-0.0111514475369367,0.00247516437015581,0.212065977768049
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NME3,Nucleoside diphosphate kinase 3,42144,0.00321552252946797,0.00257839190156699,-0.00183812559760333,0.00826917065653926,0.21238097722121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL36A,Interleukin-36 alpha,39657,-0.00772838912734574,0.00619982366253472,-0.0198800435059138,0.00442326525122231,0.212589014715242
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD58,Lymphocyte function-associated antigen 3,42100,-0.0023432299135036,0.00187991516495872,-0.0060278636368227,0.0013414038098155,0.212618977417436
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RBM19,Probable RNA-binding protein 19,39575,-0.0064297193844868,0.00519013310916363,-0.0166023802784475,0.00374294150947391,0.215433043836474
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00750216561259751,0.0060646032724527,-0.00438445680140977,0.0193887880266048,0.216098199742773
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00651817448497683,0.00527085182122344,-0.0038126950846211,0.0168490440545748,0.216245231788901
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALY,Neuron-specific vesicular protein calcyon,39575,-0.00516884311509583,0.00419496782448789,-0.0133909800510921,0.00305329382090044,0.217918250508103
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC1,Sialoadhesin,42185,0.00548834101696989,0.00448644241367708,-0.00330508611383718,0.014281768147777,0.221231229171135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RELB,Transcription factor RelB,39657,0.00617760436501135,0.00506255947477685,-0.00374501220555127,0.016100220935574,0.222394931630426
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.00533298181909858,0.00439837083476914,-0.00328782501704895,0.0139537886552461,0.225345659664882
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUSP29,Dual specificity phosphatase 29,39649,-0.00881712775434072,0.00727555858937559,-0.0230772225895169,0.00544296708083543,0.2255829811734
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00679087957071988,0.00562876343329679,-0.00424149675854182,0.0178232558999816,0.227666101774955
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.00668370104710062,0.00554002520053668,-0.0175421504401525,0.00417474834595126,0.227669407361157
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00765624570838181,0.00634845811053394,-0.00478673218826471,0.0200992236050283,0.227843206385464
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLGN,Calmegin,39649,0.00594972672937159,0.00493487550489993,-0.00372262926023227,0.0156220827189754,0.227978752749482
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRND,Prion-like protein doppel,39929,0.00636104253047215,0.00527705723241848,-0.00398198964506806,0.0167040747060124,0.228068413576406
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUMF1,Formylglycine-generating enzyme,39657,0.00856142841298441,0.00713074150995845,-0.00541482494653416,0.022537681772503,0.229917962933419
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TG,Thyroglobulin,39919,-0.0134578666463509,0.0113120145992093,-0.035629415260801,0.00871368196809924,0.234190569541977
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.00608309316587053,0.00511363705672653,-0.0161058217970545,0.00393963546531347,0.234236113759677
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.00990586246547592,0.00833306347672512,-0.00642694194890531,0.0262386668798572,0.2345667595441
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN4,Prefoldin subunit 4,39560,-0.00676258773713393,0.00569992916598089,-0.0179344489024565,0.00440927342818862,0.235476808933472
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00450532101034523,0.00381362186550555,-0.00296937784604565,0.0119800198667361,0.237474637277517
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.013458354124452,0.011435251734422,-0.0358714475239191,0.00895473927501517,0.239253742441056
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TLR2,Toll-like receptor 2,39757,-0.00290608738144071,0.00249842211047351,-0.0078029947179688,0.00199081995508737,0.244785779867328
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,REST,RE1-silencing transcription factor,39560,-0.00429910841117247,0.00369686952405636,-0.0115449726783229,0.002946755855978,0.244893328330046
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GDF15,Growth/differentiation factor 15,42310,-0.0057409136559453,0.00493757476150086,-0.015418560188487,0.00393673287659639,0.244971850749704
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CCNE1,G1/S-specific cyclin-E1,39657,0.011449399864879,0.00988676893073312,-0.00792866723935791,0.0308274669691159,0.246867526859022
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPB41L5,Band 4.1-like protein 5,39649,0.00774228896983823,0.00671831916002926,-0.00542561658381913,0.0209101945234956,0.249175683942823
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,0.00267560596045464,0.00232200437434919,-0.00187552261326977,0.00722673453417906,0.249229148664135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOP56,Nucleolar protein 56,39575,0.0139127640783501,0.0120900318147329,-0.00978369827852643,0.0376092264352265,0.249854726455884
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00774869081784402,0.00675730848125106,-0.00549563380540805,0.0209930154410961,0.251525232409143
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLB1,"Phospholipase B1, membrane-associated",39929,0.00731532731775025,0.00640464160580268,-0.00523777022962301,0.0198684248651235,0.25339856006547
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPLA2,Acyl-protein thioesterase 2,39586,0.0133547451541265,0.0117337533978521,-0.00964341150566365,0.0363529018139167,0.255083607340041
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.00447614220448064,0.00393327506361715,-0.0121853613291703,0.00323307692020898,0.255137343061337
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00581008401112297,0.0051323113540665,-0.0158694142650933,0.00424924624284738,0.257633808772025
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNW1,Interferon omega-1,39575,-0.00429326070983874,0.00380828181658668,-0.0117574930703486,0.00317097165067114,0.259619819490428
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.0092160506212516,0.00817864666202894,-0.0252461980788283,0.00681409683632511,0.259833484702465
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GH2,Growth hormone variant,41843,0.0197199637903082,0.0175074302842281,-0.0145945995667789,0.0540345271473953,0.26002646101818
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TEF,Thyrotroph embryonic factor,39575,0.00520546476653381,0.00462239061742754,-0.00385442084362418,0.0142653503766918,0.260130358245912
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VASN,Vasorin,41975,-0.00332966273420743,0.00295702356642665,-0.00912542892440365,0.0024661034559888,0.260177964744059
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.00435685580945878,0.00390991149168476,-0.0120202823331609,0.00330657071424335,0.265169590942894
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGR,Progesterone receptor,39657,0.0120242316030839,0.0108161903543385,-0.00917550149141966,0.0332239646975874,0.266296389593885
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,0.00708665863251074,0.00638786322603466,-0.00543355329051719,0.0196068705555387,0.267284456493181
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00823878028899163,0.00744397450934166,-0.00635140974931803,0.0228289703273013,0.268416510614714
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00497081514165042,0.00449407936794646,-0.00383758041952465,0.0137792107028255,0.268715001695773
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.00426181255865008,0.00385945433007974,-0.0118263430456064,0.00330271792830621,0.269507778316075
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDA1,DET1- and DDB1-associated protein 1,39575,0.00464514927880495,0.00422677951904655,-0.00363933857852629,0.0129296371361362,0.271800574506774
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,STEAP4,Metalloreductase STEAP4,39586,0.00863454154993951,0.00786235418223901,-0.00677567264724894,0.024044755747128,0.272135449236999
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00697317985091012,0.00634962583900168,-0.0194184464953534,0.00547208679353318,0.272139652603779
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTNL10,Butyrophilin-like protein 10,39560,-0.0046960724868051,0.00430703995268641,-0.0131378707940705,0.00374572582046027,0.275594063741182
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.00796911349865467,0.00732536323170516,-0.0223268254327968,0.00638859843548745,0.27666767632944
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.00518859202430846,0.00478755091630781,-0.00419500777165485,0.0145721918202718,0.278487531310903
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BEX3,Protein BEX3,39560,-0.00540969589669747,0.0050516352176222,-0.015310900923237,0.00449150912984204,0.284246902010814
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOS2,"Nitric oxide synthase, inducible",39575,-0.00465740615599721,0.00435099113602491,-0.013185348782606,0.00387053647061162,0.284451956175442
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UBQLN3,Ubiquilin-3,39575,0.00647583262821134,0.00606926857081751,-0.00541993377059098,0.0183715990270137,0.286001030177422
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHP1,Calcineurin B homologous protein 1,39586,0.00849740202084877,0.00797089010175299,-0.00712554257858709,0.0241203466202846,0.286422503898288
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.00631981177949807,0.00592995593787783,-0.0179425254177386,0.00530290185874248,0.286563045413882
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CALCB,Calcitonin gene-related peptide 2,39929,0.00466106050658,0.00438528652206622,-0.0039341010766698,0.0132562220898298,0.287856219511047
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.00856831434166354,0.00807041244470353,-0.00724969404995537,0.0243863227332825,0.288397632029279
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,0.0135027777998914,0.0127228338214437,-0.0114339764901381,0.038439532089921,0.288574976176188
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL24,Interleukin-24,41913,-0.00552129051575376,0.0052067171978078,-0.015726456223457,0.00468387519194953,0.288974248929094
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MYL6B,Myosin light chain 6B,39649,0.0104394868679377,0.00985843303259236,-0.0088830418759433,0.0297620156118188,0.289650356877953
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,39929,0.00348711319728096,0.00329543566974813,-0.00297194071542538,0.0099461671099873,0.290002992093211
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRING1,SREBP regulating gene protein,39560,0.00705247132098426,0.00670416666096207,-0.0060876953345014,0.0201926379764699,0.292844094511823
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.00761137908772001,0.0072434131843212,-0.0218084689289896,0.00658571075354954,0.293373559782612
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00474140097338341,0.00451516156572884,-0.0135911176422119,0.00410831569544511,0.293692070542309
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MBL2,Mannose-binding protein C,39826,-0.0124660102413791,0.011905377237312,-0.0358005496265106,0.0108685291437524,0.295080274112654
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TJP3,Tight junction protein ZO-3,39586,-0.00470271285539299,0.00449209973486106,-0.0135072283357207,0.00410180262493468,0.295175547438541
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.029988049096783,0.0287870217243751,-0.0864106116765582,0.0264345134829921,0.29756380035723
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.00717232081599651,0.0068864483295993,-0.0206697595420111,0.00632511791001811,0.297656507608343
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRD2,Bromodomain-containing protein 2,39586,0.00392996405056587,0.0037833017417442,-0.00348530736325275,0.0113452354643845,0.298936582260111
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCG3,Secretogranin-3,42144,-0.00371914163846355,0.00359108092216286,-0.0107576602459028,0.00331937696897565,0.300378919954067
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTX2,Neuronal pentraxin-2,39966,-0.00380500383799202,0.00369609388511243,-0.0110493478528124,0.00343934017682835,0.303282546949231
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00381021413493895,0.00370668740567652,-0.00345489318018704,0.0110753214500649,0.30400537553651
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DKKL1,Dickkopf-like protein 1,42070,-0.00925023596845783,0.00903589623359325,-0.0269605925863006,0.00846012064938494,0.305985497497824
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA10,Ephrin type-A receptor 10,41839,0.00727247745370327,0.00710404183023651,-0.00665144453356028,0.0211963994409668,0.305991055843858
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00837433918872374,0.00823165605352065,-0.0245083850536242,0.00775970667617674,0.309016881059624
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DUOX2,Dual oxidase 2,41900,0.00769427768862728,0.00758121924284538,-0.00716491202734966,0.0225534674046042,0.310165780340394
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL22,Interleukin-22,39919,0.00771641196584963,0.00760310523230291,-0.00718567428946408,0.0226184982211633,0.310173908046169
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,39929,0.00307102098506772,0.00303055746420975,-0.00286887164478339,0.00901091361491884,0.310913775192812
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00367221810069606,0.00364113797581357,-0.0108088485332907,0.00346441233189854,0.313215518619125
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC39A14,Zinc transporter ZIP14,41839,-0.00366661946079285,0.00364464694689455,-0.0108101274767062,0.00347688855512047,0.314420147023358
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GBP6,Guanylate-binding protein 6,39575,-0.00482929874937515,0.00482601162436493,-0.0142882815331304,0.00462968403438011,0.317003056670926
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL6,Interleukin-6,42070,0.00801195927516895,0.00805680927660799,-0.00777938690698272,0.0238033054573206,0.320029835723586
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NENF,Neudesin,39919,0.012007762274005,0.0121379903842226,-0.0117826988790713,0.0357982234270813,0.322551699432962
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00440485541324165,0.00446472080485724,-0.0131557081907618,0.00434599736427854,0.323864547038804
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.0032308659071313,0.00330515341959965,-0.00324723479528402,0.00970896660954662,0.328330807178167
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00696632169086483,0.00713988695304228,-0.0209605001188277,0.00702785673709804,0.329238888977201
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRK1,Protein BRICK1,41839,0.00476122808164459,0.00490737045368338,-0.00485721800757483,0.014379674170864,0.331954657728092
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00512913872777986,0.00529832321080588,-0.0155138522209594,0.00525557476539967,0.333027946022573
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.0102962800112241,0.0108281827998846,-0.0109269582765497,0.0315195182989979,0.341686650931291
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTNNA1,Catenin alpha-1,39586,-0.00346568182083717,0.00365226521526386,-0.0106241216427543,0.00369275800107999,0.342685752006079
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASQ2,Calsequestrin-2,39575,0.00487176191687091,0.00513582735848332,-0.0051944597057564,0.0149379835394982,0.342853290621634
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GLI2,Zinc finger protein GLI2,39657,-0.00338575343448822,0.0035823209908018,-0.0104071025764598,0.00363559570748332,0.344613961718949
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,0.0153112816745179,0.0162034077188742,-0.0164473974544756,0.0470699608035113,0.344705338207348
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,-0.00501086923438595,0.00530298931689491,-0.0154047282955,0.00538298982672807,0.344723289419783
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.00359826018205509,0.00382812569752379,-0.0111013865492017,0.00390486618509153,0.347258179967171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,-0.00604994815794374,0.00643904380455476,-0.0186704740148711,0.00657057769898359,0.347457453008671
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.00266588351174549,0.00284843048426794,-0.00291704023741967,0.00824880726091065,0.349337754822174
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00282430098477436,0.00302069997948754,-0.00309627097502121,0.00874487294456994,0.349817844740147
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00465342941982715,0.00503755985637742,-0.00522018789867258,0.0145270467383269,0.355634528247854
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,0.00612823989345981,0.00663821055553978,-0.00688265279539815,0.0191391325823178,0.355931842991928
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESPL1,Separin,39560,-0.00530628300476687,0.00576395939286688,-0.016603643414786,0.00599107740525222,0.357281196319364
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,0.00334039172904659,0.00364220298046194,-0.00379832611265881,0.010479109570752,0.359091954893112
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.00764751632482696,0.00834072322295174,-0.00870030119215844,0.0239953338418124,0.359220886743505
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.00346408458847622,0.00378697002536326,-0.0108865458381882,0.00395837666123577,0.360345541031087
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ALMS1,Alstrom syndrome protein 1,39757,-0.00438378576362104,0.00479328285229578,-0.0137786201541208,0.00501104862687869,0.360437938258967
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNIP4,Kv channel-interacting protein 4,41839,0.00502187812315072,0.00550251514211594,-0.00576305155539651,0.015806807801698,0.36144253315778
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DENND2B,DENN domain-containing protein 2B,39575,-0.0048226408342578,0.00528848355241328,-0.0151880685969878,0.00554278692847223,0.361834155631612
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BSND,Barttin,39560,0.00329398957632454,0.00362387879881841,-0.00380881286935955,0.0103967920220086,0.363387046486776
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00603505250241981,0.00664506360164178,-0.0190593771616377,0.00698927215679808,0.363792029540644
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENPEP,Glutamyl aminopeptidase,39575,0.00415437259411739,0.00458018639403445,-0.00482279273819013,0.0131315379264249,0.36441013927711
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00360808097902128,0.0039790484285177,-0.011407015898916,0.00419085394087341,0.36454772147643
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00210348995696071,0.00234551859313729,-0.00249372648558838,0.00670070639950981,0.369835136806658
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENG,Endoglin,42310,0.00166853118729861,0.0018641695183952,-0.00198524106875597,0.0053223034433532,0.370774278645309
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GFRA3,GDNF family receptor alpha-3,41989,0.00268526118373957,0.00300121307747217,-0.00319711644810588,0.00856763881558502,0.370950049861485
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAPPA,Pappalysin-1,41913,0.00452654810177592,0.00512211242778945,-0.0055127922566914,0.0145658884602432,0.376859659681028
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDAC8,Histone deacetylase 8,39657,0.00573410848350232,0.00649824860814484,-0.00700245878846156,0.0184706757554662,0.377575233678801
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY2B,Alpha-amylase 2B,41300,-0.00474585245365721,0.00540545516646603,-0.0153405445799306,0.00584883967261621,0.379974100343417
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCN1,Transcobalamin-1,39806,-0.00337463707642876,0.00384776093885113,-0.010916248516577,0.00416697436371945,0.380484161918519
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.00866631691624565,0.00988502846990776,-0.0107083388847736,0.0280409727172648,0.380662641306424
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.00259912751462063,0.00298027755441586,-0.00324221649203444,0.00844047152127571,0.383164217540917
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.0046605213837839,0.00540723524986306,-0.00593765970594769,0.0152587024735155,0.388758784203986
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRC1,Protein regulator of cytokinesis 1,39919,0.00409020300445983,0.00476285197084534,-0.00524498685839705,0.0134253928673167,0.390484608806383
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.00333416477860334,0.00389221158463316,-0.0109628994844843,0.00429456992727767,0.391667465910542
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LY96,Lymphocyte antigen 96,42016,-0.00335846801886339,0.00394408533327284,-0.0110888752720782,0.00437193923435138,0.39449568985897
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTA2,"Actin, aortic smooth muscle",41900,0.0040012639753715,0.00470451971511823,-0.00521959466626023,0.0132221226170032,0.395054207575121
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.00277251259221953,0.00328885444994448,-0.00921866731411071,0.00367364212967165,0.399245430418101
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00284025154796098,0.00336953328568503,-0.00376403369198167,0.00944453678790364,0.399290826348875
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.0049800500056694,0.00594415107547783,-0.016630586113606,0.00667048610226716,0.402157505973982
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,0.00614519859632865,0.00738851395893656,-0.008336288763187,0.0206266859558443,0.405579770009954
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.00340801676569959,0.00410949886209369,-0.00464660100400404,0.0114626345354032,0.40694800520109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC123,Cell division cycle protein 123 homolog,39560,0.00558522306657665,0.0067793291310425,-0.00770226203026665,0.01887270816342,0.410036621433069
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COPE,Coatomer subunit epsilon,41839,0.00411013579022222,0.00501227911182493,-0.00571393126895464,0.0139342028493991,0.412223259064225
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.00505914477386477,0.00617162023012022,-0.0171555204249004,0.00703723087717087,0.41238020328961
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00450249485286477,0.00550239844142992,-0.00628220609233787,0.0152871957980674,0.413212854467598
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMMR,Hyaluronan mediated motility receptor,39541,0.00426928126313352,0.00522140046304294,-0.00596466364443065,0.0145032261706977,0.413574526402898
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,39586,0.0103248176788584,0.012690781815433,-0.0145491146793902,0.035198750037107,0.415909941019739
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DNLZ,DNL-type zinc finger protein,39586,-0.00741134145198461,0.00912214311276298,-0.025290741953,0.0104680590490308,0.416547531590863
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD160,CD160 antigen,42296,0.00424292748377743,0.00522674062536403,-0.00600148414193606,0.0144873391094909,0.416935943179758
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.00244353933344071,0.0030150305810214,-0.00835299927224265,0.00346592060536122,0.417694234964395
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WNT9A,Protein Wnt-9a,41913,-0.00254266683236357,0.00314687035979242,-0.0087105327375567,0.00362519907282956,0.419105827416214
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.00550498646184272,0.0068354175073262,-0.00789243185251664,0.0189024047762021,0.420627896330447
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLAMF8,SLAM family member 8,41843,0.00463173402094616,0.00581776279130697,-0.00677108105001549,0.0160345490919078,0.425966900462562
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLNS1A,Methylosome subunit pICln,39649,0.00288005035744768,0.00362887907490062,-0.00423255262935754,0.00999265334425291,0.427417786862176
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.00259792594257119,0.00327941601717532,-0.00902558133623483,0.00382972945109244,0.428265530072324
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL9,Interleukin-9,39757,-0.00474879237855635,0.00606126385856433,-0.0166288695413424,0.00713128478422973,0.433370314283639
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00589794433480299,0.00754825427775862,-0.00889663404960391,0.0206925227192099,0.434604386911888
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCNA,Proliferating cell nuclear antigen,39560,0.00542413611115725,0.00696332134870475,-0.00822397373230407,0.0190722459546186,0.436021169026069
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTN2,Contactin-2,42262,0.00369663989048869,0.00474875759067156,-0.00561092498722756,0.0130042047682049,0.436321033267403
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ACTN4,Alpha-actinin-4,41913,0.00265018089408413,0.00340632157370119,-0.0040262093903702,0.00932657117853847,0.43657198646218
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYTH3,Cytohesin-3,39560,0.00612371105039499,0.00789439834466411,-0.00934930970514667,0.0215967318059366,0.437940912936418
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL19,Interleukin-19,41756,0.00613254595586145,0.007919953198746,-0.00939056231368072,0.0216556542254036,0.43875789813377
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.005761219150554,0.00750001724828704,-0.0204612529571966,0.0089388146560886,0.442408194312481
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTRC,Chymotrypsin-C,42122,0.00536795796970206,0.00705059794810843,-0.00845121400859047,0.0191871299479946,0.446462572267345
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,39757,0.0032976464695561,0.00434184623144625,-0.00521237214407855,0.0118076650831907,0.447567597183712
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK1,Kallikrein-1,42016,-0.0104108654388056,0.0137872107651261,-0.0374337985384527,0.0166120676608416,0.450196033776946
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PTTG1,Securin,39757,0.00338396902646185,0.00449227206490351,-0.00542088422074904,0.0121888222736727,0.451293513793186
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,39586,0.0061682696891271,0.00819820949497376,-0.00990022092102146,0.0222367602992757,0.451831296558028
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDIA2,Protein disulfide-isomerase A2,39560,0.00322478795718451,0.00431634076457109,-0.00523523994137483,0.0116848158557439,0.455012267464015
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.00718729388718021,0.00963138089152096,-0.0260648004345613,0.0116902126602009,0.455539689379472
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRYBB2,Beta-crystallin B2,39929,0.00556169631259745,0.00755006043197694,-0.00923642213407735,0.0203598147592722,0.461354961788117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RUVBL1,RuvB-like 1,41843,0.00786876576418842,0.0106894449645783,-0.013082546366385,0.0288200778947618,0.461667776802296
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHH,Sonic hedgehog protein,39657,-0.0033672024662822,0.00460440630541546,-0.0123918388248965,0.0056574338923321,0.464611409729175
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.00223279800434679,0.00305435452475017,-0.00375373686416356,0.00821933287285713,0.464778830027806
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAMDC2,MAM domain-containing protein 2,39958,-0.00280303552239887,0.00384152378758712,-0.0103324221460696,0.00472635110127189,0.465608424966168
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH4,Cadherin-4,39586,0.00365618453817403,0.00502418589290168,-0.00619121981191326,0.0135035888882613,0.46680246559061
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY2A,Pancreatic alpha-amylase,41665,-0.00383958569697992,0.00527667670731224,-0.0141818720433119,0.00650270064935206,0.466839524480323
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPT,Microtubule-associated protein tau,41839,0.00412440710458249,0.00570867601739376,-0.00706459788950927,0.0153134120986743,0.470011871536135
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42248,0.00323230239109618,0.00452713342760292,-0.00564087912700555,0.0121054839091979,0.475249070252522
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00465340135790882,0.0065429271052165,-0.00817073576831552,0.0174775384841332,0.476968627941841
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0127719113972623,0.0182451063006716,-0.0229884969520541,0.0485323197465787,0.483927980663926
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,0.00224190126675318,0.0032026579079941,-0.00403530823291526,0.00851911076642163,0.483933734602996
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF20,Fibroblast growth factor 20,39657,-0.00325508729121966,0.00465820056506287,-0.0123851603987429,0.00587498581630356,0.484700214529323
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.00344238846829359,0.00493276420821152,-0.00622582937980099,0.0131106063163882,0.485275477115574
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD33,Myeloid cell surface antigen CD33,42181,0.00595975246846619,0.00857129836521108,-0.0108399923273475,0.0227594972642799,0.486869801751625
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00487905432862275,0.00702004013515336,-0.00888022433627784,0.0186383329935233,0.487058713752682
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FZD10,Frizzled-10,39649,0.00447898185695637,0.00644443498401544,-0.0081521107117139,0.0171100744256266,0.487060236802551
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF174,Zinc finger protein 174,39657,0.00275735928195989,0.00396905646967332,-0.00502199139859982,0.0105367099625196,0.487249120574935
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00399155286748893,0.00579425311435596,-0.0153482889716266,0.00736518323664876,0.490912488643935
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD2,T-cell surface antigen CD2,39575,-0.00287654760277422,0.00420025441601402,-0.0111090462581617,0.00535595105261326,0.493452536977812
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL9A1,Collagen alpha-1(IX) chain,42119,-0.00328993925226615,0.00481614856094523,-0.0127295904317188,0.0061497119271865,0.494551665739524
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00532168769281864,0.00780293132343311,-0.0206154330867475,0.00997205770111026,0.495245934373363
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN15,Tetraspanin-15,39575,-0.00367712812632878,0.00542801904582028,-0.0143160454561365,0.00696178920347897,0.498144506048636
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPRR1B,Cornifin-B,39757,0.00626206784821076,0.00932653180279236,-0.0120179344852623,0.0245420701816838,0.501963639857947
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMEM132A,Transmembrane protein 132A,39638,0.00454373014719848,0.00677758553823032,-0.00874033750773295,0.0178277978021299,0.502613399835591
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ISM2,Isthmin-2,39966,0.0031358646464319,0.00468705948227543,-0.00605077193882793,0.0123225012316917,0.50347887333001
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC7A,C-type lectin domain family 7 member A,42296,-0.00429048221041036,0.00641843078193146,-0.016870606542996,0.0082896421221753,0.503849485674362
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEPTIN7,Septin-7,39757,-0.00383768437984808,0.00574351957429824,-0.0150949827454726,0.00741961398577647,0.504034803874469
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FOLR3,Folate receptor gamma,42132,-0.0138024152024859,0.02071096801489,-0.0543959125116703,0.0267910821066985,0.505147506067831
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MELTF,Melanotransferrin,39958,0.00215760359693074,0.00324831310601005,-0.00420909009084896,0.00852429728471045,0.506561212178835
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00323744824208252,0.00487447620321715,-0.00631652511622308,0.0127914216003881,0.506599643470717
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00190911883015953,0.00288038932016822,-0.00373644423737019,0.00755468189768925,0.507473305833737
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00304277522233595,0.00459910602008373,-0.0120570230217001,0.00597147257702816,0.508240566110149
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CGN,Cingulin,39649,0.00266435048850838,0.00404369643237265,-0.00526129451894202,0.0105899954959588,0.509980242013799
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL13,Interleukin-13,41913,-0.0034451942975148,0.00524741954986048,-0.0137301366152413,0.00683974802021173,0.511481534126141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FSTL1,Follistatin-related protein 1,39638,0.00163866317915034,0.00251073868807907,-0.00328238464948463,0.00655971100778532,0.513987939956531
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00348710816724443,0.00537301564528529,-0.0140182188320036,0.00704400249751474,0.516349428613009
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.0025358955970756,0.0039502939346907,-0.0102784717090694,0.00520668051491818,0.520918241694876
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OSTN,Osteocrin,39649,0.00277677237566189,0.00437131439609453,-0.00579100384068338,0.0113445485920072,0.525294210096943
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSMB,Beta-microseminoprotein,42103,-0.00477605404084335,0.00753476990386323,-0.0195442030524153,0.00999209497072859,0.526177316884065
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.00426560965626601,0.00673016754491345,-0.00892551873176435,0.0174567380442964,0.526219593610592
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00248757314933495,0.00392936099056974,-0.0101891206908516,0.00521397439218174,0.526696714417407
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NRN1,Neuritin,39934,0.0023582296805918,0.00375282084856357,-0.00499729918259279,0.00971375854377639,0.529762093066744
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERCC1,DNA excision repair protein ERCC-1,39560,0.00226710472554911,0.00360992360937374,-0.00480834554882342,0.00934255499992164,0.530003832709375
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00230011188732659,0.00366643062357255,-0.00488609213487561,0.00948631590952878,0.530446648844851
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00365113765536883,0.00582383323271905,-0.0150658507914982,0.00776357548076051,0.530717967483504
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42040,0.00191188630972356,0.00307316890078853,-0.00411152473582195,0.00793529735526908,0.533872133396968
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HMCN2,Hemicentin-2,39721,-0.0038855720345875,0.00626338305621744,-0.0161618028247737,0.00839065875559869,0.535031440227595
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCUN1D1,DCN1-like protein 1,39586,-0.00504776178510334,0.00814259008862322,-0.0210072383588048,0.0109117147885982,0.535322721711186
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPHA2,Ephrin type-A receptor 2,41614,0.0021447621610919,0.00349076594424998,-0.00469713908963807,0.00898666341182187,0.538955045827552
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ICAM2,Intercellular adhesion molecule 2,42310,-0.00216493592855205,0.00353197690965856,-0.00908761067148283,0.00475773881437873,0.539917568545639
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AKAP12,A-kinase anchor protein 12,39736,-0.00139663870916841,0.00229488334197701,-0.00589461005944335,0.00310133264110653,0.542809902558505
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD70,CD70 antigen,42119,-0.00289794273647135,0.00477451879328345,-0.0122559995713069,0.00646011409836421,0.543887538603439
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HLA_A,,39934,0.0021367818644022,0.00354172053115324,-0.00480499037665815,0.00907855410546256,0.54630958715948
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB1,Integrin beta-1,42167,0.00136450732427447,0.00227479809036413,-0.00309409693283923,0.00582311158138818,0.548625105961711
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.0110544572716226,0.0185837288318612,-0.0253696512388254,0.0474785657820705,0.551958276588127
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLXDC1,Plexin domain-containing protein 1,41843,-0.00206539887937732,0.00347899178255813,-0.00888422277319125,0.00475342501443661,0.55273802537809
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TBR1,T-box brain protein 1,39649,0.00306751672789297,0.00518301427142348,-0.00709119124409705,0.013226224699883,0.553969642429024
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARG2,"Arginase-2, mitochondrial",39919,-0.00269224304317092,0.00455423608296642,-0.0116185457657851,0.00623405967944326,0.554430786151561
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSLNL,Mesothelin-like protein,39649,-0.00241912934351712,0.00409680627174445,-0.0104488696361362,0.005610610949102,0.554873249401195
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,OMP,Olfactory marker protein,39586,-0.00303503270654258,0.00517847828887106,-0.0131848501527299,0.0071147847396447,0.557829883662262
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSPAN7,Tetraspanin-7,39586,-0.00615745164505867,0.010536344610704,-0.0268086870820385,0.0144937837919212,0.558962469998091
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL33,Interleukin-33,41913,0.00248608209660422,0.00425934046270171,-0.00586222521029114,0.0108343894034996,0.559447053298776
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PFDN6,Prefoldin subunit 6,39649,0.00406761795391535,0.00700616606800516,-0.00966446753937475,0.0177997034472055,0.561537506623161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MN1,Transcriptional activator MN1,39649,-0.00369342619447304,0.00636358221534466,-0.0161660473365486,0.00877919494760248,0.561656415485799
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.00204227619417646,0.00353068502312356,-0.00487786645114572,0.00896241883949863,0.562979256477461
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA10,Annexin A10,41839,0.00510802240097567,0.00883321760700659,-0.0122050841087572,0.0224211289107086,0.563088803850662
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC51B,Organic solute transporter subunit beta,39575,-0.00451466121376021,0.00783102479783131,-0.0198634698175096,0.0108341473899892,0.564282585169071
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,-0.00542777183294216,0.00943059647723345,-0.0239117409283197,0.0130561972624354,0.56493166920414
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGF,Beta-nerve growth factor,42016,0.000754422114341251,0.00131437961805603,-0.00182176193704856,0.00333060616573107,0.565993788668636
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00227274649409281,0.00396583749733726,-0.0100457879888738,0.00550029500068823,0.566601449523141
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,0.00179794300225096,0.00314456448337737,-0.00436540338516868,0.0079612893896706,0.567492605030786
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00385549907469465,0.00678456700592777,-0.00944225225692378,0.0171532504063131,0.569859952186161
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.00404592999914799,0.00712560015305867,-0.018012106299143,0.00992024630084701,0.570178852791153
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PCARE,Photoreceptor cilium actin regulator,39586,-0.00502828146354672,0.00899045864724896,-0.0226495804121547,0.0125930174850612,0.57597462452681
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2RG,Cytokine receptor common subunit gamma,39919,0.00214133814478608,0.00384197135656593,-0.00538892571408315,0.00967160200365531,0.577296601496836
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00329568648310905,0.00594415548954115,-0.0083548582763916,0.0149462312426097,0.579288017674436
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00295721043892089,0.00534138866470748,-0.00751191134390577,0.0134263322217475,0.579836008829724
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00367130026371794,0.00663468174113765,-0.00933267594891185,0.0166752764763477,0.580034789188926
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL31,Interleukin-31,39657,-0.00330786259882505,0.00600060019658175,-0.0150690389841253,0.00845331378647519,0.581469822127949
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00267858536408243,0.00490827456990331,-0.0122988035210929,0.00694163279292805,0.58526358901879
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLHL41,Kelch-like protein 41,39934,-0.00308456145100936,0.0056603291146686,-0.0141788065157598,0.0080096836137411,0.585802869422152
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHC1,SHC-transforming protein 1,39560,-0.00688089382502192,0.012635204389457,-0.0316458944283576,0.0178841067783137,0.586052718600935
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHGB,Secretogranin-1,42210,0.00248030319850913,0.00455970582507176,-0.00645672021863153,0.0114173266156498,0.586477061476102
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASA1,Ras GTPase-activating protein 1,41839,0.00191128841863239,0.00352195262798895,-0.00499173873222596,0.00881431556949074,0.587360227093799
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PAEP,Glycodelin,42016,-0.00612045782664416,0.011300920292565,-0.0282702616000715,0.0160293459467832,0.588110438923411
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF6,Fibroblast growth factor 6,39657,0.00228107577423288,0.00421720392379119,-0.00598464391639784,0.0105467954648636,0.588589013515532
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNR,Tenascin-R,42016,-0.00241032201667575,0.00451860599603962,-0.0112667897689134,0.00644614573556191,0.593750608749831
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.00234635452513677,0.00440255128617925,-0.00628264599577456,0.0109753550460481,0.594076573378185
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ESR1,Estrogen receptor,39657,0.00326968668791728,0.00616881661089792,-0.00882119386944264,0.0153605672452772,0.596098534798701
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00207076082519273,0.0039127088759898,-0.00559814857174728,0.00973967022213274,0.596649820356302
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.0027027561837779,0.0051137191477303,-0.0127256457133293,0.00732013334577349,0.597141919081252
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC1A4,Neutral amino acid transporter A,39649,0.0028940959069438,0.00548887831754829,-0.00786410559545084,0.0136522974093384,0.598019848393598
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DAND5,DAN domain family member 5,39657,-0.00309371581766271,0.00590258909562418,-0.0146627904450861,0.00847535880976068,0.600199596558326
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,0.00170132621822103,0.00325060888431059,-0.00466986719502772,0.00807251963146978,0.600715225511706
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.00181637193816633,0.00350175221294679,-0.00867980627554203,0.00504706239920937,0.603977806863497
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPSD1,Tryptase delta,39934,0.00204334534923837,0.00394602339211579,-0.00569086049930858,0.00977755119778532,0.604591225856349
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.00165648691869055,0.00320630726933428,-0.00462787532920464,0.00794084916658574,0.605420256498818
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA11,Carbonic anhydrase-related protein 11,41843,-0.00169522145289658,0.00329631704992883,-0.0081560028707571,0.00476555996496393,0.607066622468005
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TFF1,Trefoil factor 1,42084,0.004458399005947,0.00868212748460733,-0.0125585708638834,0.0214753688757774,0.607599831822683
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL17F,Interleukin-17F,41913,-0.00406326735926862,0.00792457004246757,-0.0195954246425051,0.0114688899239678,0.608139654004222
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00209034838280111,0.00407892324211611,-0.0100850379373487,0.00590434117174647,0.608328563448392
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TSLP,Thymic stromal lymphopoietin,41900,0.0033194739474878,0.00649611057020788,-0.00941290277011965,0.0160518506650952,0.609363694471146
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.00190943883254673,0.00374728342089558,-0.00543523667240861,0.00925411433750207,0.610373230991826
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.00139778617926157,0.00274439038424604,-0.00677679133238381,0.00398121897386067,0.610534806981007
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ABO,Histo-blood group ABO system transferase,39990,0.00785740973492858,0.0156444445252808,-0.0228057015346219,0.038520521004479,0.615501948127558
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDAC9,Histone deacetylase 9,39586,0.0036137944182211,0.00720564768417797,-0.0105092750427677,0.0177368638792099,0.616013498624062
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00380173858538599,0.00765739354014054,-0.0188102299240614,0.0112067527532895,0.619566111220357
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-0.00183197344764373,0.00371223305225696,-0.00910795023006736,0.0054440033347799,0.62167179570498
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SAT1,Diamine acetyltransferase 1,39575,-0.00257603925665978,0.00522086314360074,-0.0128089310181172,0.00765685250479768,0.621731008400986
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCL2,Phosducin-like protein 2,39560,-0.0027567163074949,0.00563964773392057,-0.0138104258659792,0.00829699325098941,0.624985985900265
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.0015006965861811,0.00307672964193548,-0.00753108668437465,0.00452969351201244,0.625731322244738
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.00300470115819899,0.00616293566758539,-0.0150840550666664,0.00907465275026837,0.625882667757183
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.00136109460359567,0.00281193994626812,-0.00687249689828118,0.00415030769108985,0.628366001890192
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42248,0.0015876913546263,0.00336386865978912,-0.00500549121856038,0.00818087392781298,0.636945931166164
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCN3B,Sodium channel subunit beta-3,39586,-0.00237444206931806,0.00503144734548546,-0.0122360788664696,0.00748719472783343,0.636993060610218
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,-0.00133434142739272,0.00283738899061517,-0.00689562384899845,0.00422694099421301,0.63817084170535
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MSLN,Mesothelin,42048,0.00293625243652919,0.00627003160541765,-0.0093530095100894,0.0152255143831478,0.639578041918568
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00198937207260046,0.00425370231725585,-0.0103266286144219,0.00634788446922099,0.640022483796972
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SUSD4,Sushi domain-containing protein 4,39919,0.00193253160334889,0.00416135343744411,-0.00622372113404157,0.0100887843407394,0.642370282546414
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CORO6,Coronin-6,39586,-0.0019369416089029,0.00421686617685065,-0.0102019993155302,0.00632811609772438,0.646004854109
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.00108210450745777,0.00237530858423091,-0.00357350031763481,0.00573770933255036,0.648712411515645
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDSN,Corneodesmosin,42246,0.00215213562129248,0.00472512777818508,-0.00710911482395027,0.0114133860665352,0.648781182277529
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH22,Cadherin-22,39757,0.00134574279502347,0.00297562961627536,-0.00448649125287623,0.00717797684292316,0.651094222306711
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,COL5A1,Collagen alpha-1(V) chain,39736,-0.00199959155303174,0.00443029659422484,-0.0106829728777124,0.00668378977164896,0.651749813683649
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRTAC1,Cartilage acidic protein 1,42310,-0.0014990384018744,0.00334045865509524,-0.00804633736586107,0.00504826056211226,0.653617466546113
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,42223,0.00307405425978151,0.00687318000465932,-0.0103973785493507,0.0165454870689138,0.654699100800595
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.00302498640397125,0.0068582015204053,-0.0104170885760231,0.0164670613839656,0.659166856341639
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CYB5A,Cytochrome b5,39560,0.00338467619419807,0.00768852481286843,-0.0116848324390241,0.0184541848274202,0.659783273210922
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ERVV_1,,39575,-0.002065465078624,0.00470374278703156,-0.0112848009412059,0.00715387078395786,0.660589772207746
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MORN4,MORN repeat-containing protein 4,39560,0.00369400920626467,0.00845310019549306,-0.0128740671769017,0.0202620855894311,0.662119578256025
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.00319692648962266,0.00737097719246708,-0.0176440417868581,0.0112501888076128,0.664501671510614
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KHDC3L,KH domain-containing protein 3,39560,-0.00313541265883776,0.00724741416717097,-0.0173403444264929,0.0110695191088174,0.665295725985729
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CASP4,Caspase-4,39757,-0.00774382722815892,0.0179162429493348,-0.0428596634088552,0.0273720089525374,0.665587091188216
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MLLT1,Protein ENL,39560,-0.0030797888646506,0.00716583815947191,-0.0171248316572155,0.0109652539279143,0.667358554358542
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLK,STE20-like serine/threonine-protein kinase,39757,-0.00366413426796084,0.008526444579775,-0.0203759656443198,0.0130476971083982,0.667394790547302
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,-0.00160057673869722,0.00372597259325607,-0.00890348302147911,0.00570232954408468,0.667514801373525
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PALLD,Palladin,39657,-0.00176743669496046,0.00411531040525411,-0.00983344508925851,0.00629857169933759,0.667583519419833
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00230235281494195,0.00536243074850627,-0.00820801145213035,0.0128127170820142,0.667677889328262
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGLON5,IgLON family member 5,39560,-0.0042867155363189,0.0100067083716691,-0.0238998639447903,0.0153264328721525,0.668379860501454
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DIPK1C,Divergent protein kinase domain 1C,39649,0.00191570180073891,0.00453938839656981,-0.00698149945653791,0.0108129030580157,0.673020381290474
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,42081,0.00121176997695639,0.00288167333893316,-0.0044363097673526,0.00685984972126538,0.674120256555717
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HEPACAM2,HEPACAM family member 2,39929,0.00197786191718585,0.00471663077821883,-0.00726673440812305,0.0112224582424947,0.674977172481819
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.00158644995015332,0.00381856204650882,-0.0090708315613106,0.00589793166100396,0.677815199091799
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.00240046611323975,0.00580482606434185,-0.00897699297287026,0.0137779251993498,0.679226750805719
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00134138192543741,0.00326548674543584,-0.00505897209561685,0.00774173594649166,0.68124381146263
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00212387271692112,0.00517984188756637,-0.00802861738270896,0.0122763628165512,0.681794341596937
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTLA,B- and T-lymphocyte attenuator,39560,0.00378960281075567,0.00925428432070513,-0.0143487944578264,0.0219280000793377,0.682182879760811
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPBGL,Trophoblast glycoprotein-like,39649,-0.00177993641147487,0.00439101658523043,-0.0103863289185265,0.00682645609557676,0.685221773451178
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTNAP4,Contactin-associated protein-like 4,39649,0.0046029664026009,0.011402451747331,-0.0177458390221679,0.0269517718273697,0.6864542687869
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0060378175506138,0.0149686689744037,-0.035376408740445,0.0233007736392174,0.686688281846401
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSAPL1,Proactivator polypeptide-like 1,39930,-0.00218178761201516,0.00542855146078129,-0.0128217484751465,0.00845817325111617,0.687758048103486
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF75D,Zinc finger protein 75D,39757,-0.00264803208550345,0.00660264848258186,-0.0155892231113639,0.010293158940357,0.688386541986947
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,0.0033376922521191,0.00833335845493049,-0.0129956903195447,0.0196710748237829,0.688779990654622
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00253340957640418,0.00640417716481482,-0.0100187776666329,0.0150855968194412,0.692417144621973
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SHD,SH2 domain-containing adapter protein D,39554,0.00352131521422166,0.00890192263198205,-0.0139264531444632,0.0209690835729065,0.69243149409003
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PADI2,Protein-arginine deiminase type-2,41913,0.00243199687377177,0.00615694263496072,-0.00963561069075124,0.0144996044382948,0.69284867288668
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POF1B,Protein POF1B,39657,0.00191281602061328,0.00490520718694726,-0.00770139006580336,0.0115270221070299,0.696576436639515
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IKZF2,Zinc finger protein Helios,41843,0.00373052461797782,0.00960108116785006,-0.0150875944710083,0.0225486437069639,0.6976134159969
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DCLRE1C,Protein artemis,39560,-0.00126674495380939,0.00328800354046,-0.00771123189311098,0.00517774198549221,0.700050307943455
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PITHD1,PITH domain-containing protein 1,39539,-0.00318232088942329,0.00834104271080849,-0.0195307646026079,0.0131661228237614,0.702820728013464
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,0.00482220462468615,0.0128189161443248,-0.0203028710181904,0.0299472802675628,0.706789862564976
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,39919,0.00215562935143729,0.00580099155537812,-0.00921431409710383,0.0135255727999784,0.71020009775289
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.00222148259551057,0.00597960619577478,-0.0139415107392291,0.00949854554820801,0.710264993162869
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.00193611593614892,0.00522101477348929,-0.00829707301989009,0.0121693048921879,0.710770309781514
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.00167523410213621,0.00460779161186805,-0.0107065056613976,0.00735603745712517,0.716189437335367
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SOX2,Transcription factor SOX-2,39915,0.000959357801745587,0.00264953349495338,-0.00423372784836304,0.00615244345185422,0.717294860814912
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NEFL,Neurofilament light polypeptide,41797,0.00183384733108876,0.00511255979624898,-0.00818676986955924,0.0118544645317368,0.719829344426136
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPEP2,Dipeptidase 2,42070,-0.00115644958819538,0.00324550588188426,-0.00751764111668853,0.00520474194029778,0.721603991546175
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GJA8,Gap junction alpha-8 protein,39560,-0.00236735498590807,0.00673983657778689,-0.0155774346783704,0.0108427247065542,0.725408957628226
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,0.00555381947254213,0.0158466992504946,-0.0255057110584272,0.0366133500035115,0.72599146772157
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00100425285482788,0.00287154282125603,-0.00462397107483393,0.00663247678448969,0.726551156733817
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NCLN,Nicalin,41913,0.00192304068684872,0.00552969481385584,-0.00891516114830872,0.0127612425220062,0.728021309667889
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DEFB116,Beta-defensin 116,39586,0.00281651040223831,0.00810880424699043,-0.0130767459218629,0.0187097667263396,0.728342711376656
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PSCA,Prostate stem cell antigen,39930,0.00973056228306666,0.0280559839399123,-0.0452591662391614,0.0647202908052947,0.728728012923166
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB5,Integrin beta-5,42181,0.00141774894110288,0.00414520057761743,-0.00670684419102728,0.00954234207323305,0.732339782711056
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTF,Ciliary neurotrophic factor,39586,-0.0012720071339147,0.00373185780189631,-0.00858644842563146,0.00604243415780206,0.733222338844559
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NMI,N-myc-interactor,39875,-0.00266210722205226,0.0078716056088136,-0.0180904542153269,0.0127662397712224,0.735225453930327
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAP1,Antigen peptide transporter 1,39757,0.00212284312304662,0.00629781982625217,-0.0102208837364076,0.0144665699825009,0.736066044366658
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RRP15,RRP15-like protein,39586,0.00331067499918996,0.00984907389329641,-0.015993509831671,0.0226148598300509,0.736771156623268
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAGEA3,Melanoma-associated antigen 3,39757,0.00310249966960728,0.00930166697684295,-0.0151287676050049,0.0213337669442195,0.738731210783052
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.0023118995949514,0.0069333399784616,-0.0112774467628333,0.0159012459527361,0.738803467135442
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PODXL2,Podocalyxin-like protein 2,42181,0.00102317112927363,0.0030820107788636,-0.00501756999729902,0.00706391225584628,0.739908212375441
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-0.00129943995876157,0.00396377110089469,-0.00906843131651516,0.00646955139899203,0.743047009881366
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20,Interleukin-20,41913,-0.0016502797860487,0.00503781707144852,-0.0115244012460878,0.00822384167399041,0.743235647235513
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00142431386206058,0.00435043724163856,-0.007102543131551,0.00995117085567216,0.743374957959173
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,JUN,Transcription factor AP-1,41913,0.00170331976474977,0.00521315293521587,-0.00851445998827333,0.0119210995177729,0.743873427270987
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LHB,Lutropin subunit beta,41843,-0.00306271116363235,0.00955642993494003,-0.0217933138361148,0.0156678915088501,0.748604271675115
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDC25A,M-phase inducer phosphatase 1,39560,-0.00138376216160039,0.00432617226741493,-0.00986305980573365,0.00709553548253287,0.749081837565299
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00222243455031536,0.00709276572902785,-0.01612425537921,0.0116793862785792,0.754029577027227
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL21R,Interleukin-21 receptor,39657,-0.00183002464294131,0.00584369600744919,-0.0132836688175417,0.0096236195316591,0.754163348846981
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.000916499228717868,0.0029383299459096,-0.00667562592270069,0.00484262746526495,0.755112473216997
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NPTN,Neuroplastin,41843,0.00263755544696612,0.00845827432200947,-0.0139406622241724,0.0192157731181047,0.755173575199866
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RLN1,Prorelaxin H1,39934,0.00148095388871783,0.004782484184851,-0.00789271511359014,0.0108546228910258,0.75682365250829
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.0012758096804645,0.00412458868647455,-0.00936000350595461,0.00680838414502561,0.757085482860326
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TCP11,T-complex protein 11 homolog,39757,-0.00192101437803063,0.00624348102861912,-0.0141582371941241,0.0103162084380629,0.758329128667741
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.00113013064011282,0.00369352578314128,-0.00836944117506973,0.00610917989484409,0.759627566368073
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLEC2L,C-type lectin domain family 2 member L,39649,0.00168689975489513,0.00553234786465176,-0.00915650205982232,0.0125303015696126,0.760436096568953
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UPK3A,Uroplakin-3a,39586,-0.00159159635968296,0.00523185785312261,-0.0118460377518033,0.00866284503243736,0.760971792770245
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNTNAP2,Contactin-associated protein-like 2,42119,-0.00140738552368621,0.00463634417280174,-0.0104946201023776,0.00767984905500519,0.761471599541361
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LMOD2,Leiomodin-2,39586,0.00201072022706596,0.00664102168091729,-0.0110056822675319,0.0150271227216638,0.76206880353863
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.00157280423263692,0.00520656293020933,-0.00863205911057337,0.0117776675758472,0.762595975316444
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL3,Interleukin-3,39560,0.00198220844151634,0.00661438925772638,-0.0109819945036274,0.01494641138666,0.76442598481706
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.0014100672283701,0.00472709642970581,-0.0106751762305935,0.0078550417738533,0.765483813196447
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PRTN3,Myeloblastin,41800,-0.00153805520804864,0.00519577978013148,-0.0117217835771063,0.00864567316100907,0.767219394211171
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MAG,Myelin-associated glycoprotein,39649,0.00154883056827176,0.00525586401073524,-0.00875266289276932,0.0118503240293128,0.768239146010687
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42185,0.000906096333772413,0.00309746077489214,-0.00516492678501619,0.00697711945256101,0.769886847602235
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP53BP1,TP53-binding protein 1,39657,-0.00266067368821404,0.00928135497958809,-0.0208521294482067,0.0155307820717786,0.774371400049512
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZNF830,Zinc finger protein 830,39919,0.00239423184445704,0.00838192056102594,-0.0140343324551538,0.0188227961440679,0.775157257703304
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HYAL1,Hyaluronidase-1,42077,-0.000704730286516026,0.00248928037317384,-0.00558371981793676,0.00417425924490471,0.777099906785503
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.00148120096885018,0.00525251803420689,-0.00881373437819533,0.0117761363158957,0.777949138726931
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.0016370880729754,0.00581353934128431,-0.0130316251818926,0.00975744903594184,0.778256151542896
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ANXA5,Annexin A5,41780,0.000904200744918117,0.00328421061897805,-0.00553285206827887,0.0073412535581151,0.783076616050467
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,-0.00223388415098721,0.00816400042227891,-0.0182353249786539,0.0137675566766795,0.784376914618158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.00117206539690723,0.00437072616369411,-0.00739455788393322,0.00973868867774769,0.788579149393502
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00196472239486486,0.0073672388497935,-0.0164045105404601,0.0124750657507304,0.789717646182639
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.000858277833431543,0.00322420041304641,-0.00546115497613942,0.00717771064300251,0.790091177554046
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EFNB2,Ephrin-B2,39649,-0.00165527930498398,0.0062501284319389,-0.0139055310315842,0.0105949724216163,0.791138241840582
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAGE2A,G antigen 2A,39560,-0.00186652030152034,0.00705872860278062,-0.0157016283629704,0.0119685877599297,0.791455676333373
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL11,Interleukin-11,41913,-0.00173391576567486,0.00657827979445755,-0.0146273441628117,0.0111595126314619,0.792106153926318
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GSTM4,Glutathione S-transferase Mu 4,39575,-0.0020135344262827,0.0080654398578362,-0.0178217965476416,0.0137947276950762,0.802862952990324
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CADPS,Calcium-dependent secretion activator 1,39649,-0.00109528863844856,0.00440737433922835,-0.00973374234333614,0.00754316506643901,0.80374233886997
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DLGAP5,Disks large-associated protein 5,39934,0.00131924977447131,0.00533270719502351,-0.00913285632777477,0.0117713558767174,0.804612150054367
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.00124355311723998,0.00503157630095286,-0.00861833643262763,0.0111054426671076,0.80479691070057
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PI16,Peptidase inhibitor 16,39990,0.000614178224497099,0.00260539505136356,-0.00449239607617548,0.00572075252516968,0.813643910928502
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SCIN,Adseverin,39586,0.00183485960654855,0.00796931142849951,-0.0137849907933105,0.0174547100064076,0.817909047030273
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBZ,Hemoglobin subunit zeta,39958,0.00264117489723482,0.0115969788814819,-0.0200889037104698,0.0253712535049394,0.819847182131486
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LPO,Lactoperoxidase,41647,0.00149426470028868,0.0066441458027651,-0.0115282610731309,0.0145167904737083,0.822061023523579
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PXDNL,Peroxidasin-like protein,39919,-0.00138819479455377,0.00617939579402038,-0.0134998105508337,0.0107234209617262,0.822256434232437
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KDM3A,Lysine-specific demethylase 3A,39657,-0.00210104746096024,0.00956986370086587,-0.0208579803146574,0.0166558853927369,0.826226999688566
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,-0.0011402313344265,0.00522525303707063,-0.0113817272870849,0.00910126461823194,0.827265252075634
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.00096176529135371,0.00455323749270906,-0.00796258019435604,0.00988611077706346,0.832714241613816
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HBQ1,Hemoglobin subunit theta-1,42262,-0.0013861052092243,0.00663329546596008,-0.014387364322506,0.0116151539040575,0.83448119262281
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL2,Interleukin-2,41913,-0.00071614903264769,0.00345318697989732,-0.00748439551324643,0.00605209744795105,0.835710140539318
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CBLN1,Cerebellin-1,39586,-0.00203144672531424,0.0100066589759377,-0.0216444983181521,0.0175816048675236,0.839131375097552
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00082889866455747,0.00413469539681832,-0.00727510431320644,0.00893290164232138,0.841113549184846
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CA3,Carbonic anhydrase 3,42287,-0.0012601947513688,0.00634279235358263,-0.0136920677643908,0.0111716782616532,0.84251493957356
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TXK,Tyrosine-protein kinase TXK,39757,-0.00155096429110667,0.00790453284873856,-0.0170438486746342,0.0139419200924209,0.844447800433284
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,0.00165314176232,0.0084602367489384,-0.0149289222655993,0.0182352057902393,0.845081750186066
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDAN1,Codanin-1,39929,0.000454810850625113,0.00236004355191437,-0.00417087451112704,0.00508049621237727,0.847187269928362
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TNXB,Tenascin-X,42137,-0.000541340717810073,0.00282104614495379,-0.0060705911619195,0.00498790972629936,0.847828424153827
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF3,Fibroblast growth factor 3,39657,0.000612633395784682,0.00319704863642916,-0.00565358193161647,0.00687884872318584,0.848039733975013
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,UNC5D,Netrin receptor UNC5D,39657,-0.000536326939632538,0.00281839102920822,-0.00606037335688066,0.00498771947761558,0.849081126083521
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGB7,Integrin beta-7,42262,0.000928348585826843,0.00497744867118819,-0.00882745080970201,0.0106841479813557,0.852046876787827
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,-0.000863675925874102,0.00496048616383522,-0.0105862288069911,0.00885887695524294,0.861781224124419
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ZPR1,Zinc finger protein ZPR1,39586,-0.00177081514862452,0.0104076481634224,-0.0221698055489325,0.0186281752516834,0.864898795390359
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00142078427978066,0.00864274556380027,-0.0183605655848292,0.0155189970252679,0.869426809380697
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,0.00042149300883687,0.00260646620126399,-0.00468718074564054,0.00553016676331428,0.87153670105079
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00118925293590002,0.0073647518495207,-0.0156241665609606,0.0132456606891606,0.871719103851478
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,-0.00087898447608606,0.00548127618198141,-0.0116222857927696,0.00986431684059749,0.872599438568388
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,0.000510788113283627,0.00323882206880048,-0.00583730314156531,0.00685887936813257,0.874689714840499
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,HK2,Hexokinase-2,41900,0.000453117869917742,0.00294444599986262,-0.00531799628981299,0.00622423202964847,0.877699587133692
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.00272336491008865,0.0179318860015517,-0.0378698614731299,0.0324231316529526,0.879290002285297
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TAGLN3,Transgelin-3,39560,0.000957614360477299,0.00648172578460083,-0.0117465681773403,0.0136617968982949,0.882550169729144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CEP350,Centrosome-associated protein 350,39560,0.000555067139641561,0.00394803865386345,-0.00718308862193081,0.00829322290121393,0.88819395387483
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ENO1,Alpha-enolase,42119,-0.00118638475860859,0.00848604200105434,-0.0178190270806751,0.0154462575634579,0.888816735930305
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,39657,0.000489146808488368,0.00350795946048678,-0.00638645373406572,0.00736474735104246,0.889105694214597
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LCN15,Lipocalin-15,39934,-0.000894209228288411,0.00654482381113665,-0.0137220638981162,0.0119336454415394,0.89132690267786
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRX,Cone-rod homeobox protein,41900,0.00154852706227473,0.0115998376937326,-0.0211871548174412,0.0242842089419906,0.893803479264144
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TET2,Methylcytosine dioxygenase TET2,39750,-0.00139711288639822,0.0108445379987996,-0.0226524073640454,0.019858181591249,0.897493683666832
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRP2BP,LRP2-binding protein,39649,-0.00106481500911483,0.00839488018313633,-0.017518780168062,0.0153891501498324,0.899068551448597
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PYDC1,Pyrin domain-containing protein 1,39638,0.000545132704024887,0.00445434690041655,-0.00818538722079155,0.00927565262884132,0.90259857514416
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TGFBR1,TGF-beta receptor type-1,39657,0.000289331119562594,0.00237276023223304,-0.00436127893561416,0.00493994117473935,0.90294984169025
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GAD1,Glutamate decarboxylase 1,39560,0.000343573165932391,0.00284432426071772,-0.00523130238507435,0.00591844871693913,0.903857569438742
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMP15,Matrix metalloproteinase-15,39958,0.000624834287954323,0.00525279305145594,-0.00967064009289931,0.010920308668808,0.90531487712374
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CDH17,Cadherin-17,42145,-0.000873259452260342,0.00735750630050197,-0.0152939718012442,0.0135474528967235,0.905523039320413
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LGALS4,Galectin-4,42123,0.000720231392063611,0.00608797896568956,-0.0112122073806879,0.0126526701648151,0.905828658647593
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,41839,-0.000689222927486921,0.00584261166258271,-0.012140741786149,0.0107622959311752,0.906097282445529
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.000815379375305568,0.00705086848015457,-0.0146350815964085,0.0130043228457974,0.90793803666425
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.000606801939716247,0.0052763280618434,-0.00973480106149682,0.0109484049409293,0.908443586523837
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,-0.000305107236460623,0.0027711201335787,-0.00573650269827488,0.00512628822535363,0.912330040015904
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,NLGN1,Neuroligin-1,39649,-0.000779052810139889,0.00725740892390286,-0.0150035743009895,0.0134454686807097,0.914516551823557
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TP73,Tumor protein p73,39649,0.000390924878688274,0.00370241051933685,-0.00686579973921195,0.0076476494965885,0.915912286495981
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.000680578018920232,0.00652410689345172,-0.0121066714922451,0.0134678275300856,0.916919031953075
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.000645458411493802,0.00624628272769093,-0.012888172557768,0.0115972557347804,0.917698778561581
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42070,0.000346800518426697,0.00342052071622657,-0.00635742008537737,0.00705102112223077,0.919243793743219
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KLK12,Kallikrein-12,41843,0.00141059632590881,0.0144092737607881,-0.0268315802452358,0.0296527728970535,0.922017125911458
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL25,Interleukin-25,39510,-0.000358205804207485,0.00371117996193409,-0.0076321185295983,0.00691570692118333,0.923108782398117
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,INSL4,Early placenta insulin-like peptide,39919,0.000478508898523773,0.00519835483563119,-0.00971026657931337,0.0106672843763609,0.926659891572516
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,-0.000410657361611117,0.00446630521623161,-0.00916461558542507,0.00834330086220283,0.926742893510415
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FGF12,Fibroblast growth factor 12,39657,-0.000448857758943214,0.00489326874393069,-0.0100396644970474,0.00914194897916093,0.926914512544358
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.000442500894182266,0.00489376523931541,-0.0100342807632405,0.00914927897487594,0.92795403412958
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EPGN,Epigen,39919,-0.000409947617799344,0.00500120577953791,-0.0102123109456936,0.00939241571009496,0.934672212999277
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SEZ6,Seizure protein 6 homolog,39649,0.000271274454820542,0.00338309309845115,-0.00635958801814372,0.00690213692778481,0.936091305478129
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,0.00028378148430132,0.00354036255154252,-0.00665532911672203,0.00722289208532467,0.936114604654158
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RANGAP1,Ran GTPase-activating protein 1,41843,0.000413841528618321,0.00520112193157131,-0.00978035745726145,0.0106080405144981,0.936582254143574
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,EVPL,Envoplakin,39757,-0.000285264020481636,0.00360458365841882,-0.00735024799098253,0.00677971995001926,0.936923289618811
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,0.000251663654133382,0.00326739796634956,-0.00615243635991175,0.00665576366817852,0.938606881091585
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.000445104985055767,0.00696011643750008,-0.0140869332025559,0.0131967232324444,0.949010562684613
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRNN,Cornulin,41749,-0.000445475235372229,0.00727041958881995,-0.0146954976294593,0.0138045471587149,0.951143292358375
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,39657,0.000267701492870285,0.00452470780908594,-0.00860072581293816,0.00913612879867873,0.952822256679593
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,FAM171A2,Protein FAM171A2,39934,-0.000992796656088493,0.0168546538364027,-0.0340279181754378,0.0320423248632609,0.953030077083555
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,0.000321886743702979,0.0063535644243787,-0.0121310995280793,0.0127748730154852,0.959595469499553
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.000284378152960596,0.00584753245445934,-0.0117455417637009,0.0111767854577797,0.961213316074204
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,0.000180696217132091,0.00401076274725698,-0.00768039876749159,0.00804179120175577,0.964066004733399
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.000237874248689096,0.00545257940268465,-0.010924929877951,0.0104491813805728,0.96520331719448
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CRISP2,Cysteine-rich secretory protein 2,42262,-0.000245153835486028,0.00572933253561557,-0.0114746456052926,0.0109843379343205,0.965870159640648
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42137,0.000134358596143104,0.00455602449127545,-0.00879544940675677,0.00906416659904298,0.976473978045362
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CHIT1,Chitotriosidase-1,42207,0.000493234764734932,0.0169056483596857,-0.0326418360202491,0.033628305549719,0.976724859263346
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,0.000158496392139602,0.00557733718894432,-0.0107730844981913,0.0110900772824705,0.97732935005883
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,9.77738110520906e-05,0.00362373197522608,-0.00700474086039102,0.0072002884824952,0.978474961659107
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IL10,Interleukin-10,41913,0.000197889935980946,0.00830437168665309,-0.0160786785698591,0.016474458441821,0.980988878778922
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.000112352225284173,0.00475173483771553,-0.00920104805663827,0.00942575250720662,0.981136635020969
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,IFNL2,Interferon lambda-2,39586,0.000145255162195245,0.00632190277248589,-0.0122456742718771,0.0125361845962676,0.981669440220016
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,CLINT1,Clathrin interactor 1,39560,0.000116629245094393,0.00539743564916409,-0.0104623446272672,0.010695603117456,0.982760830177302
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,ITGAX,Integrin alpha-X,39757,-0.000116074558124555,0.00557489961965863,-0.0110428778126555,0.0108107286964064,0.983388879195381
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",39575,-4.30775099164892e-05,0.00435784165639101,-0.00858444715644286,0.00849829213660988,0.992113174346691
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,TPT1,Translationally-controlled tumor protein,41913,-3.96142178140205e-05,0.00691801667776256,-0.0135989269062286,0.0135196984706006,0.995431232971898
NMR metabolomics,X23489.Total Lipids in Very Large VLDL,SKIV2L,Helicase SKI2W,39575,-6.71830589539543e-06,0.00427149035573848,-0.00837883940314282,0.00836540279135202,0.998745096491412
